{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 1,
   "id": "1f3d4e46",
   "metadata": {},
   "outputs": [],
   "source": [
    "import pandas as pd\n",
    "import os\n",
    "import csv\n",
    "import re\n",
    "from groq import Groq\n",
    "import time"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "id": "2e23dd74",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "True"
      ]
     },
     "execution_count": 2,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "from dotenv import load_dotenv\n",
    "load_dotenv(override=True)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "id": "67c4b19a",
   "metadata": {},
   "outputs": [],
   "source": [
    "def safe_filename(text, max_length=40):\n",
    "    filename = re.sub(r'[^a-zA-Z0-9_-]', '_', text)\n",
    "    filename = filename[:max_length].rstrip('_')\n",
    "    return filename\n",
    "\n",
    "def parse_markdown_table(markdown_text):\n",
    "    lines = markdown_text.strip().splitlines()\n",
    "    table_lines = [line for line in lines if \"|\" in line]\n",
    "    if len(table_lines) > 1 and \"---\" in table_lines[1]:\n",
    "        table_lines.pop(1)\n",
    "    table = [ [cell.strip() for cell in row.split(\"|\")[1:-1]] for row in table_lines]\n",
    "    return table"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "id": "67b42cc7",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Question</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>What are the approved drugs for triple-negativ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>List all ALK inhibitors used for treating non-...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>What is the mechanism of action of nivolumab?</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>Drugs with approval status for hepatitis C vir...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>Biomarkers associated with the PI3KAKT pathwa...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>95</th>\n",
       "      <td>What are the approved drugs for EGFR exon 20 i...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>96</th>\n",
       "      <td>List all TRK inhibitors used for treating NTRK...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>97</th>\n",
       "      <td>What is the mechanism of action of darolutamide?</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>98</th>\n",
       "      <td>Which genes are targeted by monoclonal antibod...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>99</th>\n",
       "      <td>What drugs are used to treat fever?</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>100 rows × 1 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "                                             Question\n",
       "0   What are the approved drugs for triple-negativ...\n",
       "1   List all ALK inhibitors used for treating non-...\n",
       "2       What is the mechanism of action of nivolumab?\n",
       "3   Drugs with approval status for hepatitis C vir...\n",
       "4   Biomarkers associated with the PI3KAKT pathwa...\n",
       "..                                                ...\n",
       "95  What are the approved drugs for EGFR exon 20 i...\n",
       "96  List all TRK inhibitors used for treating NTRK...\n",
       "97   What is the mechanism of action of darolutamide?\n",
       "98  Which genes are targeted by monoclonal antibod...\n",
       "99                What drugs are used to treat fever?\n",
       "\n",
       "[100 rows x 1 columns]"
      ]
     },
     "execution_count": 4,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df = pd.read_csv(\"../in_scope_benchmark_questions.csv\")\n",
    "df"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "id": "c20e71bb",
   "metadata": {},
   "outputs": [],
   "source": [
    "system_prompt = (\n",
    "    \"Return the results in a table. For each entry, include a citation of the source within the table. \"\n",
    "    \"Each answer row should contain only a single atomic fact per cellno multiple values, no commas, \"\n",
    "    \"no slashes (/), and no other separators within any cell. \"\n",
    "    \"Return only unique rows; do not include duplicate entries in the table.\"\n",
    ")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "id": "9547db45",
   "metadata": {},
   "outputs": [],
   "source": [
    "models = [\"llama-3.3-70b-versatile\"]\n",
    "trial_numbers = [0, 1, 2, 3, 4, 5, 6, 7, 8, 9]\n",
    "root_folder = \"result\""
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "id": "a3c0b2cd",
   "metadata": {},
   "outputs": [],
   "source": [
    "groq_api_key = os.getenv(\"GROQ_API_KEY\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "id": "da3fa71b",
   "metadata": {},
   "outputs": [],
   "source": [
    "client = Groq(api_key=groq_api_key)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "id": "b1a45a23",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Processing: What are the approved drugs for triple-negative breast cancer? | Model: llama-3.3-70b-versatile | Trial: 0\n",
      "Saved to result/llama-3_3-70b-versatile/trial_0/what_are_the_approved_drugs_for_triple-n.xlsx\n",
      "Processing: List all ALK inhibitors used for treating non-small cell lung cancer. | Model: llama-3.3-70b-versatile | Trial: 0\n",
      "Saved to result/llama-3_3-70b-versatile/trial_0/list_all_alk_inhibitors_used_for_treatin.xlsx\n",
      "Processing: What is the mechanism of action of nivolumab? | Model: llama-3.3-70b-versatile | Trial: 0\n",
      "Saved to result/llama-3_3-70b-versatile/trial_0/what_is_the_mechanism_of_action_of_nivol.xlsx\n",
      "Processing: Drugs with approval status for hepatitis C virus infection. | Model: llama-3.3-70b-versatile | Trial: 0\n",
      "Saved to result/llama-3_3-70b-versatile/trial_0/drugs_with_approval_status_for_hepatitis.xlsx\n",
      "Processing: Biomarkers associated with the PI3KAKT pathway in breast cancer. | Model: llama-3.3-70b-versatile | Trial: 0\n",
      "Saved to result/llama-3_3-70b-versatile/trial_0/biomarkers_associated_with_the_pi3k_akt.xlsx\n",
      "Processing: Show drugs that inhibit the KRAS G12C variant. | Model: llama-3.3-70b-versatile | Trial: 0\n",
      "Saved to result/llama-3_3-70b-versatile/trial_0/show_drugs_that_inhibit_the_kras_g12c_va.xlsx\n",
      "Processing: What diseases are treated with atezolizumab? | Model: llama-3.3-70b-versatile | Trial: 0\n",
      "Saved to result/llama-3_3-70b-versatile/trial_0/what_diseases_are_treated_with_atezolizu.xlsx\n",
      "Processing: Which pathways are targeted by PARP inhibitors? | Model: llama-3.3-70b-versatile | Trial: 0\n",
      "Saved to result/llama-3_3-70b-versatile/trial_0/which_pathways_are_targeted_by_parp_inhi.xlsx\n",
      "Processing: Approved drugs for multiple sclerosis and their mechanisms of action. | Model: llama-3.3-70b-versatile | Trial: 0\n",
      "Saved to result/llama-3_3-70b-versatile/trial_0/approved_drugs_for_multiple_sclerosis_an.xlsx\n",
      "Processing: What are the known targets of sunitinib? | Model: llama-3.3-70b-versatile | Trial: 0\n",
      "Saved to result/llama-3_3-70b-versatile/trial_0/what_are_the_known_targets_of_sunitinib.xlsx\n",
      "Processing: Provide the SMILES for dasatinib. | Model: llama-3.3-70b-versatile | Trial: 0\n",
      "----- Some error occured-----\n",
      "Processing: Provide the SMILES for dasatinib. | Model: llama-3.3-70b-versatile | Trial: 0\n",
      "Processing: Genes linked to amyotrophic lateral sclerosis. | Model: llama-3.3-70b-versatile | Trial: 0\n",
      "Saved to result/llama-3_3-70b-versatile/trial_0/genes_linked_to_amyotrophic_lateral_scle.xlsx\n",
      "Processing: List of drugs and approval status for malaria. | Model: llama-3.3-70b-versatile | Trial: 0\n",
      "Saved to result/llama-3_3-70b-versatile/trial_0/list_of_drugs_and_approval_status_for_ma.xlsx\n",
      "Processing: What drugs target the JAKSTAT pathway in myelofibrosis? | Model: llama-3.3-70b-versatile | Trial: 0\n",
      "Saved to result/llama-3_3-70b-versatile/trial_0/what_drugs_target_the_jak_stat_pathway_i.xlsx\n",
      "Processing: Diseases associated with the gene BRCA1. | Model: llama-3.3-70b-versatile | Trial: 0\n",
      "Saved to result/llama-3_3-70b-versatile/trial_0/diseases_associated_with_the_gene_brca1.xlsx\n",
      "Processing: Biomarkers for early detection of pancreatic cancer. | Model: llama-3.3-70b-versatile | Trial: 0\n",
      "Saved to result/llama-3_3-70b-versatile/trial_0/biomarkers_for_early_detection_of_pancre.xlsx\n",
      "Processing: Which drugs act as VEGF inhibitors? | Model: llama-3.3-70b-versatile | Trial: 0\n",
      "Saved to result/llama-3_3-70b-versatile/trial_0/which_drugs_act_as_vegf_inhibitors.xlsx\n",
      "Processing: Drugs for chronic hepatitis B and their approval status. | Model: llama-3.3-70b-versatile | Trial: 0\n",
      "Saved to result/llama-3_3-70b-versatile/trial_0/drugs_for_chronic_hepatitis_b_and_their.xlsx\n",
      "Processing: What are the mechanisms of action for beta-lactam antibiotics? | Model: llama-3.3-70b-versatile | Trial: 0\n",
      "Saved to result/llama-3_3-70b-versatile/trial_0/what_are_the_mechanisms_of_action_for_be.xlsx\n",
      "Processing: Which approved drugs are used for treating rheumatoid arthritis? | Model: llama-3.3-70b-versatile | Trial: 0\n",
      "Saved to result/llama-3_3-70b-versatile/trial_0/which_approved_drugs_are_used_for_treati.xlsx\n",
      "Processing: What are the targets and mechanisms for dulaglutide? | Model: llama-3.3-70b-versatile | Trial: 0\n",
      "Saved to result/llama-3_3-70b-versatile/trial_0/what_are_the_targets_and_mechanisms_for.xlsx\n",
      "Processing: Provide drugs approved for ovarian cancer with their target names. | Model: llama-3.3-70b-versatile | Trial: 0\n",
      "Saved to result/llama-3_3-70b-versatile/trial_0/provide_drugs_approved_for_ovarian_cance.xlsx\n",
      "Processing: List pathways implicated in chronic lymphocytic leukemia. | Model: llama-3.3-70b-versatile | Trial: 0\n",
      "Saved to result/llama-3_3-70b-versatile/trial_0/list_pathways_implicated_in_chronic_lymp.xlsx\n",
      "Processing: What are the approved drugs for HER2-low breast cancer? | Model: llama-3.3-70b-versatile | Trial: 0\n",
      "Saved to result/llama-3_3-70b-versatile/trial_0/what_are_the_approved_drugs_for_her2-low.xlsx\n",
      "Processing: List all BTK inhibitors used for treating mantle cell lymphoma. | Model: llama-3.3-70b-versatile | Trial: 0\n",
      "Saved to result/llama-3_3-70b-versatile/trial_0/list_all_btk_inhibitors_used_for_treatin.xlsx\n",
      "Processing: What is the mechanism of action of pembrolizumab? | Model: llama-3.3-70b-versatile | Trial: 0\n",
      "Saved to result/llama-3_3-70b-versatile/trial_0/what_is_the_mechanism_of_action_of_pembr.xlsx\n",
      "Processing: Which genes are targeted by monoclonal antibodies in psoriasis? | Model: llama-3.3-70b-versatile | Trial: 0\n",
      "Saved to result/llama-3_3-70b-versatile/trial_0/which_genes_are_targeted_by_monoclonal_a.xlsx\n",
      "Processing: Drugs with approval status for HIV/AIDS. | Model: llama-3.3-70b-versatile | Trial: 0\n",
      "Saved to result/llama-3_3-70b-versatile/trial_0/drugs_with_approval_status_for_hiv_aids.xlsx\n",
      "Processing: Biomarkers associated with the RASRAFMEK pathway in colorectal cancer. | Model: llama-3.3-70b-versatile | Trial: 0\n",
      "Saved to result/llama-3_3-70b-versatile/trial_0/biomarkers_associated_with_the_ras_raf_m.xlsx\n",
      "Processing: Show drugs that inhibit the IDH1 gene. | Model: llama-3.3-70b-versatile | Trial: 0\n",
      "Saved to result/llama-3_3-70b-versatile/trial_0/show_drugs_that_inhibit_the_idh1_gene.xlsx\n",
      "Processing: What diseases are treated with durvalumab? | Model: llama-3.3-70b-versatile | Trial: 0\n",
      "Saved to result/llama-3_3-70b-versatile/trial_0/what_diseases_are_treated_with_durvaluma.xlsx\n",
      "Processing: Which pathways are targeted by MEK inhibitors? | Model: llama-3.3-70b-versatile | Trial: 0\n",
      "Saved to result/llama-3_3-70b-versatile/trial_0/which_pathways_are_targeted_by_mek_inhib.xlsx\n",
      "Processing: Approved drugs for ulcerative colitis and their mechanisms of action. | Model: llama-3.3-70b-versatile | Trial: 0\n",
      "Saved to result/llama-3_3-70b-versatile/trial_0/approved_drugs_for_ulcerative_colitis_an.xlsx\n",
      "Processing: What are the known targets of regorafenib? | Model: llama-3.3-70b-versatile | Trial: 0\n",
      "Saved to result/llama-3_3-70b-versatile/trial_0/what_are_the_known_targets_of_regorafeni.xlsx\n",
      "Processing: Provide the SMILES for erlotinib. | Model: llama-3.3-70b-versatile | Trial: 0\n",
      "----- Some error occured-----\n",
      "Processing: Provide the SMILES for erlotinib. | Model: llama-3.3-70b-versatile | Trial: 0\n",
      "Processing: Genes linked to Parkinsons disease. | Model: llama-3.3-70b-versatile | Trial: 0\n",
      "Saved to result/llama-3_3-70b-versatile/trial_0/genes_linked_to_parkinson_s_disease.xlsx\n",
      "Processing: List of drugs and approval status for influenza. | Model: llama-3.3-70b-versatile | Trial: 0\n",
      "Saved to result/llama-3_3-70b-versatile/trial_0/list_of_drugs_and_approval_status_for_in.xlsx\n",
      "Processing: What drugs target the PI3K pathway in lymphoma? | Model: llama-3.3-70b-versatile | Trial: 0\n",
      "Saved to result/llama-3_3-70b-versatile/trial_0/what_drugs_target_the_pi3k_pathway_in_ly.xlsx\n",
      "Processing: Diseases associated with the gene PIK3CA. | Model: llama-3.3-70b-versatile | Trial: 0\n",
      "Saved to result/llama-3_3-70b-versatile/trial_0/diseases_associated_with_the_gene_pik3ca.xlsx\n",
      "Processing: Biomarkers for early detection of gastric cancer. | Model: llama-3.3-70b-versatile | Trial: 0\n",
      "Saved to result/llama-3_3-70b-versatile/trial_0/biomarkers_for_early_detection_of_gastri.xlsx\n",
      "Processing: Which drugs act as PD-1 inhibitors? | Model: llama-3.3-70b-versatile | Trial: 0\n",
      "Saved to result/llama-3_3-70b-versatile/trial_0/which_drugs_act_as_pd-1_inhibitors.xlsx\n",
      "Processing: Drugs for hepatitis D and their approval status. | Model: llama-3.3-70b-versatile | Trial: 0\n",
      "Saved to result/llama-3_3-70b-versatile/trial_0/drugs_for_hepatitis_d_and_their_approval.xlsx\n",
      "Processing: What are the mechanisms of action for SGLT2 inhibitors? | Model: llama-3.3-70b-versatile | Trial: 0\n",
      "Saved to result/llama-3_3-70b-versatile/trial_0/what_are_the_mechanisms_of_action_for_sg.xlsx\n",
      "Processing: Which approved drugs are used for treating systemic lupus erythematosus? | Model: llama-3.3-70b-versatile | Trial: 0\n",
      "Saved to result/llama-3_3-70b-versatile/trial_0/which_approved_drugs_are_used_for_treati.xlsx\n",
      "Processing: What are the targets and mechanisms for tofacitinib? | Model: llama-3.3-70b-versatile | Trial: 0\n",
      "Saved to result/llama-3_3-70b-versatile/trial_0/what_are_the_targets_and_mechanisms_for.xlsx\n",
      "Processing: Provide drugs approved for prostate cancer with their target names. | Model: llama-3.3-70b-versatile | Trial: 0\n",
      "Saved to result/llama-3_3-70b-versatile/trial_0/provide_drugs_approved_for_prostate_canc.xlsx\n",
      "Processing: List pathways implicated in glioblastoma. | Model: llama-3.3-70b-versatile | Trial: 0\n",
      "Saved to result/llama-3_3-70b-versatile/trial_0/list_pathways_implicated_in_glioblastoma.xlsx\n",
      "Processing: What are the approved drugs for EGFR-mutant non-small cell lung cancer? | Model: llama-3.3-70b-versatile | Trial: 0\n",
      "Saved to result/llama-3_3-70b-versatile/trial_0/what_are_the_approved_drugs_for_egfr-mut.xlsx\n",
      "Processing: List all CDK4/6 inhibitors used for treating breast cancer. | Model: llama-3.3-70b-versatile | Trial: 0\n",
      "Saved to result/llama-3_3-70b-versatile/trial_0/list_all_cdk4_6_inhibitors_used_for_trea.xlsx\n",
      "Processing: What is the mechanism of action of osimertinib? | Model: llama-3.3-70b-versatile | Trial: 0\n",
      "Saved to result/llama-3_3-70b-versatile/trial_0/what_is_the_mechanism_of_action_of_osime.xlsx\n",
      "Processing: Which genes are targeted by monoclonal antibodies in asthma? | Model: llama-3.3-70b-versatile | Trial: 0\n",
      "Saved to result/llama-3_3-70b-versatile/trial_0/which_genes_are_targeted_by_monoclonal_a.xlsx\n",
      "Processing: Drugs with approval status for Clostridioides difficile infection. | Model: llama-3.3-70b-versatile | Trial: 0\n",
      "Saved to result/llama-3_3-70b-versatile/trial_0/drugs_with_approval_status_for_clostridi.xlsx\n",
      "Processing: Biomarkers associated with the WNT/ß-catenin pathway in cancer. | Model: llama-3.3-70b-versatile | Trial: 0\n",
      "Saved to result/llama-3_3-70b-versatile/trial_0/biomarkers_associated_with_the_wnt__-cat.xlsx\n",
      "Processing: Show drugs that inhibit the FGFR2 gene. | Model: llama-3.3-70b-versatile | Trial: 0\n",
      "Saved to result/llama-3_3-70b-versatile/trial_0/show_drugs_that_inhibit_the_fgfr2_gene.xlsx\n",
      "Processing: What diseases are treated with bevacizumab? | Model: llama-3.3-70b-versatile | Trial: 0\n",
      "Saved to result/llama-3_3-70b-versatile/trial_0/what_diseases_are_treated_with_bevacizum.xlsx\n",
      "Processing: Which pathways are targeted by mTOR inhibitors? | Model: llama-3.3-70b-versatile | Trial: 0\n",
      "Saved to result/llama-3_3-70b-versatile/trial_0/which_pathways_are_targeted_by_mtor_inhi.xlsx\n",
      "Processing: Approved drugs for plaque psoriasis and their mechanisms of action. | Model: llama-3.3-70b-versatile | Trial: 0\n",
      "Saved to result/llama-3_3-70b-versatile/trial_0/approved_drugs_for_plaque_psoriasis_and.xlsx\n",
      "Processing: What are the known targets of cabozantinib? | Model: llama-3.3-70b-versatile | Trial: 0\n",
      "Saved to result/llama-3_3-70b-versatile/trial_0/what_are_the_known_targets_of_cabozantin.xlsx\n",
      "Processing: Provide the SMILES for gefitinib. | Model: llama-3.3-70b-versatile | Trial: 0\n",
      "----- Some error occured-----\n",
      "Processing: Provide the SMILES for gefitinib. | Model: llama-3.3-70b-versatile | Trial: 0\n",
      "Processing: Genes linked to Crohns disease. | Model: llama-3.3-70b-versatile | Trial: 0\n",
      "Saved to result/llama-3_3-70b-versatile/trial_0/genes_linked_to_crohn_s_disease.xlsx\n",
      "Processing: List of drugs and approval status for respiratory syncytial virus infection. | Model: llama-3.3-70b-versatile | Trial: 0\n",
      "Saved to result/llama-3_3-70b-versatile/trial_0/list_of_drugs_and_approval_status_for_re.xlsx\n",
      "Processing: What drugs target the Hedgehog pathway in oncology? | Model: llama-3.3-70b-versatile | Trial: 0\n",
      "Saved to result/llama-3_3-70b-versatile/trial_0/what_drugs_target_the_hedgehog_pathway_i.xlsx\n",
      "Processing: Diseases associated with the gene NPM1. | Model: llama-3.3-70b-versatile | Trial: 0\n",
      "Saved to result/llama-3_3-70b-versatile/trial_0/diseases_associated_with_the_gene_npm1.xlsx\n",
      "Processing: Biomarkers for early detection of hepatocellular carcinoma. | Model: llama-3.3-70b-versatile | Trial: 0\n",
      "Saved to result/llama-3_3-70b-versatile/trial_0/biomarkers_for_early_detection_of_hepato.xlsx\n",
      "Processing: Which drugs act as CTLA-4 inhibitors? | Model: llama-3.3-70b-versatile | Trial: 0\n",
      "Saved to result/llama-3_3-70b-versatile/trial_0/which_drugs_act_as_ctla-4_inhibitors.xlsx\n",
      "Processing: Drugs for pulmonary arterial hypertension and their approval status. | Model: llama-3.3-70b-versatile | Trial: 0\n",
      "Saved to result/llama-3_3-70b-versatile/trial_0/drugs_for_pulmonary_arterial_hypertensio.xlsx\n",
      "Processing: What are the mechanisms of action for ACE inhibitors? | Model: llama-3.3-70b-versatile | Trial: 0\n",
      "Saved to result/llama-3_3-70b-versatile/trial_0/what_are_the_mechanisms_of_action_for_ac.xlsx\n",
      "Processing: Which approved drugs are used for treating migraine? | Model: llama-3.3-70b-versatile | Trial: 0\n",
      "Saved to result/llama-3_3-70b-versatile/trial_0/which_approved_drugs_are_used_for_treati.xlsx\n",
      "Processing: What are the targets and mechanisms for rituximab? | Model: llama-3.3-70b-versatile | Trial: 0\n",
      "Saved to result/llama-3_3-70b-versatile/trial_0/what_are_the_targets_and_mechanisms_for.xlsx\n",
      "Processing: Provide drugs approved for colorectal cancer with their target names. | Model: llama-3.3-70b-versatile | Trial: 0\n",
      "Saved to result/llama-3_3-70b-versatile/trial_0/provide_drugs_approved_for_colorectal_ca.xlsx\n",
      "Processing: List pathways implicated in myelodysplastic syndromes. | Model: llama-3.3-70b-versatile | Trial: 0\n",
      "Saved to result/llama-3_3-70b-versatile/trial_0/list_pathways_implicated_in_myelodysplas.xlsx\n",
      "Processing: What are the approved drugs for BRAF V600Emutant melanoma? | Model: llama-3.3-70b-versatile | Trial: 0\n",
      "Saved to result/llama-3_3-70b-versatile/trial_0/what_are_the_approved_drugs_for_braf_v60.xlsx\n",
      "Processing: List all FLT3 inhibitors used for treating acute myeloid leukemia. | Model: llama-3.3-70b-versatile | Trial: 0\n",
      "Saved to result/llama-3_3-70b-versatile/trial_0/list_all_flt3_inhibitors_used_for_treati.xlsx\n",
      "Processing: What is the mechanism of action of lenvatinib? | Model: llama-3.3-70b-versatile | Trial: 0\n",
      "Saved to result/llama-3_3-70b-versatile/trial_0/what_is_the_mechanism_of_action_of_lenva.xlsx\n",
      "Processing: Which genes are targeted by monoclonal antibodies in multiple sclerosis? | Model: llama-3.3-70b-versatile | Trial: 0\n",
      "Saved to result/llama-3_3-70b-versatile/trial_0/which_genes_are_targeted_by_monoclonal_a.xlsx\n",
      "Processing: Drugs with approval status for leprosy. | Model: llama-3.3-70b-versatile | Trial: 0\n",
      "Saved to result/llama-3_3-70b-versatile/trial_0/drugs_with_approval_status_for_leprosy.xlsx\n",
      "Processing: Biomarkers associated with the TGF-ß pathway in fibrosis. | Model: llama-3.3-70b-versatile | Trial: 0\n",
      "Saved to result/llama-3_3-70b-versatile/trial_0/biomarkers_associated_with_the_tgf-__pat.xlsx\n",
      "Processing: Show drugs that inhibit the RET gene. | Model: llama-3.3-70b-versatile | Trial: 0\n",
      "Saved to result/llama-3_3-70b-versatile/trial_0/show_drugs_that_inhibit_the_ret_gene.xlsx\n",
      "Processing: What diseases are treated with trastuzumab deruxtecan? | Model: llama-3.3-70b-versatile | Trial: 0\n",
      "Saved to result/llama-3_3-70b-versatile/trial_0/what_diseases_are_treated_with_trastuzum.xlsx\n",
      "Processing: Which pathways are targeted by PI3K inhibitors? | Model: llama-3.3-70b-versatile | Trial: 0\n",
      "Saved to result/llama-3_3-70b-versatile/trial_0/which_pathways_are_targeted_by_pi3k_inhi.xlsx\n",
      "Processing: Approved drugs for atopic dermatitis and their mechanisms of action. | Model: llama-3.3-70b-versatile | Trial: 0\n",
      "Saved to result/llama-3_3-70b-versatile/trial_0/approved_drugs_for_atopic_dermatitis_and.xlsx\n",
      "Processing: What are the known targets of vandetanib? | Model: llama-3.3-70b-versatile | Trial: 0\n",
      "Saved to result/llama-3_3-70b-versatile/trial_0/what_are_the_known_targets_of_vandetanib.xlsx\n",
      "Processing: Provide the SMILES for sorafenib. | Model: llama-3.3-70b-versatile | Trial: 0\n",
      "----- Some error occured-----\n",
      "Processing: Provide the SMILES for sorafenib. | Model: llama-3.3-70b-versatile | Trial: 0\n",
      "Processing: Genes linked to schizophrenia. | Model: llama-3.3-70b-versatile | Trial: 0\n",
      "Saved to result/llama-3_3-70b-versatile/trial_0/genes_linked_to_schizophrenia.xlsx\n",
      "Processing: List of drugs and approval status for dengue. | Model: llama-3.3-70b-versatile | Trial: 0\n",
      "Saved to result/llama-3_3-70b-versatile/trial_0/list_of_drugs_and_approval_status_for_de.xlsx\n",
      "Processing: What drugs target the JAKSTAT pathway in atopic dermatitis? | Model: llama-3.3-70b-versatile | Trial: 0\n",
      "Saved to result/llama-3_3-70b-versatile/trial_0/what_drugs_target_the_jak_stat_pathway_i.xlsx\n",
      "Processing: Diseases associated with the gene KRAS. | Model: llama-3.3-70b-versatile | Trial: 0\n",
      "Saved to result/llama-3_3-70b-versatile/trial_0/diseases_associated_with_the_gene_kras.xlsx\n",
      "Processing: Biomarkers for early detection of ovarian cancer. | Model: llama-3.3-70b-versatile | Trial: 0\n",
      "Saved to result/llama-3_3-70b-versatile/trial_0/biomarkers_for_early_detection_of_ovaria.xlsx\n",
      "Processing: Which drugs act as BCR-ABL inhibitors? | Model: llama-3.3-70b-versatile | Trial: 0\n",
      "Saved to result/llama-3_3-70b-versatile/trial_0/which_drugs_act_as_bcr-abl_inhibitors.xlsx\n",
      "Processing: Drugs for idiopathic pulmonary fibrosis and their approval status. | Model: llama-3.3-70b-versatile | Trial: 0\n",
      "Saved to result/llama-3_3-70b-versatile/trial_0/drugs_for_idiopathic_pulmonary_fibrosis.xlsx\n",
      "Processing: What are the mechanisms of action for monoclonal antibodies targeting IL-6? | Model: llama-3.3-70b-versatile | Trial: 0\n",
      "Saved to result/llama-3_3-70b-versatile/trial_0/what_are_the_mechanisms_of_action_for_mo.xlsx\n",
      "Processing: Which approved drugs are used for treating osteoporosis? | Model: llama-3.3-70b-versatile | Trial: 0\n",
      "Saved to result/llama-3_3-70b-versatile/trial_0/which_approved_drugs_are_used_for_treati.xlsx\n",
      "Processing: What are the targets and mechanisms for dupilumab? | Model: llama-3.3-70b-versatile | Trial: 0\n",
      "Saved to result/llama-3_3-70b-versatile/trial_0/what_are_the_targets_and_mechanisms_for.xlsx\n",
      "Processing: Provide drugs approved for renal cell carcinoma with their target names. | Model: llama-3.3-70b-versatile | Trial: 0\n",
      "Saved to result/llama-3_3-70b-versatile/trial_0/provide_drugs_approved_for_renal_cell_ca.xlsx\n",
      "Processing: List pathways implicated in prostate cancer. | Model: llama-3.3-70b-versatile | Trial: 0\n",
      "Saved to result/llama-3_3-70b-versatile/trial_0/list_pathways_implicated_in_prostate_can.xlsx\n",
      "Processing: What are the approved drugs for EGFR exon 20 insertionmutant lung cancer? | Model: llama-3.3-70b-versatile | Trial: 0\n",
      "Saved to result/llama-3_3-70b-versatile/trial_0/what_are_the_approved_drugs_for_egfr_exo.xlsx\n",
      "Processing: List all TRK inhibitors used for treating NTRK-fusion cancers. | Model: llama-3.3-70b-versatile | Trial: 0\n",
      "Saved to result/llama-3_3-70b-versatile/trial_0/list_all_trk_inhibitors_used_for_treatin.xlsx\n",
      "Processing: What is the mechanism of action of darolutamide? | Model: llama-3.3-70b-versatile | Trial: 0\n",
      "Saved to result/llama-3_3-70b-versatile/trial_0/what_is_the_mechanism_of_action_of_darol.xlsx\n",
      "Processing: Which genes are targeted by monoclonal antibodies in oncology immunotherapy? | Model: llama-3.3-70b-versatile | Trial: 0\n",
      "Saved to result/llama-3_3-70b-versatile/trial_0/which_genes_are_targeted_by_monoclonal_a.xlsx\n",
      "Processing: What drugs are used to treat fever? | Model: llama-3.3-70b-versatile | Trial: 0\n",
      "Saved to result/llama-3_3-70b-versatile/trial_0/what_drugs_are_used_to_treat_fever.xlsx\n",
      "Processing: What are the approved drugs for triple-negative breast cancer? | Model: llama-3.3-70b-versatile | Trial: 1\n",
      "Saved to result/llama-3_3-70b-versatile/trial_1/what_are_the_approved_drugs_for_triple-n.xlsx\n",
      "Processing: List all ALK inhibitors used for treating non-small cell lung cancer. | Model: llama-3.3-70b-versatile | Trial: 1\n",
      "Saved to result/llama-3_3-70b-versatile/trial_1/list_all_alk_inhibitors_used_for_treatin.xlsx\n",
      "Processing: What is the mechanism of action of nivolumab? | Model: llama-3.3-70b-versatile | Trial: 1\n",
      "Saved to result/llama-3_3-70b-versatile/trial_1/what_is_the_mechanism_of_action_of_nivol.xlsx\n",
      "Processing: Drugs with approval status for hepatitis C virus infection. | Model: llama-3.3-70b-versatile | Trial: 1\n",
      "Saved to result/llama-3_3-70b-versatile/trial_1/drugs_with_approval_status_for_hepatitis.xlsx\n",
      "Processing: Biomarkers associated with the PI3KAKT pathway in breast cancer. | Model: llama-3.3-70b-versatile | Trial: 1\n",
      "Saved to result/llama-3_3-70b-versatile/trial_1/biomarkers_associated_with_the_pi3k_akt.xlsx\n",
      "Processing: Show drugs that inhibit the KRAS G12C variant. | Model: llama-3.3-70b-versatile | Trial: 1\n",
      "Saved to result/llama-3_3-70b-versatile/trial_1/show_drugs_that_inhibit_the_kras_g12c_va.xlsx\n",
      "Processing: What diseases are treated with atezolizumab? | Model: llama-3.3-70b-versatile | Trial: 1\n",
      "Saved to result/llama-3_3-70b-versatile/trial_1/what_diseases_are_treated_with_atezolizu.xlsx\n",
      "Processing: Which pathways are targeted by PARP inhibitors? | Model: llama-3.3-70b-versatile | Trial: 1\n",
      "Saved to result/llama-3_3-70b-versatile/trial_1/which_pathways_are_targeted_by_parp_inhi.xlsx\n",
      "Processing: Approved drugs for multiple sclerosis and their mechanisms of action. | Model: llama-3.3-70b-versatile | Trial: 1\n",
      "Saved to result/llama-3_3-70b-versatile/trial_1/approved_drugs_for_multiple_sclerosis_an.xlsx\n",
      "Processing: What are the known targets of sunitinib? | Model: llama-3.3-70b-versatile | Trial: 1\n",
      "Saved to result/llama-3_3-70b-versatile/trial_1/what_are_the_known_targets_of_sunitinib.xlsx\n",
      "Processing: Provide the SMILES for dasatinib. | Model: llama-3.3-70b-versatile | Trial: 1\n",
      "----- Some error occured-----\n",
      "Processing: Provide the SMILES for dasatinib. | Model: llama-3.3-70b-versatile | Trial: 1\n",
      "Processing: Genes linked to amyotrophic lateral sclerosis. | Model: llama-3.3-70b-versatile | Trial: 1\n",
      "Saved to result/llama-3_3-70b-versatile/trial_1/genes_linked_to_amyotrophic_lateral_scle.xlsx\n",
      "Processing: List of drugs and approval status for malaria. | Model: llama-3.3-70b-versatile | Trial: 1\n",
      "Saved to result/llama-3_3-70b-versatile/trial_1/list_of_drugs_and_approval_status_for_ma.xlsx\n",
      "Processing: What drugs target the JAKSTAT pathway in myelofibrosis? | Model: llama-3.3-70b-versatile | Trial: 1\n",
      "Saved to result/llama-3_3-70b-versatile/trial_1/what_drugs_target_the_jak_stat_pathway_i.xlsx\n",
      "Processing: Diseases associated with the gene BRCA1. | Model: llama-3.3-70b-versatile | Trial: 1\n",
      "Saved to result/llama-3_3-70b-versatile/trial_1/diseases_associated_with_the_gene_brca1.xlsx\n",
      "Processing: Biomarkers for early detection of pancreatic cancer. | Model: llama-3.3-70b-versatile | Trial: 1\n",
      "Saved to result/llama-3_3-70b-versatile/trial_1/biomarkers_for_early_detection_of_pancre.xlsx\n",
      "Processing: Which drugs act as VEGF inhibitors? | Model: llama-3.3-70b-versatile | Trial: 1\n",
      "Saved to result/llama-3_3-70b-versatile/trial_1/which_drugs_act_as_vegf_inhibitors.xlsx\n",
      "Processing: Drugs for chronic hepatitis B and their approval status. | Model: llama-3.3-70b-versatile | Trial: 1\n",
      "Saved to result/llama-3_3-70b-versatile/trial_1/drugs_for_chronic_hepatitis_b_and_their.xlsx\n",
      "Processing: What are the mechanisms of action for beta-lactam antibiotics? | Model: llama-3.3-70b-versatile | Trial: 1\n",
      "Saved to result/llama-3_3-70b-versatile/trial_1/what_are_the_mechanisms_of_action_for_be.xlsx\n",
      "Processing: Which approved drugs are used for treating rheumatoid arthritis? | Model: llama-3.3-70b-versatile | Trial: 1\n",
      "Saved to result/llama-3_3-70b-versatile/trial_1/which_approved_drugs_are_used_for_treati.xlsx\n",
      "Processing: What are the targets and mechanisms for dulaglutide? | Model: llama-3.3-70b-versatile | Trial: 1\n",
      "Saved to result/llama-3_3-70b-versatile/trial_1/what_are_the_targets_and_mechanisms_for.xlsx\n",
      "Processing: Provide drugs approved for ovarian cancer with their target names. | Model: llama-3.3-70b-versatile | Trial: 1\n",
      "Saved to result/llama-3_3-70b-versatile/trial_1/provide_drugs_approved_for_ovarian_cance.xlsx\n",
      "Processing: List pathways implicated in chronic lymphocytic leukemia. | Model: llama-3.3-70b-versatile | Trial: 1\n",
      "Saved to result/llama-3_3-70b-versatile/trial_1/list_pathways_implicated_in_chronic_lymp.xlsx\n",
      "Processing: What are the approved drugs for HER2-low breast cancer? | Model: llama-3.3-70b-versatile | Trial: 1\n",
      "Saved to result/llama-3_3-70b-versatile/trial_1/what_are_the_approved_drugs_for_her2-low.xlsx\n",
      "Processing: List all BTK inhibitors used for treating mantle cell lymphoma. | Model: llama-3.3-70b-versatile | Trial: 1\n",
      "Saved to result/llama-3_3-70b-versatile/trial_1/list_all_btk_inhibitors_used_for_treatin.xlsx\n",
      "Processing: What is the mechanism of action of pembrolizumab? | Model: llama-3.3-70b-versatile | Trial: 1\n",
      "Saved to result/llama-3_3-70b-versatile/trial_1/what_is_the_mechanism_of_action_of_pembr.xlsx\n",
      "Processing: Which genes are targeted by monoclonal antibodies in psoriasis? | Model: llama-3.3-70b-versatile | Trial: 1\n",
      "Saved to result/llama-3_3-70b-versatile/trial_1/which_genes_are_targeted_by_monoclonal_a.xlsx\n",
      "Processing: Drugs with approval status for HIV/AIDS. | Model: llama-3.3-70b-versatile | Trial: 1\n",
      "Saved to result/llama-3_3-70b-versatile/trial_1/drugs_with_approval_status_for_hiv_aids.xlsx\n",
      "Processing: Biomarkers associated with the RASRAFMEK pathway in colorectal cancer. | Model: llama-3.3-70b-versatile | Trial: 1\n",
      "Saved to result/llama-3_3-70b-versatile/trial_1/biomarkers_associated_with_the_ras_raf_m.xlsx\n",
      "Processing: Show drugs that inhibit the IDH1 gene. | Model: llama-3.3-70b-versatile | Trial: 1\n",
      "Saved to result/llama-3_3-70b-versatile/trial_1/show_drugs_that_inhibit_the_idh1_gene.xlsx\n",
      "Processing: What diseases are treated with durvalumab? | Model: llama-3.3-70b-versatile | Trial: 1\n",
      "Saved to result/llama-3_3-70b-versatile/trial_1/what_diseases_are_treated_with_durvaluma.xlsx\n",
      "Processing: Which pathways are targeted by MEK inhibitors? | Model: llama-3.3-70b-versatile | Trial: 1\n",
      "Saved to result/llama-3_3-70b-versatile/trial_1/which_pathways_are_targeted_by_mek_inhib.xlsx\n",
      "Processing: Approved drugs for ulcerative colitis and their mechanisms of action. | Model: llama-3.3-70b-versatile | Trial: 1\n",
      "Saved to result/llama-3_3-70b-versatile/trial_1/approved_drugs_for_ulcerative_colitis_an.xlsx\n",
      "Processing: What are the known targets of regorafenib? | Model: llama-3.3-70b-versatile | Trial: 1\n",
      "Saved to result/llama-3_3-70b-versatile/trial_1/what_are_the_known_targets_of_regorafeni.xlsx\n",
      "Processing: Provide the SMILES for erlotinib. | Model: llama-3.3-70b-versatile | Trial: 1\n",
      "----- Some error occured-----\n",
      "Processing: Provide the SMILES for erlotinib. | Model: llama-3.3-70b-versatile | Trial: 1\n",
      "Processing: Genes linked to Parkinsons disease. | Model: llama-3.3-70b-versatile | Trial: 1\n",
      "Saved to result/llama-3_3-70b-versatile/trial_1/genes_linked_to_parkinson_s_disease.xlsx\n",
      "Processing: List of drugs and approval status for influenza. | Model: llama-3.3-70b-versatile | Trial: 1\n",
      "Saved to result/llama-3_3-70b-versatile/trial_1/list_of_drugs_and_approval_status_for_in.xlsx\n",
      "Processing: What drugs target the PI3K pathway in lymphoma? | Model: llama-3.3-70b-versatile | Trial: 1\n",
      "Saved to result/llama-3_3-70b-versatile/trial_1/what_drugs_target_the_pi3k_pathway_in_ly.xlsx\n",
      "Processing: Diseases associated with the gene PIK3CA. | Model: llama-3.3-70b-versatile | Trial: 1\n",
      "Saved to result/llama-3_3-70b-versatile/trial_1/diseases_associated_with_the_gene_pik3ca.xlsx\n",
      "Processing: Biomarkers for early detection of gastric cancer. | Model: llama-3.3-70b-versatile | Trial: 1\n",
      "Saved to result/llama-3_3-70b-versatile/trial_1/biomarkers_for_early_detection_of_gastri.xlsx\n",
      "Processing: Which drugs act as PD-1 inhibitors? | Model: llama-3.3-70b-versatile | Trial: 1\n",
      "Saved to result/llama-3_3-70b-versatile/trial_1/which_drugs_act_as_pd-1_inhibitors.xlsx\n",
      "Processing: Drugs for hepatitis D and their approval status. | Model: llama-3.3-70b-versatile | Trial: 1\n",
      "Saved to result/llama-3_3-70b-versatile/trial_1/drugs_for_hepatitis_d_and_their_approval.xlsx\n",
      "Processing: What are the mechanisms of action for SGLT2 inhibitors? | Model: llama-3.3-70b-versatile | Trial: 1\n",
      "Saved to result/llama-3_3-70b-versatile/trial_1/what_are_the_mechanisms_of_action_for_sg.xlsx\n",
      "Processing: Which approved drugs are used for treating systemic lupus erythematosus? | Model: llama-3.3-70b-versatile | Trial: 1\n",
      "Saved to result/llama-3_3-70b-versatile/trial_1/which_approved_drugs_are_used_for_treati.xlsx\n",
      "Processing: What are the targets and mechanisms for tofacitinib? | Model: llama-3.3-70b-versatile | Trial: 1\n",
      "Saved to result/llama-3_3-70b-versatile/trial_1/what_are_the_targets_and_mechanisms_for.xlsx\n",
      "Processing: Provide drugs approved for prostate cancer with their target names. | Model: llama-3.3-70b-versatile | Trial: 1\n",
      "Saved to result/llama-3_3-70b-versatile/trial_1/provide_drugs_approved_for_prostate_canc.xlsx\n",
      "Processing: List pathways implicated in glioblastoma. | Model: llama-3.3-70b-versatile | Trial: 1\n",
      "Saved to result/llama-3_3-70b-versatile/trial_1/list_pathways_implicated_in_glioblastoma.xlsx\n",
      "Processing: What are the approved drugs for EGFR-mutant non-small cell lung cancer? | Model: llama-3.3-70b-versatile | Trial: 1\n",
      "Saved to result/llama-3_3-70b-versatile/trial_1/what_are_the_approved_drugs_for_egfr-mut.xlsx\n",
      "Processing: List all CDK4/6 inhibitors used for treating breast cancer. | Model: llama-3.3-70b-versatile | Trial: 1\n",
      "Saved to result/llama-3_3-70b-versatile/trial_1/list_all_cdk4_6_inhibitors_used_for_trea.xlsx\n",
      "Processing: What is the mechanism of action of osimertinib? | Model: llama-3.3-70b-versatile | Trial: 1\n",
      "Saved to result/llama-3_3-70b-versatile/trial_1/what_is_the_mechanism_of_action_of_osime.xlsx\n",
      "Processing: Which genes are targeted by monoclonal antibodies in asthma? | Model: llama-3.3-70b-versatile | Trial: 1\n",
      "Saved to result/llama-3_3-70b-versatile/trial_1/which_genes_are_targeted_by_monoclonal_a.xlsx\n",
      "Processing: Drugs with approval status for Clostridioides difficile infection. | Model: llama-3.3-70b-versatile | Trial: 1\n",
      "Saved to result/llama-3_3-70b-versatile/trial_1/drugs_with_approval_status_for_clostridi.xlsx\n",
      "Processing: Biomarkers associated with the WNT/ß-catenin pathway in cancer. | Model: llama-3.3-70b-versatile | Trial: 1\n",
      "Saved to result/llama-3_3-70b-versatile/trial_1/biomarkers_associated_with_the_wnt__-cat.xlsx\n",
      "Processing: Show drugs that inhibit the FGFR2 gene. | Model: llama-3.3-70b-versatile | Trial: 1\n",
      "Saved to result/llama-3_3-70b-versatile/trial_1/show_drugs_that_inhibit_the_fgfr2_gene.xlsx\n",
      "Processing: What diseases are treated with bevacizumab? | Model: llama-3.3-70b-versatile | Trial: 1\n",
      "Saved to result/llama-3_3-70b-versatile/trial_1/what_diseases_are_treated_with_bevacizum.xlsx\n",
      "Processing: Which pathways are targeted by mTOR inhibitors? | Model: llama-3.3-70b-versatile | Trial: 1\n",
      "Saved to result/llama-3_3-70b-versatile/trial_1/which_pathways_are_targeted_by_mtor_inhi.xlsx\n",
      "Processing: Approved drugs for plaque psoriasis and their mechanisms of action. | Model: llama-3.3-70b-versatile | Trial: 1\n",
      "Saved to result/llama-3_3-70b-versatile/trial_1/approved_drugs_for_plaque_psoriasis_and.xlsx\n",
      "Processing: What are the known targets of cabozantinib? | Model: llama-3.3-70b-versatile | Trial: 1\n",
      "Saved to result/llama-3_3-70b-versatile/trial_1/what_are_the_known_targets_of_cabozantin.xlsx\n",
      "Processing: Provide the SMILES for gefitinib. | Model: llama-3.3-70b-versatile | Trial: 1\n",
      "----- Some error occured-----\n",
      "Processing: Provide the SMILES for gefitinib. | Model: llama-3.3-70b-versatile | Trial: 1\n",
      "Processing: Genes linked to Crohns disease. | Model: llama-3.3-70b-versatile | Trial: 1\n",
      "Saved to result/llama-3_3-70b-versatile/trial_1/genes_linked_to_crohn_s_disease.xlsx\n",
      "Processing: List of drugs and approval status for respiratory syncytial virus infection. | Model: llama-3.3-70b-versatile | Trial: 1\n",
      "Saved to result/llama-3_3-70b-versatile/trial_1/list_of_drugs_and_approval_status_for_re.xlsx\n",
      "Processing: What drugs target the Hedgehog pathway in oncology? | Model: llama-3.3-70b-versatile | Trial: 1\n",
      "Saved to result/llama-3_3-70b-versatile/trial_1/what_drugs_target_the_hedgehog_pathway_i.xlsx\n",
      "Processing: Diseases associated with the gene NPM1. | Model: llama-3.3-70b-versatile | Trial: 1\n",
      "Saved to result/llama-3_3-70b-versatile/trial_1/diseases_associated_with_the_gene_npm1.xlsx\n",
      "Processing: Biomarkers for early detection of hepatocellular carcinoma. | Model: llama-3.3-70b-versatile | Trial: 1\n",
      "Saved to result/llama-3_3-70b-versatile/trial_1/biomarkers_for_early_detection_of_hepato.xlsx\n",
      "Processing: Which drugs act as CTLA-4 inhibitors? | Model: llama-3.3-70b-versatile | Trial: 1\n",
      "Saved to result/llama-3_3-70b-versatile/trial_1/which_drugs_act_as_ctla-4_inhibitors.xlsx\n",
      "Processing: Drugs for pulmonary arterial hypertension and their approval status. | Model: llama-3.3-70b-versatile | Trial: 1\n",
      "Saved to result/llama-3_3-70b-versatile/trial_1/drugs_for_pulmonary_arterial_hypertensio.xlsx\n",
      "Processing: What are the mechanisms of action for ACE inhibitors? | Model: llama-3.3-70b-versatile | Trial: 1\n",
      "Saved to result/llama-3_3-70b-versatile/trial_1/what_are_the_mechanisms_of_action_for_ac.xlsx\n",
      "Processing: Which approved drugs are used for treating migraine? | Model: llama-3.3-70b-versatile | Trial: 1\n",
      "Saved to result/llama-3_3-70b-versatile/trial_1/which_approved_drugs_are_used_for_treati.xlsx\n",
      "Processing: What are the targets and mechanisms for rituximab? | Model: llama-3.3-70b-versatile | Trial: 1\n",
      "Saved to result/llama-3_3-70b-versatile/trial_1/what_are_the_targets_and_mechanisms_for.xlsx\n",
      "Processing: Provide drugs approved for colorectal cancer with their target names. | Model: llama-3.3-70b-versatile | Trial: 1\n",
      "Saved to result/llama-3_3-70b-versatile/trial_1/provide_drugs_approved_for_colorectal_ca.xlsx\n",
      "Processing: List pathways implicated in myelodysplastic syndromes. | Model: llama-3.3-70b-versatile | Trial: 1\n",
      "Saved to result/llama-3_3-70b-versatile/trial_1/list_pathways_implicated_in_myelodysplas.xlsx\n",
      "Processing: What are the approved drugs for BRAF V600Emutant melanoma? | Model: llama-3.3-70b-versatile | Trial: 1\n",
      "Saved to result/llama-3_3-70b-versatile/trial_1/what_are_the_approved_drugs_for_braf_v60.xlsx\n",
      "Processing: List all FLT3 inhibitors used for treating acute myeloid leukemia. | Model: llama-3.3-70b-versatile | Trial: 1\n",
      "Saved to result/llama-3_3-70b-versatile/trial_1/list_all_flt3_inhibitors_used_for_treati.xlsx\n",
      "Processing: What is the mechanism of action of lenvatinib? | Model: llama-3.3-70b-versatile | Trial: 1\n",
      "Saved to result/llama-3_3-70b-versatile/trial_1/what_is_the_mechanism_of_action_of_lenva.xlsx\n",
      "Processing: Which genes are targeted by monoclonal antibodies in multiple sclerosis? | Model: llama-3.3-70b-versatile | Trial: 1\n",
      "Saved to result/llama-3_3-70b-versatile/trial_1/which_genes_are_targeted_by_monoclonal_a.xlsx\n",
      "Processing: Drugs with approval status for leprosy. | Model: llama-3.3-70b-versatile | Trial: 1\n",
      "Saved to result/llama-3_3-70b-versatile/trial_1/drugs_with_approval_status_for_leprosy.xlsx\n",
      "Processing: Biomarkers associated with the TGF-ß pathway in fibrosis. | Model: llama-3.3-70b-versatile | Trial: 1\n",
      "Saved to result/llama-3_3-70b-versatile/trial_1/biomarkers_associated_with_the_tgf-__pat.xlsx\n",
      "Processing: Show drugs that inhibit the RET gene. | Model: llama-3.3-70b-versatile | Trial: 1\n",
      "Saved to result/llama-3_3-70b-versatile/trial_1/show_drugs_that_inhibit_the_ret_gene.xlsx\n",
      "Processing: What diseases are treated with trastuzumab deruxtecan? | Model: llama-3.3-70b-versatile | Trial: 1\n",
      "Saved to result/llama-3_3-70b-versatile/trial_1/what_diseases_are_treated_with_trastuzum.xlsx\n",
      "Processing: Which pathways are targeted by PI3K inhibitors? | Model: llama-3.3-70b-versatile | Trial: 1\n",
      "Saved to result/llama-3_3-70b-versatile/trial_1/which_pathways_are_targeted_by_pi3k_inhi.xlsx\n",
      "Processing: Approved drugs for atopic dermatitis and their mechanisms of action. | Model: llama-3.3-70b-versatile | Trial: 1\n",
      "Saved to result/llama-3_3-70b-versatile/trial_1/approved_drugs_for_atopic_dermatitis_and.xlsx\n",
      "Processing: What are the known targets of vandetanib? | Model: llama-3.3-70b-versatile | Trial: 1\n",
      "Saved to result/llama-3_3-70b-versatile/trial_1/what_are_the_known_targets_of_vandetanib.xlsx\n",
      "Processing: Provide the SMILES for sorafenib. | Model: llama-3.3-70b-versatile | Trial: 1\n",
      "----- Some error occured-----\n",
      "Processing: Provide the SMILES for sorafenib. | Model: llama-3.3-70b-versatile | Trial: 1\n",
      "Processing: Genes linked to schizophrenia. | Model: llama-3.3-70b-versatile | Trial: 1\n",
      "Saved to result/llama-3_3-70b-versatile/trial_1/genes_linked_to_schizophrenia.xlsx\n",
      "Processing: List of drugs and approval status for dengue. | Model: llama-3.3-70b-versatile | Trial: 1\n",
      "Saved to result/llama-3_3-70b-versatile/trial_1/list_of_drugs_and_approval_status_for_de.xlsx\n",
      "Processing: What drugs target the JAKSTAT pathway in atopic dermatitis? | Model: llama-3.3-70b-versatile | Trial: 1\n",
      "Saved to result/llama-3_3-70b-versatile/trial_1/what_drugs_target_the_jak_stat_pathway_i.xlsx\n",
      "Processing: Diseases associated with the gene KRAS. | Model: llama-3.3-70b-versatile | Trial: 1\n",
      "Saved to result/llama-3_3-70b-versatile/trial_1/diseases_associated_with_the_gene_kras.xlsx\n",
      "Processing: Biomarkers for early detection of ovarian cancer. | Model: llama-3.3-70b-versatile | Trial: 1\n",
      "Saved to result/llama-3_3-70b-versatile/trial_1/biomarkers_for_early_detection_of_ovaria.xlsx\n",
      "Processing: Which drugs act as BCR-ABL inhibitors? | Model: llama-3.3-70b-versatile | Trial: 1\n",
      "Saved to result/llama-3_3-70b-versatile/trial_1/which_drugs_act_as_bcr-abl_inhibitors.xlsx\n",
      "Processing: Drugs for idiopathic pulmonary fibrosis and their approval status. | Model: llama-3.3-70b-versatile | Trial: 1\n",
      "Saved to result/llama-3_3-70b-versatile/trial_1/drugs_for_idiopathic_pulmonary_fibrosis.xlsx\n",
      "Processing: What are the mechanisms of action for monoclonal antibodies targeting IL-6? | Model: llama-3.3-70b-versatile | Trial: 1\n",
      "Saved to result/llama-3_3-70b-versatile/trial_1/what_are_the_mechanisms_of_action_for_mo.xlsx\n",
      "Processing: Which approved drugs are used for treating osteoporosis? | Model: llama-3.3-70b-versatile | Trial: 1\n",
      "Saved to result/llama-3_3-70b-versatile/trial_1/which_approved_drugs_are_used_for_treati.xlsx\n",
      "Processing: What are the targets and mechanisms for dupilumab? | Model: llama-3.3-70b-versatile | Trial: 1\n",
      "Saved to result/llama-3_3-70b-versatile/trial_1/what_are_the_targets_and_mechanisms_for.xlsx\n",
      "Processing: Provide drugs approved for renal cell carcinoma with their target names. | Model: llama-3.3-70b-versatile | Trial: 1\n",
      "Saved to result/llama-3_3-70b-versatile/trial_1/provide_drugs_approved_for_renal_cell_ca.xlsx\n",
      "Processing: List pathways implicated in prostate cancer. | Model: llama-3.3-70b-versatile | Trial: 1\n",
      "Saved to result/llama-3_3-70b-versatile/trial_1/list_pathways_implicated_in_prostate_can.xlsx\n",
      "Processing: What are the approved drugs for EGFR exon 20 insertionmutant lung cancer? | Model: llama-3.3-70b-versatile | Trial: 1\n",
      "Saved to result/llama-3_3-70b-versatile/trial_1/what_are_the_approved_drugs_for_egfr_exo.xlsx\n",
      "Processing: List all TRK inhibitors used for treating NTRK-fusion cancers. | Model: llama-3.3-70b-versatile | Trial: 1\n",
      "Saved to result/llama-3_3-70b-versatile/trial_1/list_all_trk_inhibitors_used_for_treatin.xlsx\n",
      "Processing: What is the mechanism of action of darolutamide? | Model: llama-3.3-70b-versatile | Trial: 1\n",
      "Saved to result/llama-3_3-70b-versatile/trial_1/what_is_the_mechanism_of_action_of_darol.xlsx\n",
      "Processing: Which genes are targeted by monoclonal antibodies in oncology immunotherapy? | Model: llama-3.3-70b-versatile | Trial: 1\n",
      "Saved to result/llama-3_3-70b-versatile/trial_1/which_genes_are_targeted_by_monoclonal_a.xlsx\n",
      "Processing: What drugs are used to treat fever? | Model: llama-3.3-70b-versatile | Trial: 1\n",
      "Saved to result/llama-3_3-70b-versatile/trial_1/what_drugs_are_used_to_treat_fever.xlsx\n",
      "Processing: What are the approved drugs for triple-negative breast cancer? | Model: llama-3.3-70b-versatile | Trial: 2\n",
      "Saved to result/llama-3_3-70b-versatile/trial_2/what_are_the_approved_drugs_for_triple-n.xlsx\n",
      "Processing: List all ALK inhibitors used for treating non-small cell lung cancer. | Model: llama-3.3-70b-versatile | Trial: 2\n",
      "Saved to result/llama-3_3-70b-versatile/trial_2/list_all_alk_inhibitors_used_for_treatin.xlsx\n",
      "Processing: What is the mechanism of action of nivolumab? | Model: llama-3.3-70b-versatile | Trial: 2\n",
      "Saved to result/llama-3_3-70b-versatile/trial_2/what_is_the_mechanism_of_action_of_nivol.xlsx\n",
      "Processing: Drugs with approval status for hepatitis C virus infection. | Model: llama-3.3-70b-versatile | Trial: 2\n",
      "Saved to result/llama-3_3-70b-versatile/trial_2/drugs_with_approval_status_for_hepatitis.xlsx\n",
      "Processing: Biomarkers associated with the PI3KAKT pathway in breast cancer. | Model: llama-3.3-70b-versatile | Trial: 2\n",
      "Saved to result/llama-3_3-70b-versatile/trial_2/biomarkers_associated_with_the_pi3k_akt.xlsx\n",
      "Processing: Show drugs that inhibit the KRAS G12C variant. | Model: llama-3.3-70b-versatile | Trial: 2\n",
      "Saved to result/llama-3_3-70b-versatile/trial_2/show_drugs_that_inhibit_the_kras_g12c_va.xlsx\n",
      "Processing: What diseases are treated with atezolizumab? | Model: llama-3.3-70b-versatile | Trial: 2\n",
      "Saved to result/llama-3_3-70b-versatile/trial_2/what_diseases_are_treated_with_atezolizu.xlsx\n",
      "Processing: Which pathways are targeted by PARP inhibitors? | Model: llama-3.3-70b-versatile | Trial: 2\n",
      "Saved to result/llama-3_3-70b-versatile/trial_2/which_pathways_are_targeted_by_parp_inhi.xlsx\n",
      "Processing: Approved drugs for multiple sclerosis and their mechanisms of action. | Model: llama-3.3-70b-versatile | Trial: 2\n",
      "Saved to result/llama-3_3-70b-versatile/trial_2/approved_drugs_for_multiple_sclerosis_an.xlsx\n",
      "Processing: What are the known targets of sunitinib? | Model: llama-3.3-70b-versatile | Trial: 2\n",
      "Saved to result/llama-3_3-70b-versatile/trial_2/what_are_the_known_targets_of_sunitinib.xlsx\n",
      "Processing: Provide the SMILES for dasatinib. | Model: llama-3.3-70b-versatile | Trial: 2\n",
      "----- Some error occured-----\n",
      "Processing: Provide the SMILES for dasatinib. | Model: llama-3.3-70b-versatile | Trial: 2\n",
      "Processing: Genes linked to amyotrophic lateral sclerosis. | Model: llama-3.3-70b-versatile | Trial: 2\n",
      "Saved to result/llama-3_3-70b-versatile/trial_2/genes_linked_to_amyotrophic_lateral_scle.xlsx\n",
      "Processing: List of drugs and approval status for malaria. | Model: llama-3.3-70b-versatile | Trial: 2\n",
      "Saved to result/llama-3_3-70b-versatile/trial_2/list_of_drugs_and_approval_status_for_ma.xlsx\n",
      "Processing: What drugs target the JAKSTAT pathway in myelofibrosis? | Model: llama-3.3-70b-versatile | Trial: 2\n",
      "Saved to result/llama-3_3-70b-versatile/trial_2/what_drugs_target_the_jak_stat_pathway_i.xlsx\n",
      "Processing: Diseases associated with the gene BRCA1. | Model: llama-3.3-70b-versatile | Trial: 2\n",
      "Saved to result/llama-3_3-70b-versatile/trial_2/diseases_associated_with_the_gene_brca1.xlsx\n",
      "Processing: Biomarkers for early detection of pancreatic cancer. | Model: llama-3.3-70b-versatile | Trial: 2\n",
      "Saved to result/llama-3_3-70b-versatile/trial_2/biomarkers_for_early_detection_of_pancre.xlsx\n",
      "Processing: Which drugs act as VEGF inhibitors? | Model: llama-3.3-70b-versatile | Trial: 2\n",
      "Saved to result/llama-3_3-70b-versatile/trial_2/which_drugs_act_as_vegf_inhibitors.xlsx\n",
      "Processing: Drugs for chronic hepatitis B and their approval status. | Model: llama-3.3-70b-versatile | Trial: 2\n",
      "Saved to result/llama-3_3-70b-versatile/trial_2/drugs_for_chronic_hepatitis_b_and_their.xlsx\n",
      "Processing: What are the mechanisms of action for beta-lactam antibiotics? | Model: llama-3.3-70b-versatile | Trial: 2\n",
      "Saved to result/llama-3_3-70b-versatile/trial_2/what_are_the_mechanisms_of_action_for_be.xlsx\n",
      "Processing: Which approved drugs are used for treating rheumatoid arthritis? | Model: llama-3.3-70b-versatile | Trial: 2\n",
      "Saved to result/llama-3_3-70b-versatile/trial_2/which_approved_drugs_are_used_for_treati.xlsx\n",
      "Processing: What are the targets and mechanisms for dulaglutide? | Model: llama-3.3-70b-versatile | Trial: 2\n",
      "Saved to result/llama-3_3-70b-versatile/trial_2/what_are_the_targets_and_mechanisms_for.xlsx\n",
      "Processing: Provide drugs approved for ovarian cancer with their target names. | Model: llama-3.3-70b-versatile | Trial: 2\n",
      "Saved to result/llama-3_3-70b-versatile/trial_2/provide_drugs_approved_for_ovarian_cance.xlsx\n",
      "Processing: List pathways implicated in chronic lymphocytic leukemia. | Model: llama-3.3-70b-versatile | Trial: 2\n",
      "Saved to result/llama-3_3-70b-versatile/trial_2/list_pathways_implicated_in_chronic_lymp.xlsx\n",
      "Processing: What are the approved drugs for HER2-low breast cancer? | Model: llama-3.3-70b-versatile | Trial: 2\n",
      "Saved to result/llama-3_3-70b-versatile/trial_2/what_are_the_approved_drugs_for_her2-low.xlsx\n",
      "Processing: List all BTK inhibitors used for treating mantle cell lymphoma. | Model: llama-3.3-70b-versatile | Trial: 2\n",
      "Saved to result/llama-3_3-70b-versatile/trial_2/list_all_btk_inhibitors_used_for_treatin.xlsx\n",
      "Processing: What is the mechanism of action of pembrolizumab? | Model: llama-3.3-70b-versatile | Trial: 2\n",
      "Saved to result/llama-3_3-70b-versatile/trial_2/what_is_the_mechanism_of_action_of_pembr.xlsx\n",
      "Processing: Which genes are targeted by monoclonal antibodies in psoriasis? | Model: llama-3.3-70b-versatile | Trial: 2\n",
      "Saved to result/llama-3_3-70b-versatile/trial_2/which_genes_are_targeted_by_monoclonal_a.xlsx\n",
      "Processing: Drugs with approval status for HIV/AIDS. | Model: llama-3.3-70b-versatile | Trial: 2\n",
      "Saved to result/llama-3_3-70b-versatile/trial_2/drugs_with_approval_status_for_hiv_aids.xlsx\n",
      "Processing: Biomarkers associated with the RASRAFMEK pathway in colorectal cancer. | Model: llama-3.3-70b-versatile | Trial: 2\n",
      "Saved to result/llama-3_3-70b-versatile/trial_2/biomarkers_associated_with_the_ras_raf_m.xlsx\n",
      "Processing: Show drugs that inhibit the IDH1 gene. | Model: llama-3.3-70b-versatile | Trial: 2\n",
      "Saved to result/llama-3_3-70b-versatile/trial_2/show_drugs_that_inhibit_the_idh1_gene.xlsx\n",
      "Processing: What diseases are treated with durvalumab? | Model: llama-3.3-70b-versatile | Trial: 2\n",
      "Saved to result/llama-3_3-70b-versatile/trial_2/what_diseases_are_treated_with_durvaluma.xlsx\n",
      "Processing: Which pathways are targeted by MEK inhibitors? | Model: llama-3.3-70b-versatile | Trial: 2\n",
      "Saved to result/llama-3_3-70b-versatile/trial_2/which_pathways_are_targeted_by_mek_inhib.xlsx\n",
      "Processing: Approved drugs for ulcerative colitis and their mechanisms of action. | Model: llama-3.3-70b-versatile | Trial: 2\n",
      "Saved to result/llama-3_3-70b-versatile/trial_2/approved_drugs_for_ulcerative_colitis_an.xlsx\n",
      "Processing: What are the known targets of regorafenib? | Model: llama-3.3-70b-versatile | Trial: 2\n",
      "Saved to result/llama-3_3-70b-versatile/trial_2/what_are_the_known_targets_of_regorafeni.xlsx\n",
      "Processing: Provide the SMILES for erlotinib. | Model: llama-3.3-70b-versatile | Trial: 2\n",
      "----- Some error occured-----\n",
      "Processing: Provide the SMILES for erlotinib. | Model: llama-3.3-70b-versatile | Trial: 2\n",
      "Processing: Genes linked to Parkinsons disease. | Model: llama-3.3-70b-versatile | Trial: 2\n",
      "Saved to result/llama-3_3-70b-versatile/trial_2/genes_linked_to_parkinson_s_disease.xlsx\n",
      "Processing: List of drugs and approval status for influenza. | Model: llama-3.3-70b-versatile | Trial: 2\n",
      "Saved to result/llama-3_3-70b-versatile/trial_2/list_of_drugs_and_approval_status_for_in.xlsx\n",
      "Processing: What drugs target the PI3K pathway in lymphoma? | Model: llama-3.3-70b-versatile | Trial: 2\n",
      "Saved to result/llama-3_3-70b-versatile/trial_2/what_drugs_target_the_pi3k_pathway_in_ly.xlsx\n",
      "Processing: Diseases associated with the gene PIK3CA. | Model: llama-3.3-70b-versatile | Trial: 2\n",
      "Saved to result/llama-3_3-70b-versatile/trial_2/diseases_associated_with_the_gene_pik3ca.xlsx\n",
      "Processing: Biomarkers for early detection of gastric cancer. | Model: llama-3.3-70b-versatile | Trial: 2\n",
      "Saved to result/llama-3_3-70b-versatile/trial_2/biomarkers_for_early_detection_of_gastri.xlsx\n",
      "Processing: Which drugs act as PD-1 inhibitors? | Model: llama-3.3-70b-versatile | Trial: 2\n",
      "Saved to result/llama-3_3-70b-versatile/trial_2/which_drugs_act_as_pd-1_inhibitors.xlsx\n",
      "Processing: Drugs for hepatitis D and their approval status. | Model: llama-3.3-70b-versatile | Trial: 2\n",
      "Saved to result/llama-3_3-70b-versatile/trial_2/drugs_for_hepatitis_d_and_their_approval.xlsx\n",
      "Processing: What are the mechanisms of action for SGLT2 inhibitors? | Model: llama-3.3-70b-versatile | Trial: 2\n",
      "Saved to result/llama-3_3-70b-versatile/trial_2/what_are_the_mechanisms_of_action_for_sg.xlsx\n",
      "Processing: Which approved drugs are used for treating systemic lupus erythematosus? | Model: llama-3.3-70b-versatile | Trial: 2\n",
      "Saved to result/llama-3_3-70b-versatile/trial_2/which_approved_drugs_are_used_for_treati.xlsx\n",
      "Processing: What are the targets and mechanisms for tofacitinib? | Model: llama-3.3-70b-versatile | Trial: 2\n",
      "Saved to result/llama-3_3-70b-versatile/trial_2/what_are_the_targets_and_mechanisms_for.xlsx\n",
      "Processing: Provide drugs approved for prostate cancer with their target names. | Model: llama-3.3-70b-versatile | Trial: 2\n",
      "Saved to result/llama-3_3-70b-versatile/trial_2/provide_drugs_approved_for_prostate_canc.xlsx\n",
      "Processing: List pathways implicated in glioblastoma. | Model: llama-3.3-70b-versatile | Trial: 2\n",
      "Saved to result/llama-3_3-70b-versatile/trial_2/list_pathways_implicated_in_glioblastoma.xlsx\n",
      "Processing: What are the approved drugs for EGFR-mutant non-small cell lung cancer? | Model: llama-3.3-70b-versatile | Trial: 2\n",
      "Saved to result/llama-3_3-70b-versatile/trial_2/what_are_the_approved_drugs_for_egfr-mut.xlsx\n",
      "Processing: List all CDK4/6 inhibitors used for treating breast cancer. | Model: llama-3.3-70b-versatile | Trial: 2\n",
      "Saved to result/llama-3_3-70b-versatile/trial_2/list_all_cdk4_6_inhibitors_used_for_trea.xlsx\n",
      "Processing: What is the mechanism of action of osimertinib? | Model: llama-3.3-70b-versatile | Trial: 2\n",
      "Saved to result/llama-3_3-70b-versatile/trial_2/what_is_the_mechanism_of_action_of_osime.xlsx\n",
      "Processing: Which genes are targeted by monoclonal antibodies in asthma? | Model: llama-3.3-70b-versatile | Trial: 2\n",
      "Saved to result/llama-3_3-70b-versatile/trial_2/which_genes_are_targeted_by_monoclonal_a.xlsx\n",
      "Processing: Drugs with approval status for Clostridioides difficile infection. | Model: llama-3.3-70b-versatile | Trial: 2\n",
      "Saved to result/llama-3_3-70b-versatile/trial_2/drugs_with_approval_status_for_clostridi.xlsx\n",
      "Processing: Biomarkers associated with the WNT/ß-catenin pathway in cancer. | Model: llama-3.3-70b-versatile | Trial: 2\n",
      "Saved to result/llama-3_3-70b-versatile/trial_2/biomarkers_associated_with_the_wnt__-cat.xlsx\n",
      "Processing: Show drugs that inhibit the FGFR2 gene. | Model: llama-3.3-70b-versatile | Trial: 2\n",
      "Saved to result/llama-3_3-70b-versatile/trial_2/show_drugs_that_inhibit_the_fgfr2_gene.xlsx\n",
      "Processing: What diseases are treated with bevacizumab? | Model: llama-3.3-70b-versatile | Trial: 2\n",
      "Saved to result/llama-3_3-70b-versatile/trial_2/what_diseases_are_treated_with_bevacizum.xlsx\n",
      "Processing: Which pathways are targeted by mTOR inhibitors? | Model: llama-3.3-70b-versatile | Trial: 2\n",
      "Saved to result/llama-3_3-70b-versatile/trial_2/which_pathways_are_targeted_by_mtor_inhi.xlsx\n",
      "Processing: Approved drugs for plaque psoriasis and their mechanisms of action. | Model: llama-3.3-70b-versatile | Trial: 2\n",
      "Saved to result/llama-3_3-70b-versatile/trial_2/approved_drugs_for_plaque_psoriasis_and.xlsx\n",
      "Processing: What are the known targets of cabozantinib? | Model: llama-3.3-70b-versatile | Trial: 2\n",
      "Saved to result/llama-3_3-70b-versatile/trial_2/what_are_the_known_targets_of_cabozantin.xlsx\n",
      "Processing: Provide the SMILES for gefitinib. | Model: llama-3.3-70b-versatile | Trial: 2\n",
      "----- Some error occured-----\n",
      "Processing: Provide the SMILES for gefitinib. | Model: llama-3.3-70b-versatile | Trial: 2\n",
      "Processing: Genes linked to Crohns disease. | Model: llama-3.3-70b-versatile | Trial: 2\n",
      "Saved to result/llama-3_3-70b-versatile/trial_2/genes_linked_to_crohn_s_disease.xlsx\n",
      "Processing: List of drugs and approval status for respiratory syncytial virus infection. | Model: llama-3.3-70b-versatile | Trial: 2\n",
      "Saved to result/llama-3_3-70b-versatile/trial_2/list_of_drugs_and_approval_status_for_re.xlsx\n",
      "Processing: What drugs target the Hedgehog pathway in oncology? | Model: llama-3.3-70b-versatile | Trial: 2\n",
      "Saved to result/llama-3_3-70b-versatile/trial_2/what_drugs_target_the_hedgehog_pathway_i.xlsx\n",
      "Processing: Diseases associated with the gene NPM1. | Model: llama-3.3-70b-versatile | Trial: 2\n",
      "Saved to result/llama-3_3-70b-versatile/trial_2/diseases_associated_with_the_gene_npm1.xlsx\n",
      "Processing: Biomarkers for early detection of hepatocellular carcinoma. | Model: llama-3.3-70b-versatile | Trial: 2\n",
      "Saved to result/llama-3_3-70b-versatile/trial_2/biomarkers_for_early_detection_of_hepato.xlsx\n",
      "Processing: Which drugs act as CTLA-4 inhibitors? | Model: llama-3.3-70b-versatile | Trial: 2\n",
      "Saved to result/llama-3_3-70b-versatile/trial_2/which_drugs_act_as_ctla-4_inhibitors.xlsx\n",
      "Processing: Drugs for pulmonary arterial hypertension and their approval status. | Model: llama-3.3-70b-versatile | Trial: 2\n",
      "Saved to result/llama-3_3-70b-versatile/trial_2/drugs_for_pulmonary_arterial_hypertensio.xlsx\n",
      "Processing: What are the mechanisms of action for ACE inhibitors? | Model: llama-3.3-70b-versatile | Trial: 2\n",
      "Saved to result/llama-3_3-70b-versatile/trial_2/what_are_the_mechanisms_of_action_for_ac.xlsx\n",
      "Processing: Which approved drugs are used for treating migraine? | Model: llama-3.3-70b-versatile | Trial: 2\n",
      "Saved to result/llama-3_3-70b-versatile/trial_2/which_approved_drugs_are_used_for_treati.xlsx\n",
      "Processing: What are the targets and mechanisms for rituximab? | Model: llama-3.3-70b-versatile | Trial: 2\n",
      "Saved to result/llama-3_3-70b-versatile/trial_2/what_are_the_targets_and_mechanisms_for.xlsx\n",
      "Processing: Provide drugs approved for colorectal cancer with their target names. | Model: llama-3.3-70b-versatile | Trial: 2\n",
      "Saved to result/llama-3_3-70b-versatile/trial_2/provide_drugs_approved_for_colorectal_ca.xlsx\n",
      "Processing: List pathways implicated in myelodysplastic syndromes. | Model: llama-3.3-70b-versatile | Trial: 2\n",
      "Saved to result/llama-3_3-70b-versatile/trial_2/list_pathways_implicated_in_myelodysplas.xlsx\n",
      "Processing: What are the approved drugs for BRAF V600Emutant melanoma? | Model: llama-3.3-70b-versatile | Trial: 2\n",
      "Saved to result/llama-3_3-70b-versatile/trial_2/what_are_the_approved_drugs_for_braf_v60.xlsx\n",
      "Processing: List all FLT3 inhibitors used for treating acute myeloid leukemia. | Model: llama-3.3-70b-versatile | Trial: 2\n",
      "Saved to result/llama-3_3-70b-versatile/trial_2/list_all_flt3_inhibitors_used_for_treati.xlsx\n",
      "Processing: What is the mechanism of action of lenvatinib? | Model: llama-3.3-70b-versatile | Trial: 2\n",
      "Saved to result/llama-3_3-70b-versatile/trial_2/what_is_the_mechanism_of_action_of_lenva.xlsx\n",
      "Processing: Which genes are targeted by monoclonal antibodies in multiple sclerosis? | Model: llama-3.3-70b-versatile | Trial: 2\n",
      "Saved to result/llama-3_3-70b-versatile/trial_2/which_genes_are_targeted_by_monoclonal_a.xlsx\n",
      "Processing: Drugs with approval status for leprosy. | Model: llama-3.3-70b-versatile | Trial: 2\n",
      "Saved to result/llama-3_3-70b-versatile/trial_2/drugs_with_approval_status_for_leprosy.xlsx\n",
      "Processing: Biomarkers associated with the TGF-ß pathway in fibrosis. | Model: llama-3.3-70b-versatile | Trial: 2\n",
      "Saved to result/llama-3_3-70b-versatile/trial_2/biomarkers_associated_with_the_tgf-__pat.xlsx\n",
      "Processing: Show drugs that inhibit the RET gene. | Model: llama-3.3-70b-versatile | Trial: 2\n",
      "Saved to result/llama-3_3-70b-versatile/trial_2/show_drugs_that_inhibit_the_ret_gene.xlsx\n",
      "Processing: What diseases are treated with trastuzumab deruxtecan? | Model: llama-3.3-70b-versatile | Trial: 2\n",
      "Saved to result/llama-3_3-70b-versatile/trial_2/what_diseases_are_treated_with_trastuzum.xlsx\n",
      "Processing: Which pathways are targeted by PI3K inhibitors? | Model: llama-3.3-70b-versatile | Trial: 2\n",
      "Saved to result/llama-3_3-70b-versatile/trial_2/which_pathways_are_targeted_by_pi3k_inhi.xlsx\n",
      "Processing: Approved drugs for atopic dermatitis and their mechanisms of action. | Model: llama-3.3-70b-versatile | Trial: 2\n",
      "Saved to result/llama-3_3-70b-versatile/trial_2/approved_drugs_for_atopic_dermatitis_and.xlsx\n",
      "Processing: What are the known targets of vandetanib? | Model: llama-3.3-70b-versatile | Trial: 2\n",
      "Saved to result/llama-3_3-70b-versatile/trial_2/what_are_the_known_targets_of_vandetanib.xlsx\n",
      "Processing: Provide the SMILES for sorafenib. | Model: llama-3.3-70b-versatile | Trial: 2\n",
      "----- Some error occured-----\n",
      "Processing: Provide the SMILES for sorafenib. | Model: llama-3.3-70b-versatile | Trial: 2\n",
      "Processing: Genes linked to schizophrenia. | Model: llama-3.3-70b-versatile | Trial: 2\n",
      "Saved to result/llama-3_3-70b-versatile/trial_2/genes_linked_to_schizophrenia.xlsx\n",
      "Processing: List of drugs and approval status for dengue. | Model: llama-3.3-70b-versatile | Trial: 2\n",
      "Saved to result/llama-3_3-70b-versatile/trial_2/list_of_drugs_and_approval_status_for_de.xlsx\n",
      "Processing: What drugs target the JAKSTAT pathway in atopic dermatitis? | Model: llama-3.3-70b-versatile | Trial: 2\n",
      "Saved to result/llama-3_3-70b-versatile/trial_2/what_drugs_target_the_jak_stat_pathway_i.xlsx\n",
      "Processing: Diseases associated with the gene KRAS. | Model: llama-3.3-70b-versatile | Trial: 2\n",
      "Saved to result/llama-3_3-70b-versatile/trial_2/diseases_associated_with_the_gene_kras.xlsx\n",
      "Processing: Biomarkers for early detection of ovarian cancer. | Model: llama-3.3-70b-versatile | Trial: 2\n",
      "Saved to result/llama-3_3-70b-versatile/trial_2/biomarkers_for_early_detection_of_ovaria.xlsx\n",
      "Processing: Which drugs act as BCR-ABL inhibitors? | Model: llama-3.3-70b-versatile | Trial: 2\n",
      "Saved to result/llama-3_3-70b-versatile/trial_2/which_drugs_act_as_bcr-abl_inhibitors.xlsx\n",
      "Processing: Drugs for idiopathic pulmonary fibrosis and their approval status. | Model: llama-3.3-70b-versatile | Trial: 2\n",
      "Saved to result/llama-3_3-70b-versatile/trial_2/drugs_for_idiopathic_pulmonary_fibrosis.xlsx\n",
      "Processing: What are the mechanisms of action for monoclonal antibodies targeting IL-6? | Model: llama-3.3-70b-versatile | Trial: 2\n",
      "Saved to result/llama-3_3-70b-versatile/trial_2/what_are_the_mechanisms_of_action_for_mo.xlsx\n",
      "Processing: Which approved drugs are used for treating osteoporosis? | Model: llama-3.3-70b-versatile | Trial: 2\n",
      "Saved to result/llama-3_3-70b-versatile/trial_2/which_approved_drugs_are_used_for_treati.xlsx\n",
      "Processing: What are the targets and mechanisms for dupilumab? | Model: llama-3.3-70b-versatile | Trial: 2\n",
      "Saved to result/llama-3_3-70b-versatile/trial_2/what_are_the_targets_and_mechanisms_for.xlsx\n",
      "Processing: Provide drugs approved for renal cell carcinoma with their target names. | Model: llama-3.3-70b-versatile | Trial: 2\n",
      "Saved to result/llama-3_3-70b-versatile/trial_2/provide_drugs_approved_for_renal_cell_ca.xlsx\n",
      "Processing: List pathways implicated in prostate cancer. | Model: llama-3.3-70b-versatile | Trial: 2\n",
      "Saved to result/llama-3_3-70b-versatile/trial_2/list_pathways_implicated_in_prostate_can.xlsx\n",
      "Processing: What are the approved drugs for EGFR exon 20 insertionmutant lung cancer? | Model: llama-3.3-70b-versatile | Trial: 2\n",
      "Saved to result/llama-3_3-70b-versatile/trial_2/what_are_the_approved_drugs_for_egfr_exo.xlsx\n",
      "Processing: List all TRK inhibitors used for treating NTRK-fusion cancers. | Model: llama-3.3-70b-versatile | Trial: 2\n",
      "Saved to result/llama-3_3-70b-versatile/trial_2/list_all_trk_inhibitors_used_for_treatin.xlsx\n",
      "Processing: What is the mechanism of action of darolutamide? | Model: llama-3.3-70b-versatile | Trial: 2\n",
      "Saved to result/llama-3_3-70b-versatile/trial_2/what_is_the_mechanism_of_action_of_darol.xlsx\n",
      "Processing: Which genes are targeted by monoclonal antibodies in oncology immunotherapy? | Model: llama-3.3-70b-versatile | Trial: 2\n",
      "Saved to result/llama-3_3-70b-versatile/trial_2/which_genes_are_targeted_by_monoclonal_a.xlsx\n",
      "Processing: What drugs are used to treat fever? | Model: llama-3.3-70b-versatile | Trial: 2\n",
      "Saved to result/llama-3_3-70b-versatile/trial_2/what_drugs_are_used_to_treat_fever.xlsx\n",
      "Processing: What are the approved drugs for triple-negative breast cancer? | Model: llama-3.3-70b-versatile | Trial: 3\n",
      "Saved to result/llama-3_3-70b-versatile/trial_3/what_are_the_approved_drugs_for_triple-n.xlsx\n",
      "Processing: List all ALK inhibitors used for treating non-small cell lung cancer. | Model: llama-3.3-70b-versatile | Trial: 3\n",
      "Saved to result/llama-3_3-70b-versatile/trial_3/list_all_alk_inhibitors_used_for_treatin.xlsx\n",
      "Processing: What is the mechanism of action of nivolumab? | Model: llama-3.3-70b-versatile | Trial: 3\n",
      "Saved to result/llama-3_3-70b-versatile/trial_3/what_is_the_mechanism_of_action_of_nivol.xlsx\n",
      "Processing: Drugs with approval status for hepatitis C virus infection. | Model: llama-3.3-70b-versatile | Trial: 3\n",
      "Saved to result/llama-3_3-70b-versatile/trial_3/drugs_with_approval_status_for_hepatitis.xlsx\n",
      "Processing: Biomarkers associated with the PI3KAKT pathway in breast cancer. | Model: llama-3.3-70b-versatile | Trial: 3\n",
      "Saved to result/llama-3_3-70b-versatile/trial_3/biomarkers_associated_with_the_pi3k_akt.xlsx\n",
      "Processing: Show drugs that inhibit the KRAS G12C variant. | Model: llama-3.3-70b-versatile | Trial: 3\n",
      "Saved to result/llama-3_3-70b-versatile/trial_3/show_drugs_that_inhibit_the_kras_g12c_va.xlsx\n",
      "Processing: What diseases are treated with atezolizumab? | Model: llama-3.3-70b-versatile | Trial: 3\n",
      "Saved to result/llama-3_3-70b-versatile/trial_3/what_diseases_are_treated_with_atezolizu.xlsx\n",
      "Processing: Which pathways are targeted by PARP inhibitors? | Model: llama-3.3-70b-versatile | Trial: 3\n",
      "Saved to result/llama-3_3-70b-versatile/trial_3/which_pathways_are_targeted_by_parp_inhi.xlsx\n",
      "Processing: Approved drugs for multiple sclerosis and their mechanisms of action. | Model: llama-3.3-70b-versatile | Trial: 3\n",
      "Saved to result/llama-3_3-70b-versatile/trial_3/approved_drugs_for_multiple_sclerosis_an.xlsx\n",
      "Processing: What are the known targets of sunitinib? | Model: llama-3.3-70b-versatile | Trial: 3\n",
      "Saved to result/llama-3_3-70b-versatile/trial_3/what_are_the_known_targets_of_sunitinib.xlsx\n",
      "Processing: Provide the SMILES for dasatinib. | Model: llama-3.3-70b-versatile | Trial: 3\n",
      "----- Some error occured-----\n",
      "Processing: Provide the SMILES for dasatinib. | Model: llama-3.3-70b-versatile | Trial: 3\n",
      "Processing: Genes linked to amyotrophic lateral sclerosis. | Model: llama-3.3-70b-versatile | Trial: 3\n",
      "Saved to result/llama-3_3-70b-versatile/trial_3/genes_linked_to_amyotrophic_lateral_scle.xlsx\n",
      "Processing: List of drugs and approval status for malaria. | Model: llama-3.3-70b-versatile | Trial: 3\n",
      "Saved to result/llama-3_3-70b-versatile/trial_3/list_of_drugs_and_approval_status_for_ma.xlsx\n",
      "Processing: What drugs target the JAKSTAT pathway in myelofibrosis? | Model: llama-3.3-70b-versatile | Trial: 3\n",
      "Saved to result/llama-3_3-70b-versatile/trial_3/what_drugs_target_the_jak_stat_pathway_i.xlsx\n",
      "Processing: Diseases associated with the gene BRCA1. | Model: llama-3.3-70b-versatile | Trial: 3\n",
      "Saved to result/llama-3_3-70b-versatile/trial_3/diseases_associated_with_the_gene_brca1.xlsx\n",
      "Processing: Biomarkers for early detection of pancreatic cancer. | Model: llama-3.3-70b-versatile | Trial: 3\n",
      "Saved to result/llama-3_3-70b-versatile/trial_3/biomarkers_for_early_detection_of_pancre.xlsx\n",
      "Processing: Which drugs act as VEGF inhibitors? | Model: llama-3.3-70b-versatile | Trial: 3\n",
      "Saved to result/llama-3_3-70b-versatile/trial_3/which_drugs_act_as_vegf_inhibitors.xlsx\n",
      "Processing: Drugs for chronic hepatitis B and their approval status. | Model: llama-3.3-70b-versatile | Trial: 3\n",
      "Saved to result/llama-3_3-70b-versatile/trial_3/drugs_for_chronic_hepatitis_b_and_their.xlsx\n",
      "Processing: What are the mechanisms of action for beta-lactam antibiotics? | Model: llama-3.3-70b-versatile | Trial: 3\n",
      "Saved to result/llama-3_3-70b-versatile/trial_3/what_are_the_mechanisms_of_action_for_be.xlsx\n",
      "Processing: Which approved drugs are used for treating rheumatoid arthritis? | Model: llama-3.3-70b-versatile | Trial: 3\n",
      "Saved to result/llama-3_3-70b-versatile/trial_3/which_approved_drugs_are_used_for_treati.xlsx\n",
      "Processing: What are the targets and mechanisms for dulaglutide? | Model: llama-3.3-70b-versatile | Trial: 3\n",
      "Saved to result/llama-3_3-70b-versatile/trial_3/what_are_the_targets_and_mechanisms_for.xlsx\n",
      "Processing: Provide drugs approved for ovarian cancer with their target names. | Model: llama-3.3-70b-versatile | Trial: 3\n",
      "Saved to result/llama-3_3-70b-versatile/trial_3/provide_drugs_approved_for_ovarian_cance.xlsx\n",
      "Processing: List pathways implicated in chronic lymphocytic leukemia. | Model: llama-3.3-70b-versatile | Trial: 3\n",
      "Saved to result/llama-3_3-70b-versatile/trial_3/list_pathways_implicated_in_chronic_lymp.xlsx\n",
      "Processing: What are the approved drugs for HER2-low breast cancer? | Model: llama-3.3-70b-versatile | Trial: 3\n",
      "Saved to result/llama-3_3-70b-versatile/trial_3/what_are_the_approved_drugs_for_her2-low.xlsx\n",
      "Processing: List all BTK inhibitors used for treating mantle cell lymphoma. | Model: llama-3.3-70b-versatile | Trial: 3\n",
      "Saved to result/llama-3_3-70b-versatile/trial_3/list_all_btk_inhibitors_used_for_treatin.xlsx\n",
      "Processing: What is the mechanism of action of pembrolizumab? | Model: llama-3.3-70b-versatile | Trial: 3\n",
      "Saved to result/llama-3_3-70b-versatile/trial_3/what_is_the_mechanism_of_action_of_pembr.xlsx\n",
      "Processing: Which genes are targeted by monoclonal antibodies in psoriasis? | Model: llama-3.3-70b-versatile | Trial: 3\n",
      "Saved to result/llama-3_3-70b-versatile/trial_3/which_genes_are_targeted_by_monoclonal_a.xlsx\n",
      "Processing: Drugs with approval status for HIV/AIDS. | Model: llama-3.3-70b-versatile | Trial: 3\n",
      "Saved to result/llama-3_3-70b-versatile/trial_3/drugs_with_approval_status_for_hiv_aids.xlsx\n",
      "Processing: Biomarkers associated with the RASRAFMEK pathway in colorectal cancer. | Model: llama-3.3-70b-versatile | Trial: 3\n",
      "Saved to result/llama-3_3-70b-versatile/trial_3/biomarkers_associated_with_the_ras_raf_m.xlsx\n",
      "Processing: Show drugs that inhibit the IDH1 gene. | Model: llama-3.3-70b-versatile | Trial: 3\n",
      "Saved to result/llama-3_3-70b-versatile/trial_3/show_drugs_that_inhibit_the_idh1_gene.xlsx\n",
      "Processing: What diseases are treated with durvalumab? | Model: llama-3.3-70b-versatile | Trial: 3\n",
      "Saved to result/llama-3_3-70b-versatile/trial_3/what_diseases_are_treated_with_durvaluma.xlsx\n",
      "Processing: Which pathways are targeted by MEK inhibitors? | Model: llama-3.3-70b-versatile | Trial: 3\n",
      "Saved to result/llama-3_3-70b-versatile/trial_3/which_pathways_are_targeted_by_mek_inhib.xlsx\n",
      "Processing: Approved drugs for ulcerative colitis and their mechanisms of action. | Model: llama-3.3-70b-versatile | Trial: 3\n",
      "Saved to result/llama-3_3-70b-versatile/trial_3/approved_drugs_for_ulcerative_colitis_an.xlsx\n",
      "Processing: What are the known targets of regorafenib? | Model: llama-3.3-70b-versatile | Trial: 3\n",
      "Saved to result/llama-3_3-70b-versatile/trial_3/what_are_the_known_targets_of_regorafeni.xlsx\n",
      "Processing: Provide the SMILES for erlotinib. | Model: llama-3.3-70b-versatile | Trial: 3\n",
      "----- Some error occured-----\n",
      "Processing: Provide the SMILES for erlotinib. | Model: llama-3.3-70b-versatile | Trial: 3\n",
      "Processing: Genes linked to Parkinsons disease. | Model: llama-3.3-70b-versatile | Trial: 3\n",
      "Saved to result/llama-3_3-70b-versatile/trial_3/genes_linked_to_parkinson_s_disease.xlsx\n",
      "Processing: List of drugs and approval status for influenza. | Model: llama-3.3-70b-versatile | Trial: 3\n",
      "Saved to result/llama-3_3-70b-versatile/trial_3/list_of_drugs_and_approval_status_for_in.xlsx\n",
      "Processing: What drugs target the PI3K pathway in lymphoma? | Model: llama-3.3-70b-versatile | Trial: 3\n",
      "Saved to result/llama-3_3-70b-versatile/trial_3/what_drugs_target_the_pi3k_pathway_in_ly.xlsx\n",
      "Processing: Diseases associated with the gene PIK3CA. | Model: llama-3.3-70b-versatile | Trial: 3\n",
      "Saved to result/llama-3_3-70b-versatile/trial_3/diseases_associated_with_the_gene_pik3ca.xlsx\n",
      "Processing: Biomarkers for early detection of gastric cancer. | Model: llama-3.3-70b-versatile | Trial: 3\n",
      "Saved to result/llama-3_3-70b-versatile/trial_3/biomarkers_for_early_detection_of_gastri.xlsx\n",
      "Processing: Which drugs act as PD-1 inhibitors? | Model: llama-3.3-70b-versatile | Trial: 3\n",
      "Saved to result/llama-3_3-70b-versatile/trial_3/which_drugs_act_as_pd-1_inhibitors.xlsx\n",
      "Processing: Drugs for hepatitis D and their approval status. | Model: llama-3.3-70b-versatile | Trial: 3\n",
      "Saved to result/llama-3_3-70b-versatile/trial_3/drugs_for_hepatitis_d_and_their_approval.xlsx\n",
      "Processing: What are the mechanisms of action for SGLT2 inhibitors? | Model: llama-3.3-70b-versatile | Trial: 3\n",
      "Saved to result/llama-3_3-70b-versatile/trial_3/what_are_the_mechanisms_of_action_for_sg.xlsx\n",
      "Processing: Which approved drugs are used for treating systemic lupus erythematosus? | Model: llama-3.3-70b-versatile | Trial: 3\n",
      "Saved to result/llama-3_3-70b-versatile/trial_3/which_approved_drugs_are_used_for_treati.xlsx\n",
      "Processing: What are the targets and mechanisms for tofacitinib? | Model: llama-3.3-70b-versatile | Trial: 3\n",
      "Saved to result/llama-3_3-70b-versatile/trial_3/what_are_the_targets_and_mechanisms_for.xlsx\n",
      "Processing: Provide drugs approved for prostate cancer with their target names. | Model: llama-3.3-70b-versatile | Trial: 3\n",
      "Saved to result/llama-3_3-70b-versatile/trial_3/provide_drugs_approved_for_prostate_canc.xlsx\n",
      "Processing: List pathways implicated in glioblastoma. | Model: llama-3.3-70b-versatile | Trial: 3\n",
      "Saved to result/llama-3_3-70b-versatile/trial_3/list_pathways_implicated_in_glioblastoma.xlsx\n",
      "Processing: What are the approved drugs for EGFR-mutant non-small cell lung cancer? | Model: llama-3.3-70b-versatile | Trial: 3\n",
      "Saved to result/llama-3_3-70b-versatile/trial_3/what_are_the_approved_drugs_for_egfr-mut.xlsx\n",
      "Processing: List all CDK4/6 inhibitors used for treating breast cancer. | Model: llama-3.3-70b-versatile | Trial: 3\n",
      "Saved to result/llama-3_3-70b-versatile/trial_3/list_all_cdk4_6_inhibitors_used_for_trea.xlsx\n",
      "Processing: What is the mechanism of action of osimertinib? | Model: llama-3.3-70b-versatile | Trial: 3\n",
      "Saved to result/llama-3_3-70b-versatile/trial_3/what_is_the_mechanism_of_action_of_osime.xlsx\n",
      "Processing: Which genes are targeted by monoclonal antibodies in asthma? | Model: llama-3.3-70b-versatile | Trial: 3\n",
      "Saved to result/llama-3_3-70b-versatile/trial_3/which_genes_are_targeted_by_monoclonal_a.xlsx\n",
      "Processing: Drugs with approval status for Clostridioides difficile infection. | Model: llama-3.3-70b-versatile | Trial: 3\n",
      "Saved to result/llama-3_3-70b-versatile/trial_3/drugs_with_approval_status_for_clostridi.xlsx\n",
      "Processing: Biomarkers associated with the WNT/ß-catenin pathway in cancer. | Model: llama-3.3-70b-versatile | Trial: 3\n",
      "Saved to result/llama-3_3-70b-versatile/trial_3/biomarkers_associated_with_the_wnt__-cat.xlsx\n",
      "Processing: Show drugs that inhibit the FGFR2 gene. | Model: llama-3.3-70b-versatile | Trial: 3\n",
      "Saved to result/llama-3_3-70b-versatile/trial_3/show_drugs_that_inhibit_the_fgfr2_gene.xlsx\n",
      "Processing: What diseases are treated with bevacizumab? | Model: llama-3.3-70b-versatile | Trial: 3\n",
      "Saved to result/llama-3_3-70b-versatile/trial_3/what_diseases_are_treated_with_bevacizum.xlsx\n",
      "Processing: Which pathways are targeted by mTOR inhibitors? | Model: llama-3.3-70b-versatile | Trial: 3\n",
      "Saved to result/llama-3_3-70b-versatile/trial_3/which_pathways_are_targeted_by_mtor_inhi.xlsx\n",
      "Processing: Approved drugs for plaque psoriasis and their mechanisms of action. | Model: llama-3.3-70b-versatile | Trial: 3\n",
      "Saved to result/llama-3_3-70b-versatile/trial_3/approved_drugs_for_plaque_psoriasis_and.xlsx\n",
      "Processing: What are the known targets of cabozantinib? | Model: llama-3.3-70b-versatile | Trial: 3\n",
      "Saved to result/llama-3_3-70b-versatile/trial_3/what_are_the_known_targets_of_cabozantin.xlsx\n",
      "Processing: Provide the SMILES for gefitinib. | Model: llama-3.3-70b-versatile | Trial: 3\n",
      "----- Some error occured-----\n",
      "Processing: Provide the SMILES for gefitinib. | Model: llama-3.3-70b-versatile | Trial: 3\n",
      "Processing: Genes linked to Crohns disease. | Model: llama-3.3-70b-versatile | Trial: 3\n",
      "Saved to result/llama-3_3-70b-versatile/trial_3/genes_linked_to_crohn_s_disease.xlsx\n",
      "Processing: List of drugs and approval status for respiratory syncytial virus infection. | Model: llama-3.3-70b-versatile | Trial: 3\n",
      "Saved to result/llama-3_3-70b-versatile/trial_3/list_of_drugs_and_approval_status_for_re.xlsx\n",
      "Processing: What drugs target the Hedgehog pathway in oncology? | Model: llama-3.3-70b-versatile | Trial: 3\n",
      "Saved to result/llama-3_3-70b-versatile/trial_3/what_drugs_target_the_hedgehog_pathway_i.xlsx\n",
      "Processing: Diseases associated with the gene NPM1. | Model: llama-3.3-70b-versatile | Trial: 3\n",
      "Saved to result/llama-3_3-70b-versatile/trial_3/diseases_associated_with_the_gene_npm1.xlsx\n",
      "Processing: Biomarkers for early detection of hepatocellular carcinoma. | Model: llama-3.3-70b-versatile | Trial: 3\n",
      "Saved to result/llama-3_3-70b-versatile/trial_3/biomarkers_for_early_detection_of_hepato.xlsx\n",
      "Processing: Which drugs act as CTLA-4 inhibitors? | Model: llama-3.3-70b-versatile | Trial: 3\n",
      "Saved to result/llama-3_3-70b-versatile/trial_3/which_drugs_act_as_ctla-4_inhibitors.xlsx\n",
      "Processing: Drugs for pulmonary arterial hypertension and their approval status. | Model: llama-3.3-70b-versatile | Trial: 3\n",
      "Saved to result/llama-3_3-70b-versatile/trial_3/drugs_for_pulmonary_arterial_hypertensio.xlsx\n",
      "Processing: What are the mechanisms of action for ACE inhibitors? | Model: llama-3.3-70b-versatile | Trial: 3\n",
      "Saved to result/llama-3_3-70b-versatile/trial_3/what_are_the_mechanisms_of_action_for_ac.xlsx\n",
      "Processing: Which approved drugs are used for treating migraine? | Model: llama-3.3-70b-versatile | Trial: 3\n",
      "Saved to result/llama-3_3-70b-versatile/trial_3/which_approved_drugs_are_used_for_treati.xlsx\n",
      "Processing: What are the targets and mechanisms for rituximab? | Model: llama-3.3-70b-versatile | Trial: 3\n",
      "Saved to result/llama-3_3-70b-versatile/trial_3/what_are_the_targets_and_mechanisms_for.xlsx\n",
      "Processing: Provide drugs approved for colorectal cancer with their target names. | Model: llama-3.3-70b-versatile | Trial: 3\n",
      "Saved to result/llama-3_3-70b-versatile/trial_3/provide_drugs_approved_for_colorectal_ca.xlsx\n",
      "Processing: List pathways implicated in myelodysplastic syndromes. | Model: llama-3.3-70b-versatile | Trial: 3\n",
      "Saved to result/llama-3_3-70b-versatile/trial_3/list_pathways_implicated_in_myelodysplas.xlsx\n",
      "Processing: What are the approved drugs for BRAF V600Emutant melanoma? | Model: llama-3.3-70b-versatile | Trial: 3\n",
      "Saved to result/llama-3_3-70b-versatile/trial_3/what_are_the_approved_drugs_for_braf_v60.xlsx\n",
      "Processing: List all FLT3 inhibitors used for treating acute myeloid leukemia. | Model: llama-3.3-70b-versatile | Trial: 3\n",
      "Saved to result/llama-3_3-70b-versatile/trial_3/list_all_flt3_inhibitors_used_for_treati.xlsx\n",
      "Processing: What is the mechanism of action of lenvatinib? | Model: llama-3.3-70b-versatile | Trial: 3\n",
      "Saved to result/llama-3_3-70b-versatile/trial_3/what_is_the_mechanism_of_action_of_lenva.xlsx\n",
      "Processing: Which genes are targeted by monoclonal antibodies in multiple sclerosis? | Model: llama-3.3-70b-versatile | Trial: 3\n",
      "Saved to result/llama-3_3-70b-versatile/trial_3/which_genes_are_targeted_by_monoclonal_a.xlsx\n",
      "Processing: Drugs with approval status for leprosy. | Model: llama-3.3-70b-versatile | Trial: 3\n",
      "Saved to result/llama-3_3-70b-versatile/trial_3/drugs_with_approval_status_for_leprosy.xlsx\n",
      "Processing: Biomarkers associated with the TGF-ß pathway in fibrosis. | Model: llama-3.3-70b-versatile | Trial: 3\n",
      "Saved to result/llama-3_3-70b-versatile/trial_3/biomarkers_associated_with_the_tgf-__pat.xlsx\n",
      "Processing: Show drugs that inhibit the RET gene. | Model: llama-3.3-70b-versatile | Trial: 3\n",
      "Saved to result/llama-3_3-70b-versatile/trial_3/show_drugs_that_inhibit_the_ret_gene.xlsx\n",
      "Processing: What diseases are treated with trastuzumab deruxtecan? | Model: llama-3.3-70b-versatile | Trial: 3\n",
      "Saved to result/llama-3_3-70b-versatile/trial_3/what_diseases_are_treated_with_trastuzum.xlsx\n",
      "Processing: Which pathways are targeted by PI3K inhibitors? | Model: llama-3.3-70b-versatile | Trial: 3\n",
      "Saved to result/llama-3_3-70b-versatile/trial_3/which_pathways_are_targeted_by_pi3k_inhi.xlsx\n",
      "Processing: Approved drugs for atopic dermatitis and their mechanisms of action. | Model: llama-3.3-70b-versatile | Trial: 3\n",
      "Saved to result/llama-3_3-70b-versatile/trial_3/approved_drugs_for_atopic_dermatitis_and.xlsx\n",
      "Processing: What are the known targets of vandetanib? | Model: llama-3.3-70b-versatile | Trial: 3\n",
      "Saved to result/llama-3_3-70b-versatile/trial_3/what_are_the_known_targets_of_vandetanib.xlsx\n",
      "Processing: Provide the SMILES for sorafenib. | Model: llama-3.3-70b-versatile | Trial: 3\n",
      "----- Some error occured-----\n",
      "Processing: Provide the SMILES for sorafenib. | Model: llama-3.3-70b-versatile | Trial: 3\n",
      "Processing: Genes linked to schizophrenia. | Model: llama-3.3-70b-versatile | Trial: 3\n",
      "Saved to result/llama-3_3-70b-versatile/trial_3/genes_linked_to_schizophrenia.xlsx\n",
      "Processing: List of drugs and approval status for dengue. | Model: llama-3.3-70b-versatile | Trial: 3\n",
      "Saved to result/llama-3_3-70b-versatile/trial_3/list_of_drugs_and_approval_status_for_de.xlsx\n",
      "Processing: What drugs target the JAKSTAT pathway in atopic dermatitis? | Model: llama-3.3-70b-versatile | Trial: 3\n",
      "Saved to result/llama-3_3-70b-versatile/trial_3/what_drugs_target_the_jak_stat_pathway_i.xlsx\n",
      "Processing: Diseases associated with the gene KRAS. | Model: llama-3.3-70b-versatile | Trial: 3\n",
      "Saved to result/llama-3_3-70b-versatile/trial_3/diseases_associated_with_the_gene_kras.xlsx\n",
      "Processing: Biomarkers for early detection of ovarian cancer. | Model: llama-3.3-70b-versatile | Trial: 3\n",
      "Saved to result/llama-3_3-70b-versatile/trial_3/biomarkers_for_early_detection_of_ovaria.xlsx\n",
      "Processing: Which drugs act as BCR-ABL inhibitors? | Model: llama-3.3-70b-versatile | Trial: 3\n",
      "Saved to result/llama-3_3-70b-versatile/trial_3/which_drugs_act_as_bcr-abl_inhibitors.xlsx\n",
      "Processing: Drugs for idiopathic pulmonary fibrosis and their approval status. | Model: llama-3.3-70b-versatile | Trial: 3\n",
      "Saved to result/llama-3_3-70b-versatile/trial_3/drugs_for_idiopathic_pulmonary_fibrosis.xlsx\n",
      "Processing: What are the mechanisms of action for monoclonal antibodies targeting IL-6? | Model: llama-3.3-70b-versatile | Trial: 3\n",
      "Saved to result/llama-3_3-70b-versatile/trial_3/what_are_the_mechanisms_of_action_for_mo.xlsx\n",
      "Processing: Which approved drugs are used for treating osteoporosis? | Model: llama-3.3-70b-versatile | Trial: 3\n",
      "Saved to result/llama-3_3-70b-versatile/trial_3/which_approved_drugs_are_used_for_treati.xlsx\n",
      "Processing: What are the targets and mechanisms for dupilumab? | Model: llama-3.3-70b-versatile | Trial: 3\n",
      "Saved to result/llama-3_3-70b-versatile/trial_3/what_are_the_targets_and_mechanisms_for.xlsx\n",
      "Processing: Provide drugs approved for renal cell carcinoma with their target names. | Model: llama-3.3-70b-versatile | Trial: 3\n",
      "Saved to result/llama-3_3-70b-versatile/trial_3/provide_drugs_approved_for_renal_cell_ca.xlsx\n",
      "Processing: List pathways implicated in prostate cancer. | Model: llama-3.3-70b-versatile | Trial: 3\n",
      "Saved to result/llama-3_3-70b-versatile/trial_3/list_pathways_implicated_in_prostate_can.xlsx\n",
      "Processing: What are the approved drugs for EGFR exon 20 insertionmutant lung cancer? | Model: llama-3.3-70b-versatile | Trial: 3\n",
      "Saved to result/llama-3_3-70b-versatile/trial_3/what_are_the_approved_drugs_for_egfr_exo.xlsx\n",
      "Processing: List all TRK inhibitors used for treating NTRK-fusion cancers. | Model: llama-3.3-70b-versatile | Trial: 3\n",
      "Saved to result/llama-3_3-70b-versatile/trial_3/list_all_trk_inhibitors_used_for_treatin.xlsx\n",
      "Processing: What is the mechanism of action of darolutamide? | Model: llama-3.3-70b-versatile | Trial: 3\n",
      "Saved to result/llama-3_3-70b-versatile/trial_3/what_is_the_mechanism_of_action_of_darol.xlsx\n",
      "Processing: Which genes are targeted by monoclonal antibodies in oncology immunotherapy? | Model: llama-3.3-70b-versatile | Trial: 3\n",
      "Saved to result/llama-3_3-70b-versatile/trial_3/which_genes_are_targeted_by_monoclonal_a.xlsx\n",
      "Processing: What drugs are used to treat fever? | Model: llama-3.3-70b-versatile | Trial: 3\n",
      "Saved to result/llama-3_3-70b-versatile/trial_3/what_drugs_are_used_to_treat_fever.xlsx\n",
      "Processing: What are the approved drugs for triple-negative breast cancer? | Model: llama-3.3-70b-versatile | Trial: 4\n",
      "Saved to result/llama-3_3-70b-versatile/trial_4/what_are_the_approved_drugs_for_triple-n.xlsx\n",
      "Processing: List all ALK inhibitors used for treating non-small cell lung cancer. | Model: llama-3.3-70b-versatile | Trial: 4\n",
      "Saved to result/llama-3_3-70b-versatile/trial_4/list_all_alk_inhibitors_used_for_treatin.xlsx\n",
      "Processing: What is the mechanism of action of nivolumab? | Model: llama-3.3-70b-versatile | Trial: 4\n",
      "Saved to result/llama-3_3-70b-versatile/trial_4/what_is_the_mechanism_of_action_of_nivol.xlsx\n",
      "Processing: Drugs with approval status for hepatitis C virus infection. | Model: llama-3.3-70b-versatile | Trial: 4\n",
      "Saved to result/llama-3_3-70b-versatile/trial_4/drugs_with_approval_status_for_hepatitis.xlsx\n",
      "Processing: Biomarkers associated with the PI3KAKT pathway in breast cancer. | Model: llama-3.3-70b-versatile | Trial: 4\n",
      "Saved to result/llama-3_3-70b-versatile/trial_4/biomarkers_associated_with_the_pi3k_akt.xlsx\n",
      "Processing: Show drugs that inhibit the KRAS G12C variant. | Model: llama-3.3-70b-versatile | Trial: 4\n",
      "Saved to result/llama-3_3-70b-versatile/trial_4/show_drugs_that_inhibit_the_kras_g12c_va.xlsx\n",
      "Processing: What diseases are treated with atezolizumab? | Model: llama-3.3-70b-versatile | Trial: 4\n",
      "Saved to result/llama-3_3-70b-versatile/trial_4/what_diseases_are_treated_with_atezolizu.xlsx\n",
      "Processing: Which pathways are targeted by PARP inhibitors? | Model: llama-3.3-70b-versatile | Trial: 4\n",
      "Saved to result/llama-3_3-70b-versatile/trial_4/which_pathways_are_targeted_by_parp_inhi.xlsx\n",
      "Processing: Approved drugs for multiple sclerosis and their mechanisms of action. | Model: llama-3.3-70b-versatile | Trial: 4\n",
      "Saved to result/llama-3_3-70b-versatile/trial_4/approved_drugs_for_multiple_sclerosis_an.xlsx\n",
      "Processing: What are the known targets of sunitinib? | Model: llama-3.3-70b-versatile | Trial: 4\n",
      "Saved to result/llama-3_3-70b-versatile/trial_4/what_are_the_known_targets_of_sunitinib.xlsx\n",
      "Processing: Provide the SMILES for dasatinib. | Model: llama-3.3-70b-versatile | Trial: 4\n",
      "----- Some error occured-----\n",
      "Processing: Provide the SMILES for dasatinib. | Model: llama-3.3-70b-versatile | Trial: 4\n",
      "Processing: Genes linked to amyotrophic lateral sclerosis. | Model: llama-3.3-70b-versatile | Trial: 4\n",
      "Saved to result/llama-3_3-70b-versatile/trial_4/genes_linked_to_amyotrophic_lateral_scle.xlsx\n",
      "Processing: List of drugs and approval status for malaria. | Model: llama-3.3-70b-versatile | Trial: 4\n",
      "Saved to result/llama-3_3-70b-versatile/trial_4/list_of_drugs_and_approval_status_for_ma.xlsx\n",
      "Processing: What drugs target the JAKSTAT pathway in myelofibrosis? | Model: llama-3.3-70b-versatile | Trial: 4\n",
      "Saved to result/llama-3_3-70b-versatile/trial_4/what_drugs_target_the_jak_stat_pathway_i.xlsx\n",
      "Processing: Diseases associated with the gene BRCA1. | Model: llama-3.3-70b-versatile | Trial: 4\n",
      "Saved to result/llama-3_3-70b-versatile/trial_4/diseases_associated_with_the_gene_brca1.xlsx\n",
      "Processing: Biomarkers for early detection of pancreatic cancer. | Model: llama-3.3-70b-versatile | Trial: 4\n",
      "Saved to result/llama-3_3-70b-versatile/trial_4/biomarkers_for_early_detection_of_pancre.xlsx\n",
      "Processing: Which drugs act as VEGF inhibitors? | Model: llama-3.3-70b-versatile | Trial: 4\n",
      "Saved to result/llama-3_3-70b-versatile/trial_4/which_drugs_act_as_vegf_inhibitors.xlsx\n",
      "Processing: Drugs for chronic hepatitis B and their approval status. | Model: llama-3.3-70b-versatile | Trial: 4\n",
      "Saved to result/llama-3_3-70b-versatile/trial_4/drugs_for_chronic_hepatitis_b_and_their.xlsx\n",
      "Processing: What are the mechanisms of action for beta-lactam antibiotics? | Model: llama-3.3-70b-versatile | Trial: 4\n",
      "Saved to result/llama-3_3-70b-versatile/trial_4/what_are_the_mechanisms_of_action_for_be.xlsx\n",
      "Processing: Which approved drugs are used for treating rheumatoid arthritis? | Model: llama-3.3-70b-versatile | Trial: 4\n",
      "Saved to result/llama-3_3-70b-versatile/trial_4/which_approved_drugs_are_used_for_treati.xlsx\n",
      "Processing: What are the targets and mechanisms for dulaglutide? | Model: llama-3.3-70b-versatile | Trial: 4\n",
      "Saved to result/llama-3_3-70b-versatile/trial_4/what_are_the_targets_and_mechanisms_for.xlsx\n",
      "Processing: Provide drugs approved for ovarian cancer with their target names. | Model: llama-3.3-70b-versatile | Trial: 4\n",
      "Saved to result/llama-3_3-70b-versatile/trial_4/provide_drugs_approved_for_ovarian_cance.xlsx\n",
      "Processing: List pathways implicated in chronic lymphocytic leukemia. | Model: llama-3.3-70b-versatile | Trial: 4\n",
      "Saved to result/llama-3_3-70b-versatile/trial_4/list_pathways_implicated_in_chronic_lymp.xlsx\n",
      "Processing: What are the approved drugs for HER2-low breast cancer? | Model: llama-3.3-70b-versatile | Trial: 4\n",
      "Saved to result/llama-3_3-70b-versatile/trial_4/what_are_the_approved_drugs_for_her2-low.xlsx\n",
      "Processing: List all BTK inhibitors used for treating mantle cell lymphoma. | Model: llama-3.3-70b-versatile | Trial: 4\n",
      "Saved to result/llama-3_3-70b-versatile/trial_4/list_all_btk_inhibitors_used_for_treatin.xlsx\n",
      "Processing: What is the mechanism of action of pembrolizumab? | Model: llama-3.3-70b-versatile | Trial: 4\n",
      "Saved to result/llama-3_3-70b-versatile/trial_4/what_is_the_mechanism_of_action_of_pembr.xlsx\n",
      "Processing: Which genes are targeted by monoclonal antibodies in psoriasis? | Model: llama-3.3-70b-versatile | Trial: 4\n",
      "Saved to result/llama-3_3-70b-versatile/trial_4/which_genes_are_targeted_by_monoclonal_a.xlsx\n",
      "Processing: Drugs with approval status for HIV/AIDS. | Model: llama-3.3-70b-versatile | Trial: 4\n",
      "Saved to result/llama-3_3-70b-versatile/trial_4/drugs_with_approval_status_for_hiv_aids.xlsx\n",
      "Processing: Biomarkers associated with the RASRAFMEK pathway in colorectal cancer. | Model: llama-3.3-70b-versatile | Trial: 4\n",
      "Saved to result/llama-3_3-70b-versatile/trial_4/biomarkers_associated_with_the_ras_raf_m.xlsx\n",
      "Processing: Show drugs that inhibit the IDH1 gene. | Model: llama-3.3-70b-versatile | Trial: 4\n",
      "Saved to result/llama-3_3-70b-versatile/trial_4/show_drugs_that_inhibit_the_idh1_gene.xlsx\n",
      "Processing: What diseases are treated with durvalumab? | Model: llama-3.3-70b-versatile | Trial: 4\n",
      "Saved to result/llama-3_3-70b-versatile/trial_4/what_diseases_are_treated_with_durvaluma.xlsx\n",
      "Processing: Which pathways are targeted by MEK inhibitors? | Model: llama-3.3-70b-versatile | Trial: 4\n",
      "Saved to result/llama-3_3-70b-versatile/trial_4/which_pathways_are_targeted_by_mek_inhib.xlsx\n",
      "Processing: Approved drugs for ulcerative colitis and their mechanisms of action. | Model: llama-3.3-70b-versatile | Trial: 4\n",
      "Saved to result/llama-3_3-70b-versatile/trial_4/approved_drugs_for_ulcerative_colitis_an.xlsx\n",
      "Processing: What are the known targets of regorafenib? | Model: llama-3.3-70b-versatile | Trial: 4\n",
      "Saved to result/llama-3_3-70b-versatile/trial_4/what_are_the_known_targets_of_regorafeni.xlsx\n",
      "Processing: Provide the SMILES for erlotinib. | Model: llama-3.3-70b-versatile | Trial: 4\n",
      "----- Some error occured-----\n",
      "Processing: Provide the SMILES for erlotinib. | Model: llama-3.3-70b-versatile | Trial: 4\n",
      "Processing: Genes linked to Parkinsons disease. | Model: llama-3.3-70b-versatile | Trial: 4\n",
      "Saved to result/llama-3_3-70b-versatile/trial_4/genes_linked_to_parkinson_s_disease.xlsx\n",
      "Processing: List of drugs and approval status for influenza. | Model: llama-3.3-70b-versatile | Trial: 4\n",
      "Saved to result/llama-3_3-70b-versatile/trial_4/list_of_drugs_and_approval_status_for_in.xlsx\n",
      "Processing: What drugs target the PI3K pathway in lymphoma? | Model: llama-3.3-70b-versatile | Trial: 4\n",
      "Saved to result/llama-3_3-70b-versatile/trial_4/what_drugs_target_the_pi3k_pathway_in_ly.xlsx\n",
      "Processing: Diseases associated with the gene PIK3CA. | Model: llama-3.3-70b-versatile | Trial: 4\n",
      "Saved to result/llama-3_3-70b-versatile/trial_4/diseases_associated_with_the_gene_pik3ca.xlsx\n",
      "Processing: Biomarkers for early detection of gastric cancer. | Model: llama-3.3-70b-versatile | Trial: 4\n",
      "Saved to result/llama-3_3-70b-versatile/trial_4/biomarkers_for_early_detection_of_gastri.xlsx\n",
      "Processing: Which drugs act as PD-1 inhibitors? | Model: llama-3.3-70b-versatile | Trial: 4\n",
      "Saved to result/llama-3_3-70b-versatile/trial_4/which_drugs_act_as_pd-1_inhibitors.xlsx\n",
      "Processing: Drugs for hepatitis D and their approval status. | Model: llama-3.3-70b-versatile | Trial: 4\n",
      "Saved to result/llama-3_3-70b-versatile/trial_4/drugs_for_hepatitis_d_and_their_approval.xlsx\n",
      "Processing: What are the mechanisms of action for SGLT2 inhibitors? | Model: llama-3.3-70b-versatile | Trial: 4\n",
      "Saved to result/llama-3_3-70b-versatile/trial_4/what_are_the_mechanisms_of_action_for_sg.xlsx\n",
      "Processing: Which approved drugs are used for treating systemic lupus erythematosus? | Model: llama-3.3-70b-versatile | Trial: 4\n",
      "Saved to result/llama-3_3-70b-versatile/trial_4/which_approved_drugs_are_used_for_treati.xlsx\n",
      "Processing: What are the targets and mechanisms for tofacitinib? | Model: llama-3.3-70b-versatile | Trial: 4\n",
      "Saved to result/llama-3_3-70b-versatile/trial_4/what_are_the_targets_and_mechanisms_for.xlsx\n",
      "Processing: Provide drugs approved for prostate cancer with their target names. | Model: llama-3.3-70b-versatile | Trial: 4\n",
      "Saved to result/llama-3_3-70b-versatile/trial_4/provide_drugs_approved_for_prostate_canc.xlsx\n",
      "Processing: List pathways implicated in glioblastoma. | Model: llama-3.3-70b-versatile | Trial: 4\n",
      "Saved to result/llama-3_3-70b-versatile/trial_4/list_pathways_implicated_in_glioblastoma.xlsx\n",
      "Processing: What are the approved drugs for EGFR-mutant non-small cell lung cancer? | Model: llama-3.3-70b-versatile | Trial: 4\n",
      "Saved to result/llama-3_3-70b-versatile/trial_4/what_are_the_approved_drugs_for_egfr-mut.xlsx\n",
      "Processing: List all CDK4/6 inhibitors used for treating breast cancer. | Model: llama-3.3-70b-versatile | Trial: 4\n",
      "Saved to result/llama-3_3-70b-versatile/trial_4/list_all_cdk4_6_inhibitors_used_for_trea.xlsx\n",
      "Processing: What is the mechanism of action of osimertinib? | Model: llama-3.3-70b-versatile | Trial: 4\n",
      "Saved to result/llama-3_3-70b-versatile/trial_4/what_is_the_mechanism_of_action_of_osime.xlsx\n",
      "Processing: Which genes are targeted by monoclonal antibodies in asthma? | Model: llama-3.3-70b-versatile | Trial: 4\n",
      "Saved to result/llama-3_3-70b-versatile/trial_4/which_genes_are_targeted_by_monoclonal_a.xlsx\n",
      "Processing: Drugs with approval status for Clostridioides difficile infection. | Model: llama-3.3-70b-versatile | Trial: 4\n",
      "Saved to result/llama-3_3-70b-versatile/trial_4/drugs_with_approval_status_for_clostridi.xlsx\n",
      "Processing: Biomarkers associated with the WNT/ß-catenin pathway in cancer. | Model: llama-3.3-70b-versatile | Trial: 4\n",
      "Saved to result/llama-3_3-70b-versatile/trial_4/biomarkers_associated_with_the_wnt__-cat.xlsx\n",
      "Processing: Show drugs that inhibit the FGFR2 gene. | Model: llama-3.3-70b-versatile | Trial: 4\n",
      "Saved to result/llama-3_3-70b-versatile/trial_4/show_drugs_that_inhibit_the_fgfr2_gene.xlsx\n",
      "Processing: What diseases are treated with bevacizumab? | Model: llama-3.3-70b-versatile | Trial: 4\n",
      "Saved to result/llama-3_3-70b-versatile/trial_4/what_diseases_are_treated_with_bevacizum.xlsx\n",
      "Processing: Which pathways are targeted by mTOR inhibitors? | Model: llama-3.3-70b-versatile | Trial: 4\n",
      "Saved to result/llama-3_3-70b-versatile/trial_4/which_pathways_are_targeted_by_mtor_inhi.xlsx\n",
      "Processing: Approved drugs for plaque psoriasis and their mechanisms of action. | Model: llama-3.3-70b-versatile | Trial: 4\n",
      "Saved to result/llama-3_3-70b-versatile/trial_4/approved_drugs_for_plaque_psoriasis_and.xlsx\n",
      "Processing: What are the known targets of cabozantinib? | Model: llama-3.3-70b-versatile | Trial: 4\n",
      "Saved to result/llama-3_3-70b-versatile/trial_4/what_are_the_known_targets_of_cabozantin.xlsx\n",
      "Processing: Provide the SMILES for gefitinib. | Model: llama-3.3-70b-versatile | Trial: 4\n",
      "----- Some error occured-----\n",
      "Processing: Provide the SMILES for gefitinib. | Model: llama-3.3-70b-versatile | Trial: 4\n",
      "Processing: Genes linked to Crohns disease. | Model: llama-3.3-70b-versatile | Trial: 4\n",
      "Saved to result/llama-3_3-70b-versatile/trial_4/genes_linked_to_crohn_s_disease.xlsx\n",
      "Processing: List of drugs and approval status for respiratory syncytial virus infection. | Model: llama-3.3-70b-versatile | Trial: 4\n",
      "Saved to result/llama-3_3-70b-versatile/trial_4/list_of_drugs_and_approval_status_for_re.xlsx\n",
      "Processing: What drugs target the Hedgehog pathway in oncology? | Model: llama-3.3-70b-versatile | Trial: 4\n",
      "Saved to result/llama-3_3-70b-versatile/trial_4/what_drugs_target_the_hedgehog_pathway_i.xlsx\n",
      "Processing: Diseases associated with the gene NPM1. | Model: llama-3.3-70b-versatile | Trial: 4\n",
      "Saved to result/llama-3_3-70b-versatile/trial_4/diseases_associated_with_the_gene_npm1.xlsx\n",
      "Processing: Biomarkers for early detection of hepatocellular carcinoma. | Model: llama-3.3-70b-versatile | Trial: 4\n",
      "Saved to result/llama-3_3-70b-versatile/trial_4/biomarkers_for_early_detection_of_hepato.xlsx\n",
      "Processing: Which drugs act as CTLA-4 inhibitors? | Model: llama-3.3-70b-versatile | Trial: 4\n",
      "Saved to result/llama-3_3-70b-versatile/trial_4/which_drugs_act_as_ctla-4_inhibitors.xlsx\n",
      "Processing: Drugs for pulmonary arterial hypertension and their approval status. | Model: llama-3.3-70b-versatile | Trial: 4\n",
      "Saved to result/llama-3_3-70b-versatile/trial_4/drugs_for_pulmonary_arterial_hypertensio.xlsx\n",
      "Processing: What are the mechanisms of action for ACE inhibitors? | Model: llama-3.3-70b-versatile | Trial: 4\n",
      "Saved to result/llama-3_3-70b-versatile/trial_4/what_are_the_mechanisms_of_action_for_ac.xlsx\n",
      "Processing: Which approved drugs are used for treating migraine? | Model: llama-3.3-70b-versatile | Trial: 4\n",
      "Saved to result/llama-3_3-70b-versatile/trial_4/which_approved_drugs_are_used_for_treati.xlsx\n",
      "Processing: What are the targets and mechanisms for rituximab? | Model: llama-3.3-70b-versatile | Trial: 4\n",
      "Saved to result/llama-3_3-70b-versatile/trial_4/what_are_the_targets_and_mechanisms_for.xlsx\n",
      "Processing: Provide drugs approved for colorectal cancer with their target names. | Model: llama-3.3-70b-versatile | Trial: 4\n",
      "Saved to result/llama-3_3-70b-versatile/trial_4/provide_drugs_approved_for_colorectal_ca.xlsx\n",
      "Processing: List pathways implicated in myelodysplastic syndromes. | Model: llama-3.3-70b-versatile | Trial: 4\n",
      "Saved to result/llama-3_3-70b-versatile/trial_4/list_pathways_implicated_in_myelodysplas.xlsx\n",
      "Processing: What are the approved drugs for BRAF V600Emutant melanoma? | Model: llama-3.3-70b-versatile | Trial: 4\n",
      "Saved to result/llama-3_3-70b-versatile/trial_4/what_are_the_approved_drugs_for_braf_v60.xlsx\n",
      "Processing: List all FLT3 inhibitors used for treating acute myeloid leukemia. | Model: llama-3.3-70b-versatile | Trial: 4\n",
      "Saved to result/llama-3_3-70b-versatile/trial_4/list_all_flt3_inhibitors_used_for_treati.xlsx\n",
      "Processing: What is the mechanism of action of lenvatinib? | Model: llama-3.3-70b-versatile | Trial: 4\n",
      "Saved to result/llama-3_3-70b-versatile/trial_4/what_is_the_mechanism_of_action_of_lenva.xlsx\n",
      "Processing: Which genes are targeted by monoclonal antibodies in multiple sclerosis? | Model: llama-3.3-70b-versatile | Trial: 4\n",
      "Saved to result/llama-3_3-70b-versatile/trial_4/which_genes_are_targeted_by_monoclonal_a.xlsx\n",
      "Processing: Drugs with approval status for leprosy. | Model: llama-3.3-70b-versatile | Trial: 4\n",
      "Saved to result/llama-3_3-70b-versatile/trial_4/drugs_with_approval_status_for_leprosy.xlsx\n",
      "Processing: Biomarkers associated with the TGF-ß pathway in fibrosis. | Model: llama-3.3-70b-versatile | Trial: 4\n",
      "Saved to result/llama-3_3-70b-versatile/trial_4/biomarkers_associated_with_the_tgf-__pat.xlsx\n",
      "Processing: Show drugs that inhibit the RET gene. | Model: llama-3.3-70b-versatile | Trial: 4\n",
      "Saved to result/llama-3_3-70b-versatile/trial_4/show_drugs_that_inhibit_the_ret_gene.xlsx\n",
      "Processing: What diseases are treated with trastuzumab deruxtecan? | Model: llama-3.3-70b-versatile | Trial: 4\n",
      "Saved to result/llama-3_3-70b-versatile/trial_4/what_diseases_are_treated_with_trastuzum.xlsx\n",
      "Processing: Which pathways are targeted by PI3K inhibitors? | Model: llama-3.3-70b-versatile | Trial: 4\n",
      "Saved to result/llama-3_3-70b-versatile/trial_4/which_pathways_are_targeted_by_pi3k_inhi.xlsx\n",
      "Processing: Approved drugs for atopic dermatitis and their mechanisms of action. | Model: llama-3.3-70b-versatile | Trial: 4\n",
      "Saved to result/llama-3_3-70b-versatile/trial_4/approved_drugs_for_atopic_dermatitis_and.xlsx\n",
      "Processing: What are the known targets of vandetanib? | Model: llama-3.3-70b-versatile | Trial: 4\n",
      "Saved to result/llama-3_3-70b-versatile/trial_4/what_are_the_known_targets_of_vandetanib.xlsx\n",
      "Processing: Provide the SMILES for sorafenib. | Model: llama-3.3-70b-versatile | Trial: 4\n",
      "----- Some error occured-----\n",
      "Processing: Provide the SMILES for sorafenib. | Model: llama-3.3-70b-versatile | Trial: 4\n",
      "Processing: Genes linked to schizophrenia. | Model: llama-3.3-70b-versatile | Trial: 4\n",
      "Saved to result/llama-3_3-70b-versatile/trial_4/genes_linked_to_schizophrenia.xlsx\n",
      "Processing: List of drugs and approval status for dengue. | Model: llama-3.3-70b-versatile | Trial: 4\n",
      "Saved to result/llama-3_3-70b-versatile/trial_4/list_of_drugs_and_approval_status_for_de.xlsx\n",
      "Processing: What drugs target the JAKSTAT pathway in atopic dermatitis? | Model: llama-3.3-70b-versatile | Trial: 4\n",
      "Saved to result/llama-3_3-70b-versatile/trial_4/what_drugs_target_the_jak_stat_pathway_i.xlsx\n",
      "Processing: Diseases associated with the gene KRAS. | Model: llama-3.3-70b-versatile | Trial: 4\n",
      "Saved to result/llama-3_3-70b-versatile/trial_4/diseases_associated_with_the_gene_kras.xlsx\n",
      "Processing: Biomarkers for early detection of ovarian cancer. | Model: llama-3.3-70b-versatile | Trial: 4\n",
      "Saved to result/llama-3_3-70b-versatile/trial_4/biomarkers_for_early_detection_of_ovaria.xlsx\n",
      "Processing: Which drugs act as BCR-ABL inhibitors? | Model: llama-3.3-70b-versatile | Trial: 4\n",
      "Saved to result/llama-3_3-70b-versatile/trial_4/which_drugs_act_as_bcr-abl_inhibitors.xlsx\n",
      "Processing: Drugs for idiopathic pulmonary fibrosis and their approval status. | Model: llama-3.3-70b-versatile | Trial: 4\n",
      "Saved to result/llama-3_3-70b-versatile/trial_4/drugs_for_idiopathic_pulmonary_fibrosis.xlsx\n",
      "Processing: What are the mechanisms of action for monoclonal antibodies targeting IL-6? | Model: llama-3.3-70b-versatile | Trial: 4\n",
      "Saved to result/llama-3_3-70b-versatile/trial_4/what_are_the_mechanisms_of_action_for_mo.xlsx\n",
      "Processing: Which approved drugs are used for treating osteoporosis? | Model: llama-3.3-70b-versatile | Trial: 4\n",
      "Saved to result/llama-3_3-70b-versatile/trial_4/which_approved_drugs_are_used_for_treati.xlsx\n",
      "Processing: What are the targets and mechanisms for dupilumab? | Model: llama-3.3-70b-versatile | Trial: 4\n",
      "Saved to result/llama-3_3-70b-versatile/trial_4/what_are_the_targets_and_mechanisms_for.xlsx\n",
      "Processing: Provide drugs approved for renal cell carcinoma with their target names. | Model: llama-3.3-70b-versatile | Trial: 4\n",
      "Saved to result/llama-3_3-70b-versatile/trial_4/provide_drugs_approved_for_renal_cell_ca.xlsx\n",
      "Processing: List pathways implicated in prostate cancer. | Model: llama-3.3-70b-versatile | Trial: 4\n",
      "Saved to result/llama-3_3-70b-versatile/trial_4/list_pathways_implicated_in_prostate_can.xlsx\n",
      "Processing: What are the approved drugs for EGFR exon 20 insertionmutant lung cancer? | Model: llama-3.3-70b-versatile | Trial: 4\n",
      "Saved to result/llama-3_3-70b-versatile/trial_4/what_are_the_approved_drugs_for_egfr_exo.xlsx\n",
      "Processing: List all TRK inhibitors used for treating NTRK-fusion cancers. | Model: llama-3.3-70b-versatile | Trial: 4\n",
      "Saved to result/llama-3_3-70b-versatile/trial_4/list_all_trk_inhibitors_used_for_treatin.xlsx\n",
      "Processing: What is the mechanism of action of darolutamide? | Model: llama-3.3-70b-versatile | Trial: 4\n",
      "Saved to result/llama-3_3-70b-versatile/trial_4/what_is_the_mechanism_of_action_of_darol.xlsx\n",
      "Processing: Which genes are targeted by monoclonal antibodies in oncology immunotherapy? | Model: llama-3.3-70b-versatile | Trial: 4\n",
      "Saved to result/llama-3_3-70b-versatile/trial_4/which_genes_are_targeted_by_monoclonal_a.xlsx\n",
      "Processing: What drugs are used to treat fever? | Model: llama-3.3-70b-versatile | Trial: 4\n",
      "Saved to result/llama-3_3-70b-versatile/trial_4/what_drugs_are_used_to_treat_fever.xlsx\n",
      "Processing: What are the approved drugs for triple-negative breast cancer? | Model: llama-3.3-70b-versatile | Trial: 5\n",
      "Saved to result/llama-3_3-70b-versatile/trial_5/what_are_the_approved_drugs_for_triple-n.xlsx\n",
      "Processing: List all ALK inhibitors used for treating non-small cell lung cancer. | Model: llama-3.3-70b-versatile | Trial: 5\n",
      "Saved to result/llama-3_3-70b-versatile/trial_5/list_all_alk_inhibitors_used_for_treatin.xlsx\n",
      "Processing: What is the mechanism of action of nivolumab? | Model: llama-3.3-70b-versatile | Trial: 5\n",
      "Saved to result/llama-3_3-70b-versatile/trial_5/what_is_the_mechanism_of_action_of_nivol.xlsx\n",
      "Processing: Drugs with approval status for hepatitis C virus infection. | Model: llama-3.3-70b-versatile | Trial: 5\n",
      "Saved to result/llama-3_3-70b-versatile/trial_5/drugs_with_approval_status_for_hepatitis.xlsx\n",
      "Processing: Biomarkers associated with the PI3KAKT pathway in breast cancer. | Model: llama-3.3-70b-versatile | Trial: 5\n",
      "Saved to result/llama-3_3-70b-versatile/trial_5/biomarkers_associated_with_the_pi3k_akt.xlsx\n",
      "Processing: Show drugs that inhibit the KRAS G12C variant. | Model: llama-3.3-70b-versatile | Trial: 5\n",
      "Saved to result/llama-3_3-70b-versatile/trial_5/show_drugs_that_inhibit_the_kras_g12c_va.xlsx\n",
      "Processing: What diseases are treated with atezolizumab? | Model: llama-3.3-70b-versatile | Trial: 5\n",
      "Saved to result/llama-3_3-70b-versatile/trial_5/what_diseases_are_treated_with_atezolizu.xlsx\n",
      "Processing: Which pathways are targeted by PARP inhibitors? | Model: llama-3.3-70b-versatile | Trial: 5\n",
      "Saved to result/llama-3_3-70b-versatile/trial_5/which_pathways_are_targeted_by_parp_inhi.xlsx\n",
      "Processing: Approved drugs for multiple sclerosis and their mechanisms of action. | Model: llama-3.3-70b-versatile | Trial: 5\n",
      "Saved to result/llama-3_3-70b-versatile/trial_5/approved_drugs_for_multiple_sclerosis_an.xlsx\n",
      "Processing: What are the known targets of sunitinib? | Model: llama-3.3-70b-versatile | Trial: 5\n",
      "Saved to result/llama-3_3-70b-versatile/trial_5/what_are_the_known_targets_of_sunitinib.xlsx\n",
      "Processing: Provide the SMILES for dasatinib. | Model: llama-3.3-70b-versatile | Trial: 5\n",
      "----- Some error occured-----\n",
      "Processing: Provide the SMILES for dasatinib. | Model: llama-3.3-70b-versatile | Trial: 5\n",
      "Processing: Genes linked to amyotrophic lateral sclerosis. | Model: llama-3.3-70b-versatile | Trial: 5\n",
      "Saved to result/llama-3_3-70b-versatile/trial_5/genes_linked_to_amyotrophic_lateral_scle.xlsx\n",
      "Processing: List of drugs and approval status for malaria. | Model: llama-3.3-70b-versatile | Trial: 5\n",
      "Saved to result/llama-3_3-70b-versatile/trial_5/list_of_drugs_and_approval_status_for_ma.xlsx\n",
      "Processing: What drugs target the JAKSTAT pathway in myelofibrosis? | Model: llama-3.3-70b-versatile | Trial: 5\n",
      "Saved to result/llama-3_3-70b-versatile/trial_5/what_drugs_target_the_jak_stat_pathway_i.xlsx\n",
      "Processing: Diseases associated with the gene BRCA1. | Model: llama-3.3-70b-versatile | Trial: 5\n",
      "Saved to result/llama-3_3-70b-versatile/trial_5/diseases_associated_with_the_gene_brca1.xlsx\n",
      "Processing: Biomarkers for early detection of pancreatic cancer. | Model: llama-3.3-70b-versatile | Trial: 5\n",
      "Saved to result/llama-3_3-70b-versatile/trial_5/biomarkers_for_early_detection_of_pancre.xlsx\n",
      "Processing: Which drugs act as VEGF inhibitors? | Model: llama-3.3-70b-versatile | Trial: 5\n",
      "Saved to result/llama-3_3-70b-versatile/trial_5/which_drugs_act_as_vegf_inhibitors.xlsx\n",
      "Processing: Drugs for chronic hepatitis B and their approval status. | Model: llama-3.3-70b-versatile | Trial: 5\n",
      "Saved to result/llama-3_3-70b-versatile/trial_5/drugs_for_chronic_hepatitis_b_and_their.xlsx\n",
      "Processing: What are the mechanisms of action for beta-lactam antibiotics? | Model: llama-3.3-70b-versatile | Trial: 5\n",
      "Saved to result/llama-3_3-70b-versatile/trial_5/what_are_the_mechanisms_of_action_for_be.xlsx\n",
      "Processing: Which approved drugs are used for treating rheumatoid arthritis? | Model: llama-3.3-70b-versatile | Trial: 5\n",
      "Saved to result/llama-3_3-70b-versatile/trial_5/which_approved_drugs_are_used_for_treati.xlsx\n",
      "Processing: What are the targets and mechanisms for dulaglutide? | Model: llama-3.3-70b-versatile | Trial: 5\n",
      "Saved to result/llama-3_3-70b-versatile/trial_5/what_are_the_targets_and_mechanisms_for.xlsx\n",
      "Processing: Provide drugs approved for ovarian cancer with their target names. | Model: llama-3.3-70b-versatile | Trial: 5\n",
      "Saved to result/llama-3_3-70b-versatile/trial_5/provide_drugs_approved_for_ovarian_cance.xlsx\n",
      "Processing: List pathways implicated in chronic lymphocytic leukemia. | Model: llama-3.3-70b-versatile | Trial: 5\n",
      "Saved to result/llama-3_3-70b-versatile/trial_5/list_pathways_implicated_in_chronic_lymp.xlsx\n",
      "Processing: What are the approved drugs for HER2-low breast cancer? | Model: llama-3.3-70b-versatile | Trial: 5\n",
      "Saved to result/llama-3_3-70b-versatile/trial_5/what_are_the_approved_drugs_for_her2-low.xlsx\n",
      "Processing: List all BTK inhibitors used for treating mantle cell lymphoma. | Model: llama-3.3-70b-versatile | Trial: 5\n",
      "Saved to result/llama-3_3-70b-versatile/trial_5/list_all_btk_inhibitors_used_for_treatin.xlsx\n",
      "Processing: What is the mechanism of action of pembrolizumab? | Model: llama-3.3-70b-versatile | Trial: 5\n",
      "Saved to result/llama-3_3-70b-versatile/trial_5/what_is_the_mechanism_of_action_of_pembr.xlsx\n",
      "Processing: Which genes are targeted by monoclonal antibodies in psoriasis? | Model: llama-3.3-70b-versatile | Trial: 5\n",
      "Saved to result/llama-3_3-70b-versatile/trial_5/which_genes_are_targeted_by_monoclonal_a.xlsx\n",
      "Processing: Drugs with approval status for HIV/AIDS. | Model: llama-3.3-70b-versatile | Trial: 5\n",
      "Saved to result/llama-3_3-70b-versatile/trial_5/drugs_with_approval_status_for_hiv_aids.xlsx\n",
      "Processing: Biomarkers associated with the RASRAFMEK pathway in colorectal cancer. | Model: llama-3.3-70b-versatile | Trial: 5\n",
      "Saved to result/llama-3_3-70b-versatile/trial_5/biomarkers_associated_with_the_ras_raf_m.xlsx\n",
      "Processing: Show drugs that inhibit the IDH1 gene. | Model: llama-3.3-70b-versatile | Trial: 5\n",
      "Saved to result/llama-3_3-70b-versatile/trial_5/show_drugs_that_inhibit_the_idh1_gene.xlsx\n",
      "Processing: What diseases are treated with durvalumab? | Model: llama-3.3-70b-versatile | Trial: 5\n",
      "Saved to result/llama-3_3-70b-versatile/trial_5/what_diseases_are_treated_with_durvaluma.xlsx\n",
      "Processing: Which pathways are targeted by MEK inhibitors? | Model: llama-3.3-70b-versatile | Trial: 5\n",
      "Saved to result/llama-3_3-70b-versatile/trial_5/which_pathways_are_targeted_by_mek_inhib.xlsx\n",
      "Processing: Approved drugs for ulcerative colitis and their mechanisms of action. | Model: llama-3.3-70b-versatile | Trial: 5\n",
      "Saved to result/llama-3_3-70b-versatile/trial_5/approved_drugs_for_ulcerative_colitis_an.xlsx\n",
      "Processing: What are the known targets of regorafenib? | Model: llama-3.3-70b-versatile | Trial: 5\n",
      "Saved to result/llama-3_3-70b-versatile/trial_5/what_are_the_known_targets_of_regorafeni.xlsx\n",
      "Processing: Provide the SMILES for erlotinib. | Model: llama-3.3-70b-versatile | Trial: 5\n",
      "----- Some error occured-----\n",
      "Processing: Provide the SMILES for erlotinib. | Model: llama-3.3-70b-versatile | Trial: 5\n",
      "Processing: Genes linked to Parkinsons disease. | Model: llama-3.3-70b-versatile | Trial: 5\n",
      "Saved to result/llama-3_3-70b-versatile/trial_5/genes_linked_to_parkinson_s_disease.xlsx\n",
      "Processing: List of drugs and approval status for influenza. | Model: llama-3.3-70b-versatile | Trial: 5\n",
      "Saved to result/llama-3_3-70b-versatile/trial_5/list_of_drugs_and_approval_status_for_in.xlsx\n",
      "Processing: What drugs target the PI3K pathway in lymphoma? | Model: llama-3.3-70b-versatile | Trial: 5\n",
      "Saved to result/llama-3_3-70b-versatile/trial_5/what_drugs_target_the_pi3k_pathway_in_ly.xlsx\n",
      "Processing: Diseases associated with the gene PIK3CA. | Model: llama-3.3-70b-versatile | Trial: 5\n",
      "Saved to result/llama-3_3-70b-versatile/trial_5/diseases_associated_with_the_gene_pik3ca.xlsx\n",
      "Processing: Biomarkers for early detection of gastric cancer. | Model: llama-3.3-70b-versatile | Trial: 5\n",
      "Saved to result/llama-3_3-70b-versatile/trial_5/biomarkers_for_early_detection_of_gastri.xlsx\n",
      "Processing: Which drugs act as PD-1 inhibitors? | Model: llama-3.3-70b-versatile | Trial: 5\n",
      "Saved to result/llama-3_3-70b-versatile/trial_5/which_drugs_act_as_pd-1_inhibitors.xlsx\n",
      "Processing: Drugs for hepatitis D and their approval status. | Model: llama-3.3-70b-versatile | Trial: 5\n",
      "Saved to result/llama-3_3-70b-versatile/trial_5/drugs_for_hepatitis_d_and_their_approval.xlsx\n",
      "Processing: What are the mechanisms of action for SGLT2 inhibitors? | Model: llama-3.3-70b-versatile | Trial: 5\n",
      "Saved to result/llama-3_3-70b-versatile/trial_5/what_are_the_mechanisms_of_action_for_sg.xlsx\n",
      "Processing: Which approved drugs are used for treating systemic lupus erythematosus? | Model: llama-3.3-70b-versatile | Trial: 5\n",
      "Saved to result/llama-3_3-70b-versatile/trial_5/which_approved_drugs_are_used_for_treati.xlsx\n",
      "Processing: What are the targets and mechanisms for tofacitinib? | Model: llama-3.3-70b-versatile | Trial: 5\n",
      "Saved to result/llama-3_3-70b-versatile/trial_5/what_are_the_targets_and_mechanisms_for.xlsx\n",
      "Processing: Provide drugs approved for prostate cancer with their target names. | Model: llama-3.3-70b-versatile | Trial: 5\n",
      "Saved to result/llama-3_3-70b-versatile/trial_5/provide_drugs_approved_for_prostate_canc.xlsx\n",
      "Processing: List pathways implicated in glioblastoma. | Model: llama-3.3-70b-versatile | Trial: 5\n",
      "Saved to result/llama-3_3-70b-versatile/trial_5/list_pathways_implicated_in_glioblastoma.xlsx\n",
      "Processing: What are the approved drugs for EGFR-mutant non-small cell lung cancer? | Model: llama-3.3-70b-versatile | Trial: 5\n",
      "Saved to result/llama-3_3-70b-versatile/trial_5/what_are_the_approved_drugs_for_egfr-mut.xlsx\n",
      "Processing: List all CDK4/6 inhibitors used for treating breast cancer. | Model: llama-3.3-70b-versatile | Trial: 5\n",
      "Saved to result/llama-3_3-70b-versatile/trial_5/list_all_cdk4_6_inhibitors_used_for_trea.xlsx\n",
      "Processing: What is the mechanism of action of osimertinib? | Model: llama-3.3-70b-versatile | Trial: 5\n",
      "Saved to result/llama-3_3-70b-versatile/trial_5/what_is_the_mechanism_of_action_of_osime.xlsx\n",
      "Processing: Which genes are targeted by monoclonal antibodies in asthma? | Model: llama-3.3-70b-versatile | Trial: 5\n",
      "Saved to result/llama-3_3-70b-versatile/trial_5/which_genes_are_targeted_by_monoclonal_a.xlsx\n",
      "Processing: Drugs with approval status for Clostridioides difficile infection. | Model: llama-3.3-70b-versatile | Trial: 5\n",
      "Saved to result/llama-3_3-70b-versatile/trial_5/drugs_with_approval_status_for_clostridi.xlsx\n",
      "Processing: Biomarkers associated with the WNT/ß-catenin pathway in cancer. | Model: llama-3.3-70b-versatile | Trial: 5\n",
      "Saved to result/llama-3_3-70b-versatile/trial_5/biomarkers_associated_with_the_wnt__-cat.xlsx\n",
      "Processing: Show drugs that inhibit the FGFR2 gene. | Model: llama-3.3-70b-versatile | Trial: 5\n",
      "Saved to result/llama-3_3-70b-versatile/trial_5/show_drugs_that_inhibit_the_fgfr2_gene.xlsx\n",
      "Processing: What diseases are treated with bevacizumab? | Model: llama-3.3-70b-versatile | Trial: 5\n",
      "Saved to result/llama-3_3-70b-versatile/trial_5/what_diseases_are_treated_with_bevacizum.xlsx\n",
      "Processing: Which pathways are targeted by mTOR inhibitors? | Model: llama-3.3-70b-versatile | Trial: 5\n",
      "Saved to result/llama-3_3-70b-versatile/trial_5/which_pathways_are_targeted_by_mtor_inhi.xlsx\n",
      "Processing: Approved drugs for plaque psoriasis and their mechanisms of action. | Model: llama-3.3-70b-versatile | Trial: 5\n",
      "Saved to result/llama-3_3-70b-versatile/trial_5/approved_drugs_for_plaque_psoriasis_and.xlsx\n",
      "Processing: What are the known targets of cabozantinib? | Model: llama-3.3-70b-versatile | Trial: 5\n",
      "Saved to result/llama-3_3-70b-versatile/trial_5/what_are_the_known_targets_of_cabozantin.xlsx\n",
      "Processing: Provide the SMILES for gefitinib. | Model: llama-3.3-70b-versatile | Trial: 5\n",
      "----- Some error occured-----\n",
      "Processing: Provide the SMILES for gefitinib. | Model: llama-3.3-70b-versatile | Trial: 5\n",
      "Processing: Genes linked to Crohns disease. | Model: llama-3.3-70b-versatile | Trial: 5\n",
      "Saved to result/llama-3_3-70b-versatile/trial_5/genes_linked_to_crohn_s_disease.xlsx\n",
      "Processing: List of drugs and approval status for respiratory syncytial virus infection. | Model: llama-3.3-70b-versatile | Trial: 5\n",
      "Saved to result/llama-3_3-70b-versatile/trial_5/list_of_drugs_and_approval_status_for_re.xlsx\n",
      "Processing: What drugs target the Hedgehog pathway in oncology? | Model: llama-3.3-70b-versatile | Trial: 5\n",
      "Saved to result/llama-3_3-70b-versatile/trial_5/what_drugs_target_the_hedgehog_pathway_i.xlsx\n",
      "Processing: Diseases associated with the gene NPM1. | Model: llama-3.3-70b-versatile | Trial: 5\n",
      "Saved to result/llama-3_3-70b-versatile/trial_5/diseases_associated_with_the_gene_npm1.xlsx\n",
      "Processing: Biomarkers for early detection of hepatocellular carcinoma. | Model: llama-3.3-70b-versatile | Trial: 5\n",
      "Saved to result/llama-3_3-70b-versatile/trial_5/biomarkers_for_early_detection_of_hepato.xlsx\n",
      "Processing: Which drugs act as CTLA-4 inhibitors? | Model: llama-3.3-70b-versatile | Trial: 5\n",
      "Saved to result/llama-3_3-70b-versatile/trial_5/which_drugs_act_as_ctla-4_inhibitors.xlsx\n",
      "Processing: Drugs for pulmonary arterial hypertension and their approval status. | Model: llama-3.3-70b-versatile | Trial: 5\n",
      "Saved to result/llama-3_3-70b-versatile/trial_5/drugs_for_pulmonary_arterial_hypertensio.xlsx\n",
      "Processing: What are the mechanisms of action for ACE inhibitors? | Model: llama-3.3-70b-versatile | Trial: 5\n",
      "Saved to result/llama-3_3-70b-versatile/trial_5/what_are_the_mechanisms_of_action_for_ac.xlsx\n",
      "Processing: Which approved drugs are used for treating migraine? | Model: llama-3.3-70b-versatile | Trial: 5\n",
      "Saved to result/llama-3_3-70b-versatile/trial_5/which_approved_drugs_are_used_for_treati.xlsx\n",
      "Processing: What are the targets and mechanisms for rituximab? | Model: llama-3.3-70b-versatile | Trial: 5\n",
      "Saved to result/llama-3_3-70b-versatile/trial_5/what_are_the_targets_and_mechanisms_for.xlsx\n",
      "Processing: Provide drugs approved for colorectal cancer with their target names. | Model: llama-3.3-70b-versatile | Trial: 5\n",
      "Saved to result/llama-3_3-70b-versatile/trial_5/provide_drugs_approved_for_colorectal_ca.xlsx\n",
      "Processing: List pathways implicated in myelodysplastic syndromes. | Model: llama-3.3-70b-versatile | Trial: 5\n",
      "Saved to result/llama-3_3-70b-versatile/trial_5/list_pathways_implicated_in_myelodysplas.xlsx\n",
      "Processing: What are the approved drugs for BRAF V600Emutant melanoma? | Model: llama-3.3-70b-versatile | Trial: 5\n",
      "Saved to result/llama-3_3-70b-versatile/trial_5/what_are_the_approved_drugs_for_braf_v60.xlsx\n",
      "Processing: List all FLT3 inhibitors used for treating acute myeloid leukemia. | Model: llama-3.3-70b-versatile | Trial: 5\n",
      "Saved to result/llama-3_3-70b-versatile/trial_5/list_all_flt3_inhibitors_used_for_treati.xlsx\n",
      "Processing: What is the mechanism of action of lenvatinib? | Model: llama-3.3-70b-versatile | Trial: 5\n",
      "Saved to result/llama-3_3-70b-versatile/trial_5/what_is_the_mechanism_of_action_of_lenva.xlsx\n",
      "Processing: Which genes are targeted by monoclonal antibodies in multiple sclerosis? | Model: llama-3.3-70b-versatile | Trial: 5\n",
      "Saved to result/llama-3_3-70b-versatile/trial_5/which_genes_are_targeted_by_monoclonal_a.xlsx\n",
      "Processing: Drugs with approval status for leprosy. | Model: llama-3.3-70b-versatile | Trial: 5\n",
      "Saved to result/llama-3_3-70b-versatile/trial_5/drugs_with_approval_status_for_leprosy.xlsx\n",
      "Processing: Biomarkers associated with the TGF-ß pathway in fibrosis. | Model: llama-3.3-70b-versatile | Trial: 5\n",
      "Saved to result/llama-3_3-70b-versatile/trial_5/biomarkers_associated_with_the_tgf-__pat.xlsx\n",
      "Processing: Show drugs that inhibit the RET gene. | Model: llama-3.3-70b-versatile | Trial: 5\n",
      "Saved to result/llama-3_3-70b-versatile/trial_5/show_drugs_that_inhibit_the_ret_gene.xlsx\n",
      "Processing: What diseases are treated with trastuzumab deruxtecan? | Model: llama-3.3-70b-versatile | Trial: 5\n",
      "Saved to result/llama-3_3-70b-versatile/trial_5/what_diseases_are_treated_with_trastuzum.xlsx\n",
      "Processing: Which pathways are targeted by PI3K inhibitors? | Model: llama-3.3-70b-versatile | Trial: 5\n",
      "Saved to result/llama-3_3-70b-versatile/trial_5/which_pathways_are_targeted_by_pi3k_inhi.xlsx\n",
      "Processing: Approved drugs for atopic dermatitis and their mechanisms of action. | Model: llama-3.3-70b-versatile | Trial: 5\n",
      "Saved to result/llama-3_3-70b-versatile/trial_5/approved_drugs_for_atopic_dermatitis_and.xlsx\n",
      "Processing: What are the known targets of vandetanib? | Model: llama-3.3-70b-versatile | Trial: 5\n",
      "Saved to result/llama-3_3-70b-versatile/trial_5/what_are_the_known_targets_of_vandetanib.xlsx\n",
      "Processing: Provide the SMILES for sorafenib. | Model: llama-3.3-70b-versatile | Trial: 5\n",
      "----- Some error occured-----\n",
      "Processing: Provide the SMILES for sorafenib. | Model: llama-3.3-70b-versatile | Trial: 5\n",
      "Processing: Genes linked to schizophrenia. | Model: llama-3.3-70b-versatile | Trial: 5\n",
      "Saved to result/llama-3_3-70b-versatile/trial_5/genes_linked_to_schizophrenia.xlsx\n",
      "Processing: List of drugs and approval status for dengue. | Model: llama-3.3-70b-versatile | Trial: 5\n",
      "Saved to result/llama-3_3-70b-versatile/trial_5/list_of_drugs_and_approval_status_for_de.xlsx\n",
      "Processing: What drugs target the JAKSTAT pathway in atopic dermatitis? | Model: llama-3.3-70b-versatile | Trial: 5\n",
      "Saved to result/llama-3_3-70b-versatile/trial_5/what_drugs_target_the_jak_stat_pathway_i.xlsx\n",
      "Processing: Diseases associated with the gene KRAS. | Model: llama-3.3-70b-versatile | Trial: 5\n",
      "Saved to result/llama-3_3-70b-versatile/trial_5/diseases_associated_with_the_gene_kras.xlsx\n",
      "Processing: Biomarkers for early detection of ovarian cancer. | Model: llama-3.3-70b-versatile | Trial: 5\n",
      "Saved to result/llama-3_3-70b-versatile/trial_5/biomarkers_for_early_detection_of_ovaria.xlsx\n",
      "Processing: Which drugs act as BCR-ABL inhibitors? | Model: llama-3.3-70b-versatile | Trial: 5\n",
      "Saved to result/llama-3_3-70b-versatile/trial_5/which_drugs_act_as_bcr-abl_inhibitors.xlsx\n",
      "Processing: Drugs for idiopathic pulmonary fibrosis and their approval status. | Model: llama-3.3-70b-versatile | Trial: 5\n",
      "Saved to result/llama-3_3-70b-versatile/trial_5/drugs_for_idiopathic_pulmonary_fibrosis.xlsx\n",
      "Processing: What are the mechanisms of action for monoclonal antibodies targeting IL-6? | Model: llama-3.3-70b-versatile | Trial: 5\n",
      "Saved to result/llama-3_3-70b-versatile/trial_5/what_are_the_mechanisms_of_action_for_mo.xlsx\n",
      "Processing: Which approved drugs are used for treating osteoporosis? | Model: llama-3.3-70b-versatile | Trial: 5\n",
      "Saved to result/llama-3_3-70b-versatile/trial_5/which_approved_drugs_are_used_for_treati.xlsx\n",
      "Processing: What are the targets and mechanisms for dupilumab? | Model: llama-3.3-70b-versatile | Trial: 5\n",
      "Saved to result/llama-3_3-70b-versatile/trial_5/what_are_the_targets_and_mechanisms_for.xlsx\n",
      "Processing: Provide drugs approved for renal cell carcinoma with their target names. | Model: llama-3.3-70b-versatile | Trial: 5\n",
      "Saved to result/llama-3_3-70b-versatile/trial_5/provide_drugs_approved_for_renal_cell_ca.xlsx\n",
      "Processing: List pathways implicated in prostate cancer. | Model: llama-3.3-70b-versatile | Trial: 5\n",
      "Saved to result/llama-3_3-70b-versatile/trial_5/list_pathways_implicated_in_prostate_can.xlsx\n",
      "Processing: What are the approved drugs for EGFR exon 20 insertionmutant lung cancer? | Model: llama-3.3-70b-versatile | Trial: 5\n",
      "Saved to result/llama-3_3-70b-versatile/trial_5/what_are_the_approved_drugs_for_egfr_exo.xlsx\n",
      "Processing: List all TRK inhibitors used for treating NTRK-fusion cancers. | Model: llama-3.3-70b-versatile | Trial: 5\n",
      "Saved to result/llama-3_3-70b-versatile/trial_5/list_all_trk_inhibitors_used_for_treatin.xlsx\n",
      "Processing: What is the mechanism of action of darolutamide? | Model: llama-3.3-70b-versatile | Trial: 5\n",
      "Saved to result/llama-3_3-70b-versatile/trial_5/what_is_the_mechanism_of_action_of_darol.xlsx\n",
      "Processing: Which genes are targeted by monoclonal antibodies in oncology immunotherapy? | Model: llama-3.3-70b-versatile | Trial: 5\n",
      "Saved to result/llama-3_3-70b-versatile/trial_5/which_genes_are_targeted_by_monoclonal_a.xlsx\n",
      "Processing: What drugs are used to treat fever? | Model: llama-3.3-70b-versatile | Trial: 5\n",
      "Saved to result/llama-3_3-70b-versatile/trial_5/what_drugs_are_used_to_treat_fever.xlsx\n",
      "Processing: What are the approved drugs for triple-negative breast cancer? | Model: llama-3.3-70b-versatile | Trial: 6\n",
      "Saved to result/llama-3_3-70b-versatile/trial_6/what_are_the_approved_drugs_for_triple-n.xlsx\n",
      "Processing: List all ALK inhibitors used for treating non-small cell lung cancer. | Model: llama-3.3-70b-versatile | Trial: 6\n",
      "Saved to result/llama-3_3-70b-versatile/trial_6/list_all_alk_inhibitors_used_for_treatin.xlsx\n",
      "Processing: What is the mechanism of action of nivolumab? | Model: llama-3.3-70b-versatile | Trial: 6\n",
      "Saved to result/llama-3_3-70b-versatile/trial_6/what_is_the_mechanism_of_action_of_nivol.xlsx\n",
      "Processing: Drugs with approval status for hepatitis C virus infection. | Model: llama-3.3-70b-versatile | Trial: 6\n",
      "Saved to result/llama-3_3-70b-versatile/trial_6/drugs_with_approval_status_for_hepatitis.xlsx\n",
      "Processing: Biomarkers associated with the PI3KAKT pathway in breast cancer. | Model: llama-3.3-70b-versatile | Trial: 6\n",
      "Saved to result/llama-3_3-70b-versatile/trial_6/biomarkers_associated_with_the_pi3k_akt.xlsx\n",
      "Processing: Show drugs that inhibit the KRAS G12C variant. | Model: llama-3.3-70b-versatile | Trial: 6\n",
      "Saved to result/llama-3_3-70b-versatile/trial_6/show_drugs_that_inhibit_the_kras_g12c_va.xlsx\n",
      "Processing: What diseases are treated with atezolizumab? | Model: llama-3.3-70b-versatile | Trial: 6\n",
      "Saved to result/llama-3_3-70b-versatile/trial_6/what_diseases_are_treated_with_atezolizu.xlsx\n",
      "Processing: Which pathways are targeted by PARP inhibitors? | Model: llama-3.3-70b-versatile | Trial: 6\n",
      "Saved to result/llama-3_3-70b-versatile/trial_6/which_pathways_are_targeted_by_parp_inhi.xlsx\n",
      "Processing: Approved drugs for multiple sclerosis and their mechanisms of action. | Model: llama-3.3-70b-versatile | Trial: 6\n",
      "Saved to result/llama-3_3-70b-versatile/trial_6/approved_drugs_for_multiple_sclerosis_an.xlsx\n",
      "Processing: What are the known targets of sunitinib? | Model: llama-3.3-70b-versatile | Trial: 6\n",
      "Saved to result/llama-3_3-70b-versatile/trial_6/what_are_the_known_targets_of_sunitinib.xlsx\n",
      "Processing: Provide the SMILES for dasatinib. | Model: llama-3.3-70b-versatile | Trial: 6\n",
      "----- Some error occured-----\n",
      "Processing: Provide the SMILES for dasatinib. | Model: llama-3.3-70b-versatile | Trial: 6\n",
      "Processing: Genes linked to amyotrophic lateral sclerosis. | Model: llama-3.3-70b-versatile | Trial: 6\n",
      "Saved to result/llama-3_3-70b-versatile/trial_6/genes_linked_to_amyotrophic_lateral_scle.xlsx\n",
      "Processing: List of drugs and approval status for malaria. | Model: llama-3.3-70b-versatile | Trial: 6\n",
      "Saved to result/llama-3_3-70b-versatile/trial_6/list_of_drugs_and_approval_status_for_ma.xlsx\n",
      "Processing: What drugs target the JAKSTAT pathway in myelofibrosis? | Model: llama-3.3-70b-versatile | Trial: 6\n",
      "Saved to result/llama-3_3-70b-versatile/trial_6/what_drugs_target_the_jak_stat_pathway_i.xlsx\n",
      "Processing: Diseases associated with the gene BRCA1. | Model: llama-3.3-70b-versatile | Trial: 6\n",
      "Saved to result/llama-3_3-70b-versatile/trial_6/diseases_associated_with_the_gene_brca1.xlsx\n",
      "Processing: Biomarkers for early detection of pancreatic cancer. | Model: llama-3.3-70b-versatile | Trial: 6\n",
      "Saved to result/llama-3_3-70b-versatile/trial_6/biomarkers_for_early_detection_of_pancre.xlsx\n",
      "Processing: Which drugs act as VEGF inhibitors? | Model: llama-3.3-70b-versatile | Trial: 6\n",
      "Saved to result/llama-3_3-70b-versatile/trial_6/which_drugs_act_as_vegf_inhibitors.xlsx\n",
      "Processing: Drugs for chronic hepatitis B and their approval status. | Model: llama-3.3-70b-versatile | Trial: 6\n",
      "Saved to result/llama-3_3-70b-versatile/trial_6/drugs_for_chronic_hepatitis_b_and_their.xlsx\n",
      "Processing: What are the mechanisms of action for beta-lactam antibiotics? | Model: llama-3.3-70b-versatile | Trial: 6\n",
      "Saved to result/llama-3_3-70b-versatile/trial_6/what_are_the_mechanisms_of_action_for_be.xlsx\n",
      "Processing: Which approved drugs are used for treating rheumatoid arthritis? | Model: llama-3.3-70b-versatile | Trial: 6\n",
      "Saved to result/llama-3_3-70b-versatile/trial_6/which_approved_drugs_are_used_for_treati.xlsx\n",
      "Processing: What are the targets and mechanisms for dulaglutide? | Model: llama-3.3-70b-versatile | Trial: 6\n",
      "Saved to result/llama-3_3-70b-versatile/trial_6/what_are_the_targets_and_mechanisms_for.xlsx\n",
      "Processing: Provide drugs approved for ovarian cancer with their target names. | Model: llama-3.3-70b-versatile | Trial: 6\n",
      "Saved to result/llama-3_3-70b-versatile/trial_6/provide_drugs_approved_for_ovarian_cance.xlsx\n",
      "Processing: List pathways implicated in chronic lymphocytic leukemia. | Model: llama-3.3-70b-versatile | Trial: 6\n",
      "Saved to result/llama-3_3-70b-versatile/trial_6/list_pathways_implicated_in_chronic_lymp.xlsx\n",
      "Processing: What are the approved drugs for HER2-low breast cancer? | Model: llama-3.3-70b-versatile | Trial: 6\n",
      "Saved to result/llama-3_3-70b-versatile/trial_6/what_are_the_approved_drugs_for_her2-low.xlsx\n",
      "Processing: List all BTK inhibitors used for treating mantle cell lymphoma. | Model: llama-3.3-70b-versatile | Trial: 6\n",
      "Saved to result/llama-3_3-70b-versatile/trial_6/list_all_btk_inhibitors_used_for_treatin.xlsx\n",
      "Processing: What is the mechanism of action of pembrolizumab? | Model: llama-3.3-70b-versatile | Trial: 6\n",
      "Saved to result/llama-3_3-70b-versatile/trial_6/what_is_the_mechanism_of_action_of_pembr.xlsx\n",
      "Processing: Which genes are targeted by monoclonal antibodies in psoriasis? | Model: llama-3.3-70b-versatile | Trial: 6\n",
      "Saved to result/llama-3_3-70b-versatile/trial_6/which_genes_are_targeted_by_monoclonal_a.xlsx\n",
      "Processing: Drugs with approval status for HIV/AIDS. | Model: llama-3.3-70b-versatile | Trial: 6\n",
      "Saved to result/llama-3_3-70b-versatile/trial_6/drugs_with_approval_status_for_hiv_aids.xlsx\n",
      "Processing: Biomarkers associated with the RASRAFMEK pathway in colorectal cancer. | Model: llama-3.3-70b-versatile | Trial: 6\n",
      "Saved to result/llama-3_3-70b-versatile/trial_6/biomarkers_associated_with_the_ras_raf_m.xlsx\n",
      "Processing: Show drugs that inhibit the IDH1 gene. | Model: llama-3.3-70b-versatile | Trial: 6\n",
      "Saved to result/llama-3_3-70b-versatile/trial_6/show_drugs_that_inhibit_the_idh1_gene.xlsx\n",
      "Processing: What diseases are treated with durvalumab? | Model: llama-3.3-70b-versatile | Trial: 6\n",
      "Saved to result/llama-3_3-70b-versatile/trial_6/what_diseases_are_treated_with_durvaluma.xlsx\n",
      "Processing: Which pathways are targeted by MEK inhibitors? | Model: llama-3.3-70b-versatile | Trial: 6\n",
      "Saved to result/llama-3_3-70b-versatile/trial_6/which_pathways_are_targeted_by_mek_inhib.xlsx\n",
      "Processing: Approved drugs for ulcerative colitis and their mechanisms of action. | Model: llama-3.3-70b-versatile | Trial: 6\n",
      "Saved to result/llama-3_3-70b-versatile/trial_6/approved_drugs_for_ulcerative_colitis_an.xlsx\n",
      "Processing: What are the known targets of regorafenib? | Model: llama-3.3-70b-versatile | Trial: 6\n",
      "Saved to result/llama-3_3-70b-versatile/trial_6/what_are_the_known_targets_of_regorafeni.xlsx\n",
      "Processing: Provide the SMILES for erlotinib. | Model: llama-3.3-70b-versatile | Trial: 6\n",
      "----- Some error occured-----\n",
      "Processing: Provide the SMILES for erlotinib. | Model: llama-3.3-70b-versatile | Trial: 6\n",
      "Processing: Genes linked to Parkinsons disease. | Model: llama-3.3-70b-versatile | Trial: 6\n",
      "Saved to result/llama-3_3-70b-versatile/trial_6/genes_linked_to_parkinson_s_disease.xlsx\n",
      "Processing: List of drugs and approval status for influenza. | Model: llama-3.3-70b-versatile | Trial: 6\n",
      "Saved to result/llama-3_3-70b-versatile/trial_6/list_of_drugs_and_approval_status_for_in.xlsx\n",
      "Processing: What drugs target the PI3K pathway in lymphoma? | Model: llama-3.3-70b-versatile | Trial: 6\n",
      "Saved to result/llama-3_3-70b-versatile/trial_6/what_drugs_target_the_pi3k_pathway_in_ly.xlsx\n",
      "Processing: Diseases associated with the gene PIK3CA. | Model: llama-3.3-70b-versatile | Trial: 6\n",
      "Saved to result/llama-3_3-70b-versatile/trial_6/diseases_associated_with_the_gene_pik3ca.xlsx\n",
      "Processing: Biomarkers for early detection of gastric cancer. | Model: llama-3.3-70b-versatile | Trial: 6\n",
      "Saved to result/llama-3_3-70b-versatile/trial_6/biomarkers_for_early_detection_of_gastri.xlsx\n",
      "Processing: Which drugs act as PD-1 inhibitors? | Model: llama-3.3-70b-versatile | Trial: 6\n",
      "Saved to result/llama-3_3-70b-versatile/trial_6/which_drugs_act_as_pd-1_inhibitors.xlsx\n",
      "Processing: Drugs for hepatitis D and their approval status. | Model: llama-3.3-70b-versatile | Trial: 6\n",
      "Saved to result/llama-3_3-70b-versatile/trial_6/drugs_for_hepatitis_d_and_their_approval.xlsx\n",
      "Processing: What are the mechanisms of action for SGLT2 inhibitors? | Model: llama-3.3-70b-versatile | Trial: 6\n",
      "Saved to result/llama-3_3-70b-versatile/trial_6/what_are_the_mechanisms_of_action_for_sg.xlsx\n",
      "Processing: Which approved drugs are used for treating systemic lupus erythematosus? | Model: llama-3.3-70b-versatile | Trial: 6\n",
      "Saved to result/llama-3_3-70b-versatile/trial_6/which_approved_drugs_are_used_for_treati.xlsx\n",
      "Processing: What are the targets and mechanisms for tofacitinib? | Model: llama-3.3-70b-versatile | Trial: 6\n",
      "Saved to result/llama-3_3-70b-versatile/trial_6/what_are_the_targets_and_mechanisms_for.xlsx\n",
      "Processing: Provide drugs approved for prostate cancer with their target names. | Model: llama-3.3-70b-versatile | Trial: 6\n",
      "Saved to result/llama-3_3-70b-versatile/trial_6/provide_drugs_approved_for_prostate_canc.xlsx\n",
      "Processing: List pathways implicated in glioblastoma. | Model: llama-3.3-70b-versatile | Trial: 6\n",
      "Saved to result/llama-3_3-70b-versatile/trial_6/list_pathways_implicated_in_glioblastoma.xlsx\n",
      "Processing: What are the approved drugs for EGFR-mutant non-small cell lung cancer? | Model: llama-3.3-70b-versatile | Trial: 6\n",
      "Saved to result/llama-3_3-70b-versatile/trial_6/what_are_the_approved_drugs_for_egfr-mut.xlsx\n",
      "Processing: List all CDK4/6 inhibitors used for treating breast cancer. | Model: llama-3.3-70b-versatile | Trial: 6\n",
      "Saved to result/llama-3_3-70b-versatile/trial_6/list_all_cdk4_6_inhibitors_used_for_trea.xlsx\n",
      "Processing: What is the mechanism of action of osimertinib? | Model: llama-3.3-70b-versatile | Trial: 6\n",
      "Saved to result/llama-3_3-70b-versatile/trial_6/what_is_the_mechanism_of_action_of_osime.xlsx\n",
      "Processing: Which genes are targeted by monoclonal antibodies in asthma? | Model: llama-3.3-70b-versatile | Trial: 6\n",
      "Saved to result/llama-3_3-70b-versatile/trial_6/which_genes_are_targeted_by_monoclonal_a.xlsx\n",
      "Processing: Drugs with approval status for Clostridioides difficile infection. | Model: llama-3.3-70b-versatile | Trial: 6\n",
      "Saved to result/llama-3_3-70b-versatile/trial_6/drugs_with_approval_status_for_clostridi.xlsx\n",
      "Processing: Biomarkers associated with the WNT/ß-catenin pathway in cancer. | Model: llama-3.3-70b-versatile | Trial: 6\n",
      "Saved to result/llama-3_3-70b-versatile/trial_6/biomarkers_associated_with_the_wnt__-cat.xlsx\n",
      "Processing: Show drugs that inhibit the FGFR2 gene. | Model: llama-3.3-70b-versatile | Trial: 6\n",
      "Saved to result/llama-3_3-70b-versatile/trial_6/show_drugs_that_inhibit_the_fgfr2_gene.xlsx\n",
      "Processing: What diseases are treated with bevacizumab? | Model: llama-3.3-70b-versatile | Trial: 6\n",
      "Saved to result/llama-3_3-70b-versatile/trial_6/what_diseases_are_treated_with_bevacizum.xlsx\n",
      "Processing: Which pathways are targeted by mTOR inhibitors? | Model: llama-3.3-70b-versatile | Trial: 6\n",
      "Saved to result/llama-3_3-70b-versatile/trial_6/which_pathways_are_targeted_by_mtor_inhi.xlsx\n",
      "Processing: Approved drugs for plaque psoriasis and their mechanisms of action. | Model: llama-3.3-70b-versatile | Trial: 6\n",
      "Saved to result/llama-3_3-70b-versatile/trial_6/approved_drugs_for_plaque_psoriasis_and.xlsx\n",
      "Processing: What are the known targets of cabozantinib? | Model: llama-3.3-70b-versatile | Trial: 6\n",
      "Saved to result/llama-3_3-70b-versatile/trial_6/what_are_the_known_targets_of_cabozantin.xlsx\n",
      "Processing: Provide the SMILES for gefitinib. | Model: llama-3.3-70b-versatile | Trial: 6\n",
      "----- Some error occured-----\n",
      "Processing: Provide the SMILES for gefitinib. | Model: llama-3.3-70b-versatile | Trial: 6\n",
      "Processing: Genes linked to Crohns disease. | Model: llama-3.3-70b-versatile | Trial: 6\n",
      "Saved to result/llama-3_3-70b-versatile/trial_6/genes_linked_to_crohn_s_disease.xlsx\n",
      "Processing: List of drugs and approval status for respiratory syncytial virus infection. | Model: llama-3.3-70b-versatile | Trial: 6\n",
      "Saved to result/llama-3_3-70b-versatile/trial_6/list_of_drugs_and_approval_status_for_re.xlsx\n",
      "Processing: What drugs target the Hedgehog pathway in oncology? | Model: llama-3.3-70b-versatile | Trial: 6\n",
      "Saved to result/llama-3_3-70b-versatile/trial_6/what_drugs_target_the_hedgehog_pathway_i.xlsx\n",
      "Processing: Diseases associated with the gene NPM1. | Model: llama-3.3-70b-versatile | Trial: 6\n",
      "Saved to result/llama-3_3-70b-versatile/trial_6/diseases_associated_with_the_gene_npm1.xlsx\n",
      "Processing: Biomarkers for early detection of hepatocellular carcinoma. | Model: llama-3.3-70b-versatile | Trial: 6\n",
      "Saved to result/llama-3_3-70b-versatile/trial_6/biomarkers_for_early_detection_of_hepato.xlsx\n",
      "Processing: Which drugs act as CTLA-4 inhibitors? | Model: llama-3.3-70b-versatile | Trial: 6\n",
      "Saved to result/llama-3_3-70b-versatile/trial_6/which_drugs_act_as_ctla-4_inhibitors.xlsx\n",
      "Processing: Drugs for pulmonary arterial hypertension and their approval status. | Model: llama-3.3-70b-versatile | Trial: 6\n",
      "Saved to result/llama-3_3-70b-versatile/trial_6/drugs_for_pulmonary_arterial_hypertensio.xlsx\n",
      "Processing: What are the mechanisms of action for ACE inhibitors? | Model: llama-3.3-70b-versatile | Trial: 6\n",
      "Saved to result/llama-3_3-70b-versatile/trial_6/what_are_the_mechanisms_of_action_for_ac.xlsx\n",
      "Processing: Which approved drugs are used for treating migraine? | Model: llama-3.3-70b-versatile | Trial: 6\n",
      "Saved to result/llama-3_3-70b-versatile/trial_6/which_approved_drugs_are_used_for_treati.xlsx\n",
      "Processing: What are the targets and mechanisms for rituximab? | Model: llama-3.3-70b-versatile | Trial: 6\n",
      "Saved to result/llama-3_3-70b-versatile/trial_6/what_are_the_targets_and_mechanisms_for.xlsx\n",
      "Processing: Provide drugs approved for colorectal cancer with their target names. | Model: llama-3.3-70b-versatile | Trial: 6\n",
      "Saved to result/llama-3_3-70b-versatile/trial_6/provide_drugs_approved_for_colorectal_ca.xlsx\n",
      "Processing: List pathways implicated in myelodysplastic syndromes. | Model: llama-3.3-70b-versatile | Trial: 6\n",
      "Saved to result/llama-3_3-70b-versatile/trial_6/list_pathways_implicated_in_myelodysplas.xlsx\n",
      "Processing: What are the approved drugs for BRAF V600Emutant melanoma? | Model: llama-3.3-70b-versatile | Trial: 6\n",
      "Saved to result/llama-3_3-70b-versatile/trial_6/what_are_the_approved_drugs_for_braf_v60.xlsx\n",
      "Processing: List all FLT3 inhibitors used for treating acute myeloid leukemia. | Model: llama-3.3-70b-versatile | Trial: 6\n",
      "Saved to result/llama-3_3-70b-versatile/trial_6/list_all_flt3_inhibitors_used_for_treati.xlsx\n",
      "Processing: What is the mechanism of action of lenvatinib? | Model: llama-3.3-70b-versatile | Trial: 6\n",
      "Saved to result/llama-3_3-70b-versatile/trial_6/what_is_the_mechanism_of_action_of_lenva.xlsx\n",
      "Processing: Which genes are targeted by monoclonal antibodies in multiple sclerosis? | Model: llama-3.3-70b-versatile | Trial: 6\n",
      "Saved to result/llama-3_3-70b-versatile/trial_6/which_genes_are_targeted_by_monoclonal_a.xlsx\n",
      "Processing: Drugs with approval status for leprosy. | Model: llama-3.3-70b-versatile | Trial: 6\n",
      "Saved to result/llama-3_3-70b-versatile/trial_6/drugs_with_approval_status_for_leprosy.xlsx\n",
      "Processing: Biomarkers associated with the TGF-ß pathway in fibrosis. | Model: llama-3.3-70b-versatile | Trial: 6\n",
      "Saved to result/llama-3_3-70b-versatile/trial_6/biomarkers_associated_with_the_tgf-__pat.xlsx\n",
      "Processing: Show drugs that inhibit the RET gene. | Model: llama-3.3-70b-versatile | Trial: 6\n",
      "Saved to result/llama-3_3-70b-versatile/trial_6/show_drugs_that_inhibit_the_ret_gene.xlsx\n",
      "Processing: What diseases are treated with trastuzumab deruxtecan? | Model: llama-3.3-70b-versatile | Trial: 6\n",
      "Saved to result/llama-3_3-70b-versatile/trial_6/what_diseases_are_treated_with_trastuzum.xlsx\n",
      "Processing: Which pathways are targeted by PI3K inhibitors? | Model: llama-3.3-70b-versatile | Trial: 6\n",
      "Saved to result/llama-3_3-70b-versatile/trial_6/which_pathways_are_targeted_by_pi3k_inhi.xlsx\n",
      "Processing: Approved drugs for atopic dermatitis and their mechanisms of action. | Model: llama-3.3-70b-versatile | Trial: 6\n",
      "Saved to result/llama-3_3-70b-versatile/trial_6/approved_drugs_for_atopic_dermatitis_and.xlsx\n",
      "Processing: What are the known targets of vandetanib? | Model: llama-3.3-70b-versatile | Trial: 6\n",
      "Saved to result/llama-3_3-70b-versatile/trial_6/what_are_the_known_targets_of_vandetanib.xlsx\n",
      "Processing: Provide the SMILES for sorafenib. | Model: llama-3.3-70b-versatile | Trial: 6\n",
      "----- Some error occured-----\n",
      "Processing: Provide the SMILES for sorafenib. | Model: llama-3.3-70b-versatile | Trial: 6\n",
      "Processing: Genes linked to schizophrenia. | Model: llama-3.3-70b-versatile | Trial: 6\n",
      "Saved to result/llama-3_3-70b-versatile/trial_6/genes_linked_to_schizophrenia.xlsx\n",
      "Processing: List of drugs and approval status for dengue. | Model: llama-3.3-70b-versatile | Trial: 6\n",
      "Saved to result/llama-3_3-70b-versatile/trial_6/list_of_drugs_and_approval_status_for_de.xlsx\n",
      "Processing: What drugs target the JAKSTAT pathway in atopic dermatitis? | Model: llama-3.3-70b-versatile | Trial: 6\n",
      "Saved to result/llama-3_3-70b-versatile/trial_6/what_drugs_target_the_jak_stat_pathway_i.xlsx\n",
      "Processing: Diseases associated with the gene KRAS. | Model: llama-3.3-70b-versatile | Trial: 6\n",
      "Saved to result/llama-3_3-70b-versatile/trial_6/diseases_associated_with_the_gene_kras.xlsx\n",
      "Processing: Biomarkers for early detection of ovarian cancer. | Model: llama-3.3-70b-versatile | Trial: 6\n",
      "Saved to result/llama-3_3-70b-versatile/trial_6/biomarkers_for_early_detection_of_ovaria.xlsx\n",
      "Processing: Which drugs act as BCR-ABL inhibitors? | Model: llama-3.3-70b-versatile | Trial: 6\n",
      "Saved to result/llama-3_3-70b-versatile/trial_6/which_drugs_act_as_bcr-abl_inhibitors.xlsx\n",
      "Processing: Drugs for idiopathic pulmonary fibrosis and their approval status. | Model: llama-3.3-70b-versatile | Trial: 6\n",
      "Saved to result/llama-3_3-70b-versatile/trial_6/drugs_for_idiopathic_pulmonary_fibrosis.xlsx\n",
      "Processing: What are the mechanisms of action for monoclonal antibodies targeting IL-6? | Model: llama-3.3-70b-versatile | Trial: 6\n",
      "Saved to result/llama-3_3-70b-versatile/trial_6/what_are_the_mechanisms_of_action_for_mo.xlsx\n",
      "Processing: Which approved drugs are used for treating osteoporosis? | Model: llama-3.3-70b-versatile | Trial: 6\n",
      "Saved to result/llama-3_3-70b-versatile/trial_6/which_approved_drugs_are_used_for_treati.xlsx\n",
      "Processing: What are the targets and mechanisms for dupilumab? | Model: llama-3.3-70b-versatile | Trial: 6\n",
      "Saved to result/llama-3_3-70b-versatile/trial_6/what_are_the_targets_and_mechanisms_for.xlsx\n",
      "Processing: Provide drugs approved for renal cell carcinoma with their target names. | Model: llama-3.3-70b-versatile | Trial: 6\n",
      "Saved to result/llama-3_3-70b-versatile/trial_6/provide_drugs_approved_for_renal_cell_ca.xlsx\n",
      "Processing: List pathways implicated in prostate cancer. | Model: llama-3.3-70b-versatile | Trial: 6\n",
      "Saved to result/llama-3_3-70b-versatile/trial_6/list_pathways_implicated_in_prostate_can.xlsx\n",
      "Processing: What are the approved drugs for EGFR exon 20 insertionmutant lung cancer? | Model: llama-3.3-70b-versatile | Trial: 6\n",
      "Saved to result/llama-3_3-70b-versatile/trial_6/what_are_the_approved_drugs_for_egfr_exo.xlsx\n",
      "Processing: List all TRK inhibitors used for treating NTRK-fusion cancers. | Model: llama-3.3-70b-versatile | Trial: 6\n",
      "Saved to result/llama-3_3-70b-versatile/trial_6/list_all_trk_inhibitors_used_for_treatin.xlsx\n",
      "Processing: What is the mechanism of action of darolutamide? | Model: llama-3.3-70b-versatile | Trial: 6\n",
      "Saved to result/llama-3_3-70b-versatile/trial_6/what_is_the_mechanism_of_action_of_darol.xlsx\n",
      "Processing: Which genes are targeted by monoclonal antibodies in oncology immunotherapy? | Model: llama-3.3-70b-versatile | Trial: 6\n",
      "Saved to result/llama-3_3-70b-versatile/trial_6/which_genes_are_targeted_by_monoclonal_a.xlsx\n",
      "Processing: What drugs are used to treat fever? | Model: llama-3.3-70b-versatile | Trial: 6\n",
      "Saved to result/llama-3_3-70b-versatile/trial_6/what_drugs_are_used_to_treat_fever.xlsx\n",
      "Processing: What are the approved drugs for triple-negative breast cancer? | Model: llama-3.3-70b-versatile | Trial: 7\n",
      "Saved to result/llama-3_3-70b-versatile/trial_7/what_are_the_approved_drugs_for_triple-n.xlsx\n",
      "Processing: List all ALK inhibitors used for treating non-small cell lung cancer. | Model: llama-3.3-70b-versatile | Trial: 7\n",
      "Saved to result/llama-3_3-70b-versatile/trial_7/list_all_alk_inhibitors_used_for_treatin.xlsx\n",
      "Processing: What is the mechanism of action of nivolumab? | Model: llama-3.3-70b-versatile | Trial: 7\n",
      "Saved to result/llama-3_3-70b-versatile/trial_7/what_is_the_mechanism_of_action_of_nivol.xlsx\n",
      "Processing: Drugs with approval status for hepatitis C virus infection. | Model: llama-3.3-70b-versatile | Trial: 7\n",
      "Saved to result/llama-3_3-70b-versatile/trial_7/drugs_with_approval_status_for_hepatitis.xlsx\n",
      "Processing: Biomarkers associated with the PI3KAKT pathway in breast cancer. | Model: llama-3.3-70b-versatile | Trial: 7\n",
      "Saved to result/llama-3_3-70b-versatile/trial_7/biomarkers_associated_with_the_pi3k_akt.xlsx\n",
      "Processing: Show drugs that inhibit the KRAS G12C variant. | Model: llama-3.3-70b-versatile | Trial: 7\n",
      "Saved to result/llama-3_3-70b-versatile/trial_7/show_drugs_that_inhibit_the_kras_g12c_va.xlsx\n",
      "Processing: What diseases are treated with atezolizumab? | Model: llama-3.3-70b-versatile | Trial: 7\n",
      "Saved to result/llama-3_3-70b-versatile/trial_7/what_diseases_are_treated_with_atezolizu.xlsx\n",
      "Processing: Which pathways are targeted by PARP inhibitors? | Model: llama-3.3-70b-versatile | Trial: 7\n",
      "Saved to result/llama-3_3-70b-versatile/trial_7/which_pathways_are_targeted_by_parp_inhi.xlsx\n",
      "Processing: Approved drugs for multiple sclerosis and their mechanisms of action. | Model: llama-3.3-70b-versatile | Trial: 7\n",
      "Saved to result/llama-3_3-70b-versatile/trial_7/approved_drugs_for_multiple_sclerosis_an.xlsx\n",
      "Processing: What are the known targets of sunitinib? | Model: llama-3.3-70b-versatile | Trial: 7\n",
      "Saved to result/llama-3_3-70b-versatile/trial_7/what_are_the_known_targets_of_sunitinib.xlsx\n",
      "Processing: Provide the SMILES for dasatinib. | Model: llama-3.3-70b-versatile | Trial: 7\n",
      "----- Some error occured-----\n",
      "Processing: Provide the SMILES for dasatinib. | Model: llama-3.3-70b-versatile | Trial: 7\n",
      "Processing: Genes linked to amyotrophic lateral sclerosis. | Model: llama-3.3-70b-versatile | Trial: 7\n",
      "Saved to result/llama-3_3-70b-versatile/trial_7/genes_linked_to_amyotrophic_lateral_scle.xlsx\n",
      "Processing: List of drugs and approval status for malaria. | Model: llama-3.3-70b-versatile | Trial: 7\n",
      "Saved to result/llama-3_3-70b-versatile/trial_7/list_of_drugs_and_approval_status_for_ma.xlsx\n",
      "Processing: What drugs target the JAKSTAT pathway in myelofibrosis? | Model: llama-3.3-70b-versatile | Trial: 7\n",
      "Saved to result/llama-3_3-70b-versatile/trial_7/what_drugs_target_the_jak_stat_pathway_i.xlsx\n",
      "Processing: Diseases associated with the gene BRCA1. | Model: llama-3.3-70b-versatile | Trial: 7\n",
      "Saved to result/llama-3_3-70b-versatile/trial_7/diseases_associated_with_the_gene_brca1.xlsx\n",
      "Processing: Biomarkers for early detection of pancreatic cancer. | Model: llama-3.3-70b-versatile | Trial: 7\n",
      "Saved to result/llama-3_3-70b-versatile/trial_7/biomarkers_for_early_detection_of_pancre.xlsx\n",
      "Processing: Which drugs act as VEGF inhibitors? | Model: llama-3.3-70b-versatile | Trial: 7\n",
      "Saved to result/llama-3_3-70b-versatile/trial_7/which_drugs_act_as_vegf_inhibitors.xlsx\n",
      "Processing: Drugs for chronic hepatitis B and their approval status. | Model: llama-3.3-70b-versatile | Trial: 7\n",
      "Saved to result/llama-3_3-70b-versatile/trial_7/drugs_for_chronic_hepatitis_b_and_their.xlsx\n",
      "Processing: What are the mechanisms of action for beta-lactam antibiotics? | Model: llama-3.3-70b-versatile | Trial: 7\n",
      "Saved to result/llama-3_3-70b-versatile/trial_7/what_are_the_mechanisms_of_action_for_be.xlsx\n",
      "Processing: Which approved drugs are used for treating rheumatoid arthritis? | Model: llama-3.3-70b-versatile | Trial: 7\n",
      "Saved to result/llama-3_3-70b-versatile/trial_7/which_approved_drugs_are_used_for_treati.xlsx\n",
      "Processing: What are the targets and mechanisms for dulaglutide? | Model: llama-3.3-70b-versatile | Trial: 7\n",
      "Saved to result/llama-3_3-70b-versatile/trial_7/what_are_the_targets_and_mechanisms_for.xlsx\n",
      "Processing: Provide drugs approved for ovarian cancer with their target names. | Model: llama-3.3-70b-versatile | Trial: 7\n",
      "Saved to result/llama-3_3-70b-versatile/trial_7/provide_drugs_approved_for_ovarian_cance.xlsx\n",
      "Processing: List pathways implicated in chronic lymphocytic leukemia. | Model: llama-3.3-70b-versatile | Trial: 7\n",
      "Saved to result/llama-3_3-70b-versatile/trial_7/list_pathways_implicated_in_chronic_lymp.xlsx\n",
      "Processing: What are the approved drugs for HER2-low breast cancer? | Model: llama-3.3-70b-versatile | Trial: 7\n",
      "Saved to result/llama-3_3-70b-versatile/trial_7/what_are_the_approved_drugs_for_her2-low.xlsx\n",
      "Processing: List all BTK inhibitors used for treating mantle cell lymphoma. | Model: llama-3.3-70b-versatile | Trial: 7\n",
      "Saved to result/llama-3_3-70b-versatile/trial_7/list_all_btk_inhibitors_used_for_treatin.xlsx\n",
      "Processing: What is the mechanism of action of pembrolizumab? | Model: llama-3.3-70b-versatile | Trial: 7\n",
      "Saved to result/llama-3_3-70b-versatile/trial_7/what_is_the_mechanism_of_action_of_pembr.xlsx\n",
      "Processing: Which genes are targeted by monoclonal antibodies in psoriasis? | Model: llama-3.3-70b-versatile | Trial: 7\n",
      "Saved to result/llama-3_3-70b-versatile/trial_7/which_genes_are_targeted_by_monoclonal_a.xlsx\n",
      "Processing: Drugs with approval status for HIV/AIDS. | Model: llama-3.3-70b-versatile | Trial: 7\n",
      "Saved to result/llama-3_3-70b-versatile/trial_7/drugs_with_approval_status_for_hiv_aids.xlsx\n",
      "Processing: Biomarkers associated with the RASRAFMEK pathway in colorectal cancer. | Model: llama-3.3-70b-versatile | Trial: 7\n",
      "Saved to result/llama-3_3-70b-versatile/trial_7/biomarkers_associated_with_the_ras_raf_m.xlsx\n",
      "Processing: Show drugs that inhibit the IDH1 gene. | Model: llama-3.3-70b-versatile | Trial: 7\n",
      "Saved to result/llama-3_3-70b-versatile/trial_7/show_drugs_that_inhibit_the_idh1_gene.xlsx\n",
      "Processing: What diseases are treated with durvalumab? | Model: llama-3.3-70b-versatile | Trial: 7\n",
      "Saved to result/llama-3_3-70b-versatile/trial_7/what_diseases_are_treated_with_durvaluma.xlsx\n",
      "Processing: Which pathways are targeted by MEK inhibitors? | Model: llama-3.3-70b-versatile | Trial: 7\n",
      "Saved to result/llama-3_3-70b-versatile/trial_7/which_pathways_are_targeted_by_mek_inhib.xlsx\n",
      "Processing: Approved drugs for ulcerative colitis and their mechanisms of action. | Model: llama-3.3-70b-versatile | Trial: 7\n",
      "Saved to result/llama-3_3-70b-versatile/trial_7/approved_drugs_for_ulcerative_colitis_an.xlsx\n",
      "Processing: What are the known targets of regorafenib? | Model: llama-3.3-70b-versatile | Trial: 7\n",
      "Saved to result/llama-3_3-70b-versatile/trial_7/what_are_the_known_targets_of_regorafeni.xlsx\n",
      "Processing: Provide the SMILES for erlotinib. | Model: llama-3.3-70b-versatile | Trial: 7\n",
      "----- Some error occured-----\n",
      "Processing: Provide the SMILES for erlotinib. | Model: llama-3.3-70b-versatile | Trial: 7\n",
      "Processing: Genes linked to Parkinsons disease. | Model: llama-3.3-70b-versatile | Trial: 7\n",
      "Saved to result/llama-3_3-70b-versatile/trial_7/genes_linked_to_parkinson_s_disease.xlsx\n",
      "Processing: List of drugs and approval status for influenza. | Model: llama-3.3-70b-versatile | Trial: 7\n",
      "Saved to result/llama-3_3-70b-versatile/trial_7/list_of_drugs_and_approval_status_for_in.xlsx\n",
      "Processing: What drugs target the PI3K pathway in lymphoma? | Model: llama-3.3-70b-versatile | Trial: 7\n",
      "Saved to result/llama-3_3-70b-versatile/trial_7/what_drugs_target_the_pi3k_pathway_in_ly.xlsx\n",
      "Processing: Diseases associated with the gene PIK3CA. | Model: llama-3.3-70b-versatile | Trial: 7\n",
      "Saved to result/llama-3_3-70b-versatile/trial_7/diseases_associated_with_the_gene_pik3ca.xlsx\n",
      "Processing: Biomarkers for early detection of gastric cancer. | Model: llama-3.3-70b-versatile | Trial: 7\n",
      "Saved to result/llama-3_3-70b-versatile/trial_7/biomarkers_for_early_detection_of_gastri.xlsx\n",
      "Processing: Which drugs act as PD-1 inhibitors? | Model: llama-3.3-70b-versatile | Trial: 7\n",
      "Saved to result/llama-3_3-70b-versatile/trial_7/which_drugs_act_as_pd-1_inhibitors.xlsx\n",
      "Processing: Drugs for hepatitis D and their approval status. | Model: llama-3.3-70b-versatile | Trial: 7\n",
      "Saved to result/llama-3_3-70b-versatile/trial_7/drugs_for_hepatitis_d_and_their_approval.xlsx\n",
      "Processing: What are the mechanisms of action for SGLT2 inhibitors? | Model: llama-3.3-70b-versatile | Trial: 7\n",
      "Saved to result/llama-3_3-70b-versatile/trial_7/what_are_the_mechanisms_of_action_for_sg.xlsx\n",
      "Processing: Which approved drugs are used for treating systemic lupus erythematosus? | Model: llama-3.3-70b-versatile | Trial: 7\n",
      "Saved to result/llama-3_3-70b-versatile/trial_7/which_approved_drugs_are_used_for_treati.xlsx\n",
      "Processing: What are the targets and mechanisms for tofacitinib? | Model: llama-3.3-70b-versatile | Trial: 7\n",
      "Saved to result/llama-3_3-70b-versatile/trial_7/what_are_the_targets_and_mechanisms_for.xlsx\n",
      "Processing: Provide drugs approved for prostate cancer with their target names. | Model: llama-3.3-70b-versatile | Trial: 7\n",
      "Saved to result/llama-3_3-70b-versatile/trial_7/provide_drugs_approved_for_prostate_canc.xlsx\n",
      "Processing: List pathways implicated in glioblastoma. | Model: llama-3.3-70b-versatile | Trial: 7\n",
      "Saved to result/llama-3_3-70b-versatile/trial_7/list_pathways_implicated_in_glioblastoma.xlsx\n",
      "Processing: What are the approved drugs for EGFR-mutant non-small cell lung cancer? | Model: llama-3.3-70b-versatile | Trial: 7\n",
      "Saved to result/llama-3_3-70b-versatile/trial_7/what_are_the_approved_drugs_for_egfr-mut.xlsx\n",
      "Processing: List all CDK4/6 inhibitors used for treating breast cancer. | Model: llama-3.3-70b-versatile | Trial: 7\n",
      "Saved to result/llama-3_3-70b-versatile/trial_7/list_all_cdk4_6_inhibitors_used_for_trea.xlsx\n",
      "Processing: What is the mechanism of action of osimertinib? | Model: llama-3.3-70b-versatile | Trial: 7\n",
      "Saved to result/llama-3_3-70b-versatile/trial_7/what_is_the_mechanism_of_action_of_osime.xlsx\n",
      "Processing: Which genes are targeted by monoclonal antibodies in asthma? | Model: llama-3.3-70b-versatile | Trial: 7\n",
      "Saved to result/llama-3_3-70b-versatile/trial_7/which_genes_are_targeted_by_monoclonal_a.xlsx\n",
      "Processing: Drugs with approval status for Clostridioides difficile infection. | Model: llama-3.3-70b-versatile | Trial: 7\n",
      "Saved to result/llama-3_3-70b-versatile/trial_7/drugs_with_approval_status_for_clostridi.xlsx\n",
      "Processing: Biomarkers associated with the WNT/ß-catenin pathway in cancer. | Model: llama-3.3-70b-versatile | Trial: 7\n",
      "Saved to result/llama-3_3-70b-versatile/trial_7/biomarkers_associated_with_the_wnt__-cat.xlsx\n",
      "Processing: Show drugs that inhibit the FGFR2 gene. | Model: llama-3.3-70b-versatile | Trial: 7\n",
      "Saved to result/llama-3_3-70b-versatile/trial_7/show_drugs_that_inhibit_the_fgfr2_gene.xlsx\n",
      "Processing: What diseases are treated with bevacizumab? | Model: llama-3.3-70b-versatile | Trial: 7\n",
      "Saved to result/llama-3_3-70b-versatile/trial_7/what_diseases_are_treated_with_bevacizum.xlsx\n",
      "Processing: Which pathways are targeted by mTOR inhibitors? | Model: llama-3.3-70b-versatile | Trial: 7\n",
      "Saved to result/llama-3_3-70b-versatile/trial_7/which_pathways_are_targeted_by_mtor_inhi.xlsx\n",
      "Processing: Approved drugs for plaque psoriasis and their mechanisms of action. | Model: llama-3.3-70b-versatile | Trial: 7\n",
      "Saved to result/llama-3_3-70b-versatile/trial_7/approved_drugs_for_plaque_psoriasis_and.xlsx\n",
      "Processing: What are the known targets of cabozantinib? | Model: llama-3.3-70b-versatile | Trial: 7\n",
      "Saved to result/llama-3_3-70b-versatile/trial_7/what_are_the_known_targets_of_cabozantin.xlsx\n",
      "Processing: Provide the SMILES for gefitinib. | Model: llama-3.3-70b-versatile | Trial: 7\n",
      "----- Some error occured-----\n",
      "Processing: Provide the SMILES for gefitinib. | Model: llama-3.3-70b-versatile | Trial: 7\n",
      "Processing: Genes linked to Crohns disease. | Model: llama-3.3-70b-versatile | Trial: 7\n",
      "Saved to result/llama-3_3-70b-versatile/trial_7/genes_linked_to_crohn_s_disease.xlsx\n",
      "Processing: List of drugs and approval status for respiratory syncytial virus infection. | Model: llama-3.3-70b-versatile | Trial: 7\n",
      "Saved to result/llama-3_3-70b-versatile/trial_7/list_of_drugs_and_approval_status_for_re.xlsx\n",
      "Processing: What drugs target the Hedgehog pathway in oncology? | Model: llama-3.3-70b-versatile | Trial: 7\n",
      "Saved to result/llama-3_3-70b-versatile/trial_7/what_drugs_target_the_hedgehog_pathway_i.xlsx\n",
      "Processing: Diseases associated with the gene NPM1. | Model: llama-3.3-70b-versatile | Trial: 7\n",
      "Saved to result/llama-3_3-70b-versatile/trial_7/diseases_associated_with_the_gene_npm1.xlsx\n",
      "Processing: Biomarkers for early detection of hepatocellular carcinoma. | Model: llama-3.3-70b-versatile | Trial: 7\n",
      "Saved to result/llama-3_3-70b-versatile/trial_7/biomarkers_for_early_detection_of_hepato.xlsx\n",
      "Processing: Which drugs act as CTLA-4 inhibitors? | Model: llama-3.3-70b-versatile | Trial: 7\n",
      "Saved to result/llama-3_3-70b-versatile/trial_7/which_drugs_act_as_ctla-4_inhibitors.xlsx\n",
      "Processing: Drugs for pulmonary arterial hypertension and their approval status. | Model: llama-3.3-70b-versatile | Trial: 7\n",
      "Saved to result/llama-3_3-70b-versatile/trial_7/drugs_for_pulmonary_arterial_hypertensio.xlsx\n",
      "Processing: What are the mechanisms of action for ACE inhibitors? | Model: llama-3.3-70b-versatile | Trial: 7\n",
      "Saved to result/llama-3_3-70b-versatile/trial_7/what_are_the_mechanisms_of_action_for_ac.xlsx\n",
      "Processing: Which approved drugs are used for treating migraine? | Model: llama-3.3-70b-versatile | Trial: 7\n",
      "Saved to result/llama-3_3-70b-versatile/trial_7/which_approved_drugs_are_used_for_treati.xlsx\n",
      "Processing: What are the targets and mechanisms for rituximab? | Model: llama-3.3-70b-versatile | Trial: 7\n",
      "Saved to result/llama-3_3-70b-versatile/trial_7/what_are_the_targets_and_mechanisms_for.xlsx\n",
      "Processing: Provide drugs approved for colorectal cancer with their target names. | Model: llama-3.3-70b-versatile | Trial: 7\n",
      "Saved to result/llama-3_3-70b-versatile/trial_7/provide_drugs_approved_for_colorectal_ca.xlsx\n",
      "Processing: List pathways implicated in myelodysplastic syndromes. | Model: llama-3.3-70b-versatile | Trial: 7\n",
      "Saved to result/llama-3_3-70b-versatile/trial_7/list_pathways_implicated_in_myelodysplas.xlsx\n",
      "Processing: What are the approved drugs for BRAF V600Emutant melanoma? | Model: llama-3.3-70b-versatile | Trial: 7\n",
      "Saved to result/llama-3_3-70b-versatile/trial_7/what_are_the_approved_drugs_for_braf_v60.xlsx\n",
      "Processing: List all FLT3 inhibitors used for treating acute myeloid leukemia. | Model: llama-3.3-70b-versatile | Trial: 7\n",
      "Saved to result/llama-3_3-70b-versatile/trial_7/list_all_flt3_inhibitors_used_for_treati.xlsx\n",
      "Processing: What is the mechanism of action of lenvatinib? | Model: llama-3.3-70b-versatile | Trial: 7\n",
      "Saved to result/llama-3_3-70b-versatile/trial_7/what_is_the_mechanism_of_action_of_lenva.xlsx\n",
      "Processing: Which genes are targeted by monoclonal antibodies in multiple sclerosis? | Model: llama-3.3-70b-versatile | Trial: 7\n",
      "Saved to result/llama-3_3-70b-versatile/trial_7/which_genes_are_targeted_by_monoclonal_a.xlsx\n",
      "Processing: Drugs with approval status for leprosy. | Model: llama-3.3-70b-versatile | Trial: 7\n",
      "Saved to result/llama-3_3-70b-versatile/trial_7/drugs_with_approval_status_for_leprosy.xlsx\n",
      "Processing: Biomarkers associated with the TGF-ß pathway in fibrosis. | Model: llama-3.3-70b-versatile | Trial: 7\n",
      "Saved to result/llama-3_3-70b-versatile/trial_7/biomarkers_associated_with_the_tgf-__pat.xlsx\n",
      "Processing: Show drugs that inhibit the RET gene. | Model: llama-3.3-70b-versatile | Trial: 7\n",
      "Saved to result/llama-3_3-70b-versatile/trial_7/show_drugs_that_inhibit_the_ret_gene.xlsx\n",
      "Processing: What diseases are treated with trastuzumab deruxtecan? | Model: llama-3.3-70b-versatile | Trial: 7\n",
      "Saved to result/llama-3_3-70b-versatile/trial_7/what_diseases_are_treated_with_trastuzum.xlsx\n",
      "Processing: Which pathways are targeted by PI3K inhibitors? | Model: llama-3.3-70b-versatile | Trial: 7\n",
      "Saved to result/llama-3_3-70b-versatile/trial_7/which_pathways_are_targeted_by_pi3k_inhi.xlsx\n",
      "Processing: Approved drugs for atopic dermatitis and their mechanisms of action. | Model: llama-3.3-70b-versatile | Trial: 7\n",
      "Saved to result/llama-3_3-70b-versatile/trial_7/approved_drugs_for_atopic_dermatitis_and.xlsx\n",
      "Processing: What are the known targets of vandetanib? | Model: llama-3.3-70b-versatile | Trial: 7\n",
      "Saved to result/llama-3_3-70b-versatile/trial_7/what_are_the_known_targets_of_vandetanib.xlsx\n",
      "Processing: Provide the SMILES for sorafenib. | Model: llama-3.3-70b-versatile | Trial: 7\n",
      "----- Some error occured-----\n",
      "Processing: Provide the SMILES for sorafenib. | Model: llama-3.3-70b-versatile | Trial: 7\n",
      "Processing: Genes linked to schizophrenia. | Model: llama-3.3-70b-versatile | Trial: 7\n",
      "Saved to result/llama-3_3-70b-versatile/trial_7/genes_linked_to_schizophrenia.xlsx\n",
      "Processing: List of drugs and approval status for dengue. | Model: llama-3.3-70b-versatile | Trial: 7\n",
      "Saved to result/llama-3_3-70b-versatile/trial_7/list_of_drugs_and_approval_status_for_de.xlsx\n",
      "Processing: What drugs target the JAKSTAT pathway in atopic dermatitis? | Model: llama-3.3-70b-versatile | Trial: 7\n",
      "Saved to result/llama-3_3-70b-versatile/trial_7/what_drugs_target_the_jak_stat_pathway_i.xlsx\n",
      "Processing: Diseases associated with the gene KRAS. | Model: llama-3.3-70b-versatile | Trial: 7\n",
      "Saved to result/llama-3_3-70b-versatile/trial_7/diseases_associated_with_the_gene_kras.xlsx\n",
      "Processing: Biomarkers for early detection of ovarian cancer. | Model: llama-3.3-70b-versatile | Trial: 7\n",
      "Saved to result/llama-3_3-70b-versatile/trial_7/biomarkers_for_early_detection_of_ovaria.xlsx\n",
      "Processing: Which drugs act as BCR-ABL inhibitors? | Model: llama-3.3-70b-versatile | Trial: 7\n",
      "Saved to result/llama-3_3-70b-versatile/trial_7/which_drugs_act_as_bcr-abl_inhibitors.xlsx\n",
      "Processing: Drugs for idiopathic pulmonary fibrosis and their approval status. | Model: llama-3.3-70b-versatile | Trial: 7\n",
      "Saved to result/llama-3_3-70b-versatile/trial_7/drugs_for_idiopathic_pulmonary_fibrosis.xlsx\n",
      "Processing: What are the mechanisms of action for monoclonal antibodies targeting IL-6? | Model: llama-3.3-70b-versatile | Trial: 7\n",
      "Saved to result/llama-3_3-70b-versatile/trial_7/what_are_the_mechanisms_of_action_for_mo.xlsx\n",
      "Processing: Which approved drugs are used for treating osteoporosis? | Model: llama-3.3-70b-versatile | Trial: 7\n",
      "Saved to result/llama-3_3-70b-versatile/trial_7/which_approved_drugs_are_used_for_treati.xlsx\n",
      "Processing: What are the targets and mechanisms for dupilumab? | Model: llama-3.3-70b-versatile | Trial: 7\n",
      "Saved to result/llama-3_3-70b-versatile/trial_7/what_are_the_targets_and_mechanisms_for.xlsx\n",
      "Processing: Provide drugs approved for renal cell carcinoma with their target names. | Model: llama-3.3-70b-versatile | Trial: 7\n",
      "Saved to result/llama-3_3-70b-versatile/trial_7/provide_drugs_approved_for_renal_cell_ca.xlsx\n",
      "Processing: List pathways implicated in prostate cancer. | Model: llama-3.3-70b-versatile | Trial: 7\n",
      "Saved to result/llama-3_3-70b-versatile/trial_7/list_pathways_implicated_in_prostate_can.xlsx\n",
      "Processing: What are the approved drugs for EGFR exon 20 insertionmutant lung cancer? | Model: llama-3.3-70b-versatile | Trial: 7\n",
      "Saved to result/llama-3_3-70b-versatile/trial_7/what_are_the_approved_drugs_for_egfr_exo.xlsx\n",
      "Processing: List all TRK inhibitors used for treating NTRK-fusion cancers. | Model: llama-3.3-70b-versatile | Trial: 7\n",
      "Saved to result/llama-3_3-70b-versatile/trial_7/list_all_trk_inhibitors_used_for_treatin.xlsx\n",
      "Processing: What is the mechanism of action of darolutamide? | Model: llama-3.3-70b-versatile | Trial: 7\n",
      "Saved to result/llama-3_3-70b-versatile/trial_7/what_is_the_mechanism_of_action_of_darol.xlsx\n",
      "Processing: Which genes are targeted by monoclonal antibodies in oncology immunotherapy? | Model: llama-3.3-70b-versatile | Trial: 7\n",
      "Saved to result/llama-3_3-70b-versatile/trial_7/which_genes_are_targeted_by_monoclonal_a.xlsx\n",
      "Processing: What drugs are used to treat fever? | Model: llama-3.3-70b-versatile | Trial: 7\n",
      "Saved to result/llama-3_3-70b-versatile/trial_7/what_drugs_are_used_to_treat_fever.xlsx\n",
      "Processing: What are the approved drugs for triple-negative breast cancer? | Model: llama-3.3-70b-versatile | Trial: 8\n",
      "Saved to result/llama-3_3-70b-versatile/trial_8/what_are_the_approved_drugs_for_triple-n.xlsx\n",
      "Processing: List all ALK inhibitors used for treating non-small cell lung cancer. | Model: llama-3.3-70b-versatile | Trial: 8\n",
      "Saved to result/llama-3_3-70b-versatile/trial_8/list_all_alk_inhibitors_used_for_treatin.xlsx\n",
      "Processing: What is the mechanism of action of nivolumab? | Model: llama-3.3-70b-versatile | Trial: 8\n",
      "Saved to result/llama-3_3-70b-versatile/trial_8/what_is_the_mechanism_of_action_of_nivol.xlsx\n",
      "Processing: Drugs with approval status for hepatitis C virus infection. | Model: llama-3.3-70b-versatile | Trial: 8\n",
      "Saved to result/llama-3_3-70b-versatile/trial_8/drugs_with_approval_status_for_hepatitis.xlsx\n",
      "Processing: Biomarkers associated with the PI3KAKT pathway in breast cancer. | Model: llama-3.3-70b-versatile | Trial: 8\n",
      "Saved to result/llama-3_3-70b-versatile/trial_8/biomarkers_associated_with_the_pi3k_akt.xlsx\n",
      "Processing: Show drugs that inhibit the KRAS G12C variant. | Model: llama-3.3-70b-versatile | Trial: 8\n",
      "Saved to result/llama-3_3-70b-versatile/trial_8/show_drugs_that_inhibit_the_kras_g12c_va.xlsx\n",
      "Processing: What diseases are treated with atezolizumab? | Model: llama-3.3-70b-versatile | Trial: 8\n",
      "Saved to result/llama-3_3-70b-versatile/trial_8/what_diseases_are_treated_with_atezolizu.xlsx\n",
      "Processing: Which pathways are targeted by PARP inhibitors? | Model: llama-3.3-70b-versatile | Trial: 8\n",
      "Saved to result/llama-3_3-70b-versatile/trial_8/which_pathways_are_targeted_by_parp_inhi.xlsx\n",
      "Processing: Approved drugs for multiple sclerosis and their mechanisms of action. | Model: llama-3.3-70b-versatile | Trial: 8\n",
      "Saved to result/llama-3_3-70b-versatile/trial_8/approved_drugs_for_multiple_sclerosis_an.xlsx\n",
      "Processing: What are the known targets of sunitinib? | Model: llama-3.3-70b-versatile | Trial: 8\n",
      "Saved to result/llama-3_3-70b-versatile/trial_8/what_are_the_known_targets_of_sunitinib.xlsx\n",
      "Processing: Provide the SMILES for dasatinib. | Model: llama-3.3-70b-versatile | Trial: 8\n",
      "----- Some error occured-----\n",
      "Processing: Provide the SMILES for dasatinib. | Model: llama-3.3-70b-versatile | Trial: 8\n",
      "Processing: Genes linked to amyotrophic lateral sclerosis. | Model: llama-3.3-70b-versatile | Trial: 8\n",
      "Saved to result/llama-3_3-70b-versatile/trial_8/genes_linked_to_amyotrophic_lateral_scle.xlsx\n",
      "Processing: List of drugs and approval status for malaria. | Model: llama-3.3-70b-versatile | Trial: 8\n",
      "Saved to result/llama-3_3-70b-versatile/trial_8/list_of_drugs_and_approval_status_for_ma.xlsx\n",
      "Processing: What drugs target the JAKSTAT pathway in myelofibrosis? | Model: llama-3.3-70b-versatile | Trial: 8\n",
      "Saved to result/llama-3_3-70b-versatile/trial_8/what_drugs_target_the_jak_stat_pathway_i.xlsx\n",
      "Processing: Diseases associated with the gene BRCA1. | Model: llama-3.3-70b-versatile | Trial: 8\n",
      "Saved to result/llama-3_3-70b-versatile/trial_8/diseases_associated_with_the_gene_brca1.xlsx\n",
      "Processing: Biomarkers for early detection of pancreatic cancer. | Model: llama-3.3-70b-versatile | Trial: 8\n",
      "Saved to result/llama-3_3-70b-versatile/trial_8/biomarkers_for_early_detection_of_pancre.xlsx\n",
      "Processing: Which drugs act as VEGF inhibitors? | Model: llama-3.3-70b-versatile | Trial: 8\n",
      "Saved to result/llama-3_3-70b-versatile/trial_8/which_drugs_act_as_vegf_inhibitors.xlsx\n",
      "Processing: Drugs for chronic hepatitis B and their approval status. | Model: llama-3.3-70b-versatile | Trial: 8\n",
      "Saved to result/llama-3_3-70b-versatile/trial_8/drugs_for_chronic_hepatitis_b_and_their.xlsx\n",
      "Processing: What are the mechanisms of action for beta-lactam antibiotics? | Model: llama-3.3-70b-versatile | Trial: 8\n",
      "Saved to result/llama-3_3-70b-versatile/trial_8/what_are_the_mechanisms_of_action_for_be.xlsx\n",
      "Processing: Which approved drugs are used for treating rheumatoid arthritis? | Model: llama-3.3-70b-versatile | Trial: 8\n",
      "Saved to result/llama-3_3-70b-versatile/trial_8/which_approved_drugs_are_used_for_treati.xlsx\n",
      "Processing: What are the targets and mechanisms for dulaglutide? | Model: llama-3.3-70b-versatile | Trial: 8\n",
      "Saved to result/llama-3_3-70b-versatile/trial_8/what_are_the_targets_and_mechanisms_for.xlsx\n",
      "Processing: Provide drugs approved for ovarian cancer with their target names. | Model: llama-3.3-70b-versatile | Trial: 8\n",
      "Saved to result/llama-3_3-70b-versatile/trial_8/provide_drugs_approved_for_ovarian_cance.xlsx\n",
      "Processing: List pathways implicated in chronic lymphocytic leukemia. | Model: llama-3.3-70b-versatile | Trial: 8\n",
      "Saved to result/llama-3_3-70b-versatile/trial_8/list_pathways_implicated_in_chronic_lymp.xlsx\n",
      "Processing: What are the approved drugs for HER2-low breast cancer? | Model: llama-3.3-70b-versatile | Trial: 8\n",
      "Saved to result/llama-3_3-70b-versatile/trial_8/what_are_the_approved_drugs_for_her2-low.xlsx\n",
      "Processing: List all BTK inhibitors used for treating mantle cell lymphoma. | Model: llama-3.3-70b-versatile | Trial: 8\n",
      "Saved to result/llama-3_3-70b-versatile/trial_8/list_all_btk_inhibitors_used_for_treatin.xlsx\n",
      "Processing: What is the mechanism of action of pembrolizumab? | Model: llama-3.3-70b-versatile | Trial: 8\n",
      "Saved to result/llama-3_3-70b-versatile/trial_8/what_is_the_mechanism_of_action_of_pembr.xlsx\n",
      "Processing: Which genes are targeted by monoclonal antibodies in psoriasis? | Model: llama-3.3-70b-versatile | Trial: 8\n",
      "Saved to result/llama-3_3-70b-versatile/trial_8/which_genes_are_targeted_by_monoclonal_a.xlsx\n",
      "Processing: Drugs with approval status for HIV/AIDS. | Model: llama-3.3-70b-versatile | Trial: 8\n",
      "Saved to result/llama-3_3-70b-versatile/trial_8/drugs_with_approval_status_for_hiv_aids.xlsx\n",
      "Processing: Biomarkers associated with the RASRAFMEK pathway in colorectal cancer. | Model: llama-3.3-70b-versatile | Trial: 8\n",
      "Saved to result/llama-3_3-70b-versatile/trial_8/biomarkers_associated_with_the_ras_raf_m.xlsx\n",
      "Processing: Show drugs that inhibit the IDH1 gene. | Model: llama-3.3-70b-versatile | Trial: 8\n",
      "Saved to result/llama-3_3-70b-versatile/trial_8/show_drugs_that_inhibit_the_idh1_gene.xlsx\n",
      "Processing: What diseases are treated with durvalumab? | Model: llama-3.3-70b-versatile | Trial: 8\n",
      "Saved to result/llama-3_3-70b-versatile/trial_8/what_diseases_are_treated_with_durvaluma.xlsx\n",
      "Processing: Which pathways are targeted by MEK inhibitors? | Model: llama-3.3-70b-versatile | Trial: 8\n",
      "Saved to result/llama-3_3-70b-versatile/trial_8/which_pathways_are_targeted_by_mek_inhib.xlsx\n",
      "Processing: Approved drugs for ulcerative colitis and their mechanisms of action. | Model: llama-3.3-70b-versatile | Trial: 8\n",
      "Saved to result/llama-3_3-70b-versatile/trial_8/approved_drugs_for_ulcerative_colitis_an.xlsx\n",
      "Processing: What are the known targets of regorafenib? | Model: llama-3.3-70b-versatile | Trial: 8\n",
      "Saved to result/llama-3_3-70b-versatile/trial_8/what_are_the_known_targets_of_regorafeni.xlsx\n",
      "Processing: Provide the SMILES for erlotinib. | Model: llama-3.3-70b-versatile | Trial: 8\n",
      "----- Some error occured-----\n",
      "Processing: Provide the SMILES for erlotinib. | Model: llama-3.3-70b-versatile | Trial: 8\n",
      "Processing: Genes linked to Parkinsons disease. | Model: llama-3.3-70b-versatile | Trial: 8\n",
      "Saved to result/llama-3_3-70b-versatile/trial_8/genes_linked_to_parkinson_s_disease.xlsx\n",
      "Processing: List of drugs and approval status for influenza. | Model: llama-3.3-70b-versatile | Trial: 8\n",
      "Saved to result/llama-3_3-70b-versatile/trial_8/list_of_drugs_and_approval_status_for_in.xlsx\n",
      "Processing: What drugs target the PI3K pathway in lymphoma? | Model: llama-3.3-70b-versatile | Trial: 8\n",
      "Saved to result/llama-3_3-70b-versatile/trial_8/what_drugs_target_the_pi3k_pathway_in_ly.xlsx\n",
      "Processing: Diseases associated with the gene PIK3CA. | Model: llama-3.3-70b-versatile | Trial: 8\n",
      "Saved to result/llama-3_3-70b-versatile/trial_8/diseases_associated_with_the_gene_pik3ca.xlsx\n",
      "Processing: Biomarkers for early detection of gastric cancer. | Model: llama-3.3-70b-versatile | Trial: 8\n",
      "Saved to result/llama-3_3-70b-versatile/trial_8/biomarkers_for_early_detection_of_gastri.xlsx\n",
      "Processing: Which drugs act as PD-1 inhibitors? | Model: llama-3.3-70b-versatile | Trial: 8\n",
      "Saved to result/llama-3_3-70b-versatile/trial_8/which_drugs_act_as_pd-1_inhibitors.xlsx\n",
      "Processing: Drugs for hepatitis D and their approval status. | Model: llama-3.3-70b-versatile | Trial: 8\n",
      "Saved to result/llama-3_3-70b-versatile/trial_8/drugs_for_hepatitis_d_and_their_approval.xlsx\n",
      "Processing: What are the mechanisms of action for SGLT2 inhibitors? | Model: llama-3.3-70b-versatile | Trial: 8\n",
      "Saved to result/llama-3_3-70b-versatile/trial_8/what_are_the_mechanisms_of_action_for_sg.xlsx\n",
      "Processing: Which approved drugs are used for treating systemic lupus erythematosus? | Model: llama-3.3-70b-versatile | Trial: 8\n",
      "Saved to result/llama-3_3-70b-versatile/trial_8/which_approved_drugs_are_used_for_treati.xlsx\n",
      "Processing: What are the targets and mechanisms for tofacitinib? | Model: llama-3.3-70b-versatile | Trial: 8\n",
      "Saved to result/llama-3_3-70b-versatile/trial_8/what_are_the_targets_and_mechanisms_for.xlsx\n",
      "Processing: Provide drugs approved for prostate cancer with their target names. | Model: llama-3.3-70b-versatile | Trial: 8\n",
      "Saved to result/llama-3_3-70b-versatile/trial_8/provide_drugs_approved_for_prostate_canc.xlsx\n",
      "Processing: List pathways implicated in glioblastoma. | Model: llama-3.3-70b-versatile | Trial: 8\n",
      "Saved to result/llama-3_3-70b-versatile/trial_8/list_pathways_implicated_in_glioblastoma.xlsx\n",
      "Processing: What are the approved drugs for EGFR-mutant non-small cell lung cancer? | Model: llama-3.3-70b-versatile | Trial: 8\n",
      "Saved to result/llama-3_3-70b-versatile/trial_8/what_are_the_approved_drugs_for_egfr-mut.xlsx\n",
      "Processing: List all CDK4/6 inhibitors used for treating breast cancer. | Model: llama-3.3-70b-versatile | Trial: 8\n",
      "Saved to result/llama-3_3-70b-versatile/trial_8/list_all_cdk4_6_inhibitors_used_for_trea.xlsx\n",
      "Processing: What is the mechanism of action of osimertinib? | Model: llama-3.3-70b-versatile | Trial: 8\n",
      "Saved to result/llama-3_3-70b-versatile/trial_8/what_is_the_mechanism_of_action_of_osime.xlsx\n",
      "Processing: Which genes are targeted by monoclonal antibodies in asthma? | Model: llama-3.3-70b-versatile | Trial: 8\n",
      "Saved to result/llama-3_3-70b-versatile/trial_8/which_genes_are_targeted_by_monoclonal_a.xlsx\n",
      "Processing: Drugs with approval status for Clostridioides difficile infection. | Model: llama-3.3-70b-versatile | Trial: 8\n",
      "Saved to result/llama-3_3-70b-versatile/trial_8/drugs_with_approval_status_for_clostridi.xlsx\n",
      "Processing: Biomarkers associated with the WNT/ß-catenin pathway in cancer. | Model: llama-3.3-70b-versatile | Trial: 8\n",
      "Saved to result/llama-3_3-70b-versatile/trial_8/biomarkers_associated_with_the_wnt__-cat.xlsx\n",
      "Processing: Show drugs that inhibit the FGFR2 gene. | Model: llama-3.3-70b-versatile | Trial: 8\n",
      "Saved to result/llama-3_3-70b-versatile/trial_8/show_drugs_that_inhibit_the_fgfr2_gene.xlsx\n",
      "Processing: What diseases are treated with bevacizumab? | Model: llama-3.3-70b-versatile | Trial: 8\n",
      "Saved to result/llama-3_3-70b-versatile/trial_8/what_diseases_are_treated_with_bevacizum.xlsx\n",
      "Processing: Which pathways are targeted by mTOR inhibitors? | Model: llama-3.3-70b-versatile | Trial: 8\n",
      "Saved to result/llama-3_3-70b-versatile/trial_8/which_pathways_are_targeted_by_mtor_inhi.xlsx\n",
      "Processing: Approved drugs for plaque psoriasis and their mechanisms of action. | Model: llama-3.3-70b-versatile | Trial: 8\n",
      "Saved to result/llama-3_3-70b-versatile/trial_8/approved_drugs_for_plaque_psoriasis_and.xlsx\n",
      "Processing: What are the known targets of cabozantinib? | Model: llama-3.3-70b-versatile | Trial: 8\n",
      "Saved to result/llama-3_3-70b-versatile/trial_8/what_are_the_known_targets_of_cabozantin.xlsx\n",
      "Processing: Provide the SMILES for gefitinib. | Model: llama-3.3-70b-versatile | Trial: 8\n",
      "----- Some error occured-----\n",
      "Processing: Provide the SMILES for gefitinib. | Model: llama-3.3-70b-versatile | Trial: 8\n",
      "Processing: Genes linked to Crohns disease. | Model: llama-3.3-70b-versatile | Trial: 8\n",
      "Saved to result/llama-3_3-70b-versatile/trial_8/genes_linked_to_crohn_s_disease.xlsx\n",
      "Processing: List of drugs and approval status for respiratory syncytial virus infection. | Model: llama-3.3-70b-versatile | Trial: 8\n",
      "Saved to result/llama-3_3-70b-versatile/trial_8/list_of_drugs_and_approval_status_for_re.xlsx\n",
      "Processing: What drugs target the Hedgehog pathway in oncology? | Model: llama-3.3-70b-versatile | Trial: 8\n",
      "Saved to result/llama-3_3-70b-versatile/trial_8/what_drugs_target_the_hedgehog_pathway_i.xlsx\n",
      "Processing: Diseases associated with the gene NPM1. | Model: llama-3.3-70b-versatile | Trial: 8\n",
      "Saved to result/llama-3_3-70b-versatile/trial_8/diseases_associated_with_the_gene_npm1.xlsx\n",
      "Processing: Biomarkers for early detection of hepatocellular carcinoma. | Model: llama-3.3-70b-versatile | Trial: 8\n",
      "Saved to result/llama-3_3-70b-versatile/trial_8/biomarkers_for_early_detection_of_hepato.xlsx\n",
      "Processing: Which drugs act as CTLA-4 inhibitors? | Model: llama-3.3-70b-versatile | Trial: 8\n",
      "Saved to result/llama-3_3-70b-versatile/trial_8/which_drugs_act_as_ctla-4_inhibitors.xlsx\n",
      "Processing: Drugs for pulmonary arterial hypertension and their approval status. | Model: llama-3.3-70b-versatile | Trial: 8\n",
      "Saved to result/llama-3_3-70b-versatile/trial_8/drugs_for_pulmonary_arterial_hypertensio.xlsx\n",
      "Processing: What are the mechanisms of action for ACE inhibitors? | Model: llama-3.3-70b-versatile | Trial: 8\n",
      "Saved to result/llama-3_3-70b-versatile/trial_8/what_are_the_mechanisms_of_action_for_ac.xlsx\n",
      "Processing: Which approved drugs are used for treating migraine? | Model: llama-3.3-70b-versatile | Trial: 8\n",
      "Saved to result/llama-3_3-70b-versatile/trial_8/which_approved_drugs_are_used_for_treati.xlsx\n",
      "Processing: What are the targets and mechanisms for rituximab? | Model: llama-3.3-70b-versatile | Trial: 8\n",
      "Saved to result/llama-3_3-70b-versatile/trial_8/what_are_the_targets_and_mechanisms_for.xlsx\n",
      "Processing: Provide drugs approved for colorectal cancer with their target names. | Model: llama-3.3-70b-versatile | Trial: 8\n",
      "Saved to result/llama-3_3-70b-versatile/trial_8/provide_drugs_approved_for_colorectal_ca.xlsx\n",
      "Processing: List pathways implicated in myelodysplastic syndromes. | Model: llama-3.3-70b-versatile | Trial: 8\n",
      "Saved to result/llama-3_3-70b-versatile/trial_8/list_pathways_implicated_in_myelodysplas.xlsx\n",
      "Processing: What are the approved drugs for BRAF V600Emutant melanoma? | Model: llama-3.3-70b-versatile | Trial: 8\n",
      "Saved to result/llama-3_3-70b-versatile/trial_8/what_are_the_approved_drugs_for_braf_v60.xlsx\n",
      "Processing: List all FLT3 inhibitors used for treating acute myeloid leukemia. | Model: llama-3.3-70b-versatile | Trial: 8\n",
      "Saved to result/llama-3_3-70b-versatile/trial_8/list_all_flt3_inhibitors_used_for_treati.xlsx\n",
      "Processing: What is the mechanism of action of lenvatinib? | Model: llama-3.3-70b-versatile | Trial: 8\n",
      "Saved to result/llama-3_3-70b-versatile/trial_8/what_is_the_mechanism_of_action_of_lenva.xlsx\n",
      "Processing: Which genes are targeted by monoclonal antibodies in multiple sclerosis? | Model: llama-3.3-70b-versatile | Trial: 8\n",
      "Saved to result/llama-3_3-70b-versatile/trial_8/which_genes_are_targeted_by_monoclonal_a.xlsx\n",
      "Processing: Drugs with approval status for leprosy. | Model: llama-3.3-70b-versatile | Trial: 8\n",
      "Saved to result/llama-3_3-70b-versatile/trial_8/drugs_with_approval_status_for_leprosy.xlsx\n",
      "Processing: Biomarkers associated with the TGF-ß pathway in fibrosis. | Model: llama-3.3-70b-versatile | Trial: 8\n",
      "Saved to result/llama-3_3-70b-versatile/trial_8/biomarkers_associated_with_the_tgf-__pat.xlsx\n",
      "Processing: Show drugs that inhibit the RET gene. | Model: llama-3.3-70b-versatile | Trial: 8\n",
      "Saved to result/llama-3_3-70b-versatile/trial_8/show_drugs_that_inhibit_the_ret_gene.xlsx\n",
      "Processing: What diseases are treated with trastuzumab deruxtecan? | Model: llama-3.3-70b-versatile | Trial: 8\n",
      "Saved to result/llama-3_3-70b-versatile/trial_8/what_diseases_are_treated_with_trastuzum.xlsx\n",
      "Processing: Which pathways are targeted by PI3K inhibitors? | Model: llama-3.3-70b-versatile | Trial: 8\n",
      "Saved to result/llama-3_3-70b-versatile/trial_8/which_pathways_are_targeted_by_pi3k_inhi.xlsx\n",
      "Processing: Approved drugs for atopic dermatitis and their mechanisms of action. | Model: llama-3.3-70b-versatile | Trial: 8\n",
      "Saved to result/llama-3_3-70b-versatile/trial_8/approved_drugs_for_atopic_dermatitis_and.xlsx\n",
      "Processing: What are the known targets of vandetanib? | Model: llama-3.3-70b-versatile | Trial: 8\n",
      "Saved to result/llama-3_3-70b-versatile/trial_8/what_are_the_known_targets_of_vandetanib.xlsx\n",
      "Processing: Provide the SMILES for sorafenib. | Model: llama-3.3-70b-versatile | Trial: 8\n",
      "----- Some error occured-----\n",
      "Processing: Provide the SMILES for sorafenib. | Model: llama-3.3-70b-versatile | Trial: 8\n",
      "Processing: Genes linked to schizophrenia. | Model: llama-3.3-70b-versatile | Trial: 8\n",
      "Saved to result/llama-3_3-70b-versatile/trial_8/genes_linked_to_schizophrenia.xlsx\n",
      "Processing: List of drugs and approval status for dengue. | Model: llama-3.3-70b-versatile | Trial: 8\n",
      "Saved to result/llama-3_3-70b-versatile/trial_8/list_of_drugs_and_approval_status_for_de.xlsx\n",
      "Processing: What drugs target the JAKSTAT pathway in atopic dermatitis? | Model: llama-3.3-70b-versatile | Trial: 8\n",
      "Saved to result/llama-3_3-70b-versatile/trial_8/what_drugs_target_the_jak_stat_pathway_i.xlsx\n",
      "Processing: Diseases associated with the gene KRAS. | Model: llama-3.3-70b-versatile | Trial: 8\n",
      "Saved to result/llama-3_3-70b-versatile/trial_8/diseases_associated_with_the_gene_kras.xlsx\n",
      "Processing: Biomarkers for early detection of ovarian cancer. | Model: llama-3.3-70b-versatile | Trial: 8\n",
      "Saved to result/llama-3_3-70b-versatile/trial_8/biomarkers_for_early_detection_of_ovaria.xlsx\n",
      "Processing: Which drugs act as BCR-ABL inhibitors? | Model: llama-3.3-70b-versatile | Trial: 8\n",
      "Saved to result/llama-3_3-70b-versatile/trial_8/which_drugs_act_as_bcr-abl_inhibitors.xlsx\n",
      "Processing: Drugs for idiopathic pulmonary fibrosis and their approval status. | Model: llama-3.3-70b-versatile | Trial: 8\n",
      "Saved to result/llama-3_3-70b-versatile/trial_8/drugs_for_idiopathic_pulmonary_fibrosis.xlsx\n",
      "Processing: What are the mechanisms of action for monoclonal antibodies targeting IL-6? | Model: llama-3.3-70b-versatile | Trial: 8\n",
      "Saved to result/llama-3_3-70b-versatile/trial_8/what_are_the_mechanisms_of_action_for_mo.xlsx\n",
      "Processing: Which approved drugs are used for treating osteoporosis? | Model: llama-3.3-70b-versatile | Trial: 8\n",
      "Saved to result/llama-3_3-70b-versatile/trial_8/which_approved_drugs_are_used_for_treati.xlsx\n",
      "Processing: What are the targets and mechanisms for dupilumab? | Model: llama-3.3-70b-versatile | Trial: 8\n",
      "Saved to result/llama-3_3-70b-versatile/trial_8/what_are_the_targets_and_mechanisms_for.xlsx\n",
      "Processing: Provide drugs approved for renal cell carcinoma with their target names. | Model: llama-3.3-70b-versatile | Trial: 8\n",
      "Saved to result/llama-3_3-70b-versatile/trial_8/provide_drugs_approved_for_renal_cell_ca.xlsx\n",
      "Processing: List pathways implicated in prostate cancer. | Model: llama-3.3-70b-versatile | Trial: 8\n",
      "Saved to result/llama-3_3-70b-versatile/trial_8/list_pathways_implicated_in_prostate_can.xlsx\n",
      "Processing: What are the approved drugs for EGFR exon 20 insertionmutant lung cancer? | Model: llama-3.3-70b-versatile | Trial: 8\n",
      "Saved to result/llama-3_3-70b-versatile/trial_8/what_are_the_approved_drugs_for_egfr_exo.xlsx\n",
      "Processing: List all TRK inhibitors used for treating NTRK-fusion cancers. | Model: llama-3.3-70b-versatile | Trial: 8\n",
      "Saved to result/llama-3_3-70b-versatile/trial_8/list_all_trk_inhibitors_used_for_treatin.xlsx\n",
      "Processing: What is the mechanism of action of darolutamide? | Model: llama-3.3-70b-versatile | Trial: 8\n",
      "Saved to result/llama-3_3-70b-versatile/trial_8/what_is_the_mechanism_of_action_of_darol.xlsx\n",
      "Processing: Which genes are targeted by monoclonal antibodies in oncology immunotherapy? | Model: llama-3.3-70b-versatile | Trial: 8\n",
      "Saved to result/llama-3_3-70b-versatile/trial_8/which_genes_are_targeted_by_monoclonal_a.xlsx\n",
      "Processing: What drugs are used to treat fever? | Model: llama-3.3-70b-versatile | Trial: 8\n",
      "Saved to result/llama-3_3-70b-versatile/trial_8/what_drugs_are_used_to_treat_fever.xlsx\n",
      "Processing: What are the approved drugs for triple-negative breast cancer? | Model: llama-3.3-70b-versatile | Trial: 9\n",
      "Saved to result/llama-3_3-70b-versatile/trial_9/what_are_the_approved_drugs_for_triple-n.xlsx\n",
      "Processing: List all ALK inhibitors used for treating non-small cell lung cancer. | Model: llama-3.3-70b-versatile | Trial: 9\n",
      "Saved to result/llama-3_3-70b-versatile/trial_9/list_all_alk_inhibitors_used_for_treatin.xlsx\n",
      "Processing: What is the mechanism of action of nivolumab? | Model: llama-3.3-70b-versatile | Trial: 9\n",
      "Saved to result/llama-3_3-70b-versatile/trial_9/what_is_the_mechanism_of_action_of_nivol.xlsx\n",
      "Processing: Drugs with approval status for hepatitis C virus infection. | Model: llama-3.3-70b-versatile | Trial: 9\n",
      "Saved to result/llama-3_3-70b-versatile/trial_9/drugs_with_approval_status_for_hepatitis.xlsx\n",
      "Processing: Biomarkers associated with the PI3KAKT pathway in breast cancer. | Model: llama-3.3-70b-versatile | Trial: 9\n",
      "Saved to result/llama-3_3-70b-versatile/trial_9/biomarkers_associated_with_the_pi3k_akt.xlsx\n",
      "Processing: Show drugs that inhibit the KRAS G12C variant. | Model: llama-3.3-70b-versatile | Trial: 9\n",
      "Saved to result/llama-3_3-70b-versatile/trial_9/show_drugs_that_inhibit_the_kras_g12c_va.xlsx\n",
      "Processing: What diseases are treated with atezolizumab? | Model: llama-3.3-70b-versatile | Trial: 9\n",
      "Saved to result/llama-3_3-70b-versatile/trial_9/what_diseases_are_treated_with_atezolizu.xlsx\n",
      "Processing: Which pathways are targeted by PARP inhibitors? | Model: llama-3.3-70b-versatile | Trial: 9\n",
      "Saved to result/llama-3_3-70b-versatile/trial_9/which_pathways_are_targeted_by_parp_inhi.xlsx\n",
      "Processing: Approved drugs for multiple sclerosis and their mechanisms of action. | Model: llama-3.3-70b-versatile | Trial: 9\n",
      "Saved to result/llama-3_3-70b-versatile/trial_9/approved_drugs_for_multiple_sclerosis_an.xlsx\n",
      "Processing: What are the known targets of sunitinib? | Model: llama-3.3-70b-versatile | Trial: 9\n",
      "Saved to result/llama-3_3-70b-versatile/trial_9/what_are_the_known_targets_of_sunitinib.xlsx\n",
      "Processing: Provide the SMILES for dasatinib. | Model: llama-3.3-70b-versatile | Trial: 9\n",
      "----- Some error occured-----\n",
      "Processing: Provide the SMILES for dasatinib. | Model: llama-3.3-70b-versatile | Trial: 9\n",
      "Processing: Genes linked to amyotrophic lateral sclerosis. | Model: llama-3.3-70b-versatile | Trial: 9\n",
      "Saved to result/llama-3_3-70b-versatile/trial_9/genes_linked_to_amyotrophic_lateral_scle.xlsx\n",
      "Processing: List of drugs and approval status for malaria. | Model: llama-3.3-70b-versatile | Trial: 9\n",
      "Saved to result/llama-3_3-70b-versatile/trial_9/list_of_drugs_and_approval_status_for_ma.xlsx\n",
      "Processing: What drugs target the JAKSTAT pathway in myelofibrosis? | Model: llama-3.3-70b-versatile | Trial: 9\n",
      "Saved to result/llama-3_3-70b-versatile/trial_9/what_drugs_target_the_jak_stat_pathway_i.xlsx\n",
      "Processing: Diseases associated with the gene BRCA1. | Model: llama-3.3-70b-versatile | Trial: 9\n",
      "Saved to result/llama-3_3-70b-versatile/trial_9/diseases_associated_with_the_gene_brca1.xlsx\n",
      "Processing: Biomarkers for early detection of pancreatic cancer. | Model: llama-3.3-70b-versatile | Trial: 9\n",
      "Saved to result/llama-3_3-70b-versatile/trial_9/biomarkers_for_early_detection_of_pancre.xlsx\n",
      "Processing: Which drugs act as VEGF inhibitors? | Model: llama-3.3-70b-versatile | Trial: 9\n",
      "Saved to result/llama-3_3-70b-versatile/trial_9/which_drugs_act_as_vegf_inhibitors.xlsx\n",
      "Processing: Drugs for chronic hepatitis B and their approval status. | Model: llama-3.3-70b-versatile | Trial: 9\n",
      "Saved to result/llama-3_3-70b-versatile/trial_9/drugs_for_chronic_hepatitis_b_and_their.xlsx\n",
      "Processing: What are the mechanisms of action for beta-lactam antibiotics? | Model: llama-3.3-70b-versatile | Trial: 9\n",
      "Saved to result/llama-3_3-70b-versatile/trial_9/what_are_the_mechanisms_of_action_for_be.xlsx\n",
      "Processing: Which approved drugs are used for treating rheumatoid arthritis? | Model: llama-3.3-70b-versatile | Trial: 9\n",
      "Saved to result/llama-3_3-70b-versatile/trial_9/which_approved_drugs_are_used_for_treati.xlsx\n",
      "Processing: What are the targets and mechanisms for dulaglutide? | Model: llama-3.3-70b-versatile | Trial: 9\n",
      "Saved to result/llama-3_3-70b-versatile/trial_9/what_are_the_targets_and_mechanisms_for.xlsx\n",
      "Processing: Provide drugs approved for ovarian cancer with their target names. | Model: llama-3.3-70b-versatile | Trial: 9\n",
      "Saved to result/llama-3_3-70b-versatile/trial_9/provide_drugs_approved_for_ovarian_cance.xlsx\n",
      "Processing: List pathways implicated in chronic lymphocytic leukemia. | Model: llama-3.3-70b-versatile | Trial: 9\n",
      "Saved to result/llama-3_3-70b-versatile/trial_9/list_pathways_implicated_in_chronic_lymp.xlsx\n",
      "Processing: What are the approved drugs for HER2-low breast cancer? | Model: llama-3.3-70b-versatile | Trial: 9\n",
      "Saved to result/llama-3_3-70b-versatile/trial_9/what_are_the_approved_drugs_for_her2-low.xlsx\n",
      "Processing: List all BTK inhibitors used for treating mantle cell lymphoma. | Model: llama-3.3-70b-versatile | Trial: 9\n",
      "Saved to result/llama-3_3-70b-versatile/trial_9/list_all_btk_inhibitors_used_for_treatin.xlsx\n",
      "Processing: What is the mechanism of action of pembrolizumab? | Model: llama-3.3-70b-versatile | Trial: 9\n",
      "Saved to result/llama-3_3-70b-versatile/trial_9/what_is_the_mechanism_of_action_of_pembr.xlsx\n",
      "Processing: Which genes are targeted by monoclonal antibodies in psoriasis? | Model: llama-3.3-70b-versatile | Trial: 9\n",
      "Saved to result/llama-3_3-70b-versatile/trial_9/which_genes_are_targeted_by_monoclonal_a.xlsx\n",
      "Processing: Drugs with approval status for HIV/AIDS. | Model: llama-3.3-70b-versatile | Trial: 9\n",
      "Saved to result/llama-3_3-70b-versatile/trial_9/drugs_with_approval_status_for_hiv_aids.xlsx\n",
      "Processing: Biomarkers associated with the RASRAFMEK pathway in colorectal cancer. | Model: llama-3.3-70b-versatile | Trial: 9\n",
      "Saved to result/llama-3_3-70b-versatile/trial_9/biomarkers_associated_with_the_ras_raf_m.xlsx\n",
      "Processing: Show drugs that inhibit the IDH1 gene. | Model: llama-3.3-70b-versatile | Trial: 9\n",
      "Saved to result/llama-3_3-70b-versatile/trial_9/show_drugs_that_inhibit_the_idh1_gene.xlsx\n",
      "Processing: What diseases are treated with durvalumab? | Model: llama-3.3-70b-versatile | Trial: 9\n",
      "Saved to result/llama-3_3-70b-versatile/trial_9/what_diseases_are_treated_with_durvaluma.xlsx\n",
      "Processing: Which pathways are targeted by MEK inhibitors? | Model: llama-3.3-70b-versatile | Trial: 9\n",
      "Saved to result/llama-3_3-70b-versatile/trial_9/which_pathways_are_targeted_by_mek_inhib.xlsx\n",
      "Processing: Approved drugs for ulcerative colitis and their mechanisms of action. | Model: llama-3.3-70b-versatile | Trial: 9\n",
      "Saved to result/llama-3_3-70b-versatile/trial_9/approved_drugs_for_ulcerative_colitis_an.xlsx\n",
      "Processing: What are the known targets of regorafenib? | Model: llama-3.3-70b-versatile | Trial: 9\n",
      "Saved to result/llama-3_3-70b-versatile/trial_9/what_are_the_known_targets_of_regorafeni.xlsx\n",
      "Processing: Provide the SMILES for erlotinib. | Model: llama-3.3-70b-versatile | Trial: 9\n",
      "----- Some error occured-----\n",
      "Processing: Provide the SMILES for erlotinib. | Model: llama-3.3-70b-versatile | Trial: 9\n",
      "Processing: Genes linked to Parkinsons disease. | Model: llama-3.3-70b-versatile | Trial: 9\n",
      "Saved to result/llama-3_3-70b-versatile/trial_9/genes_linked_to_parkinson_s_disease.xlsx\n",
      "Processing: List of drugs and approval status for influenza. | Model: llama-3.3-70b-versatile | Trial: 9\n",
      "Saved to result/llama-3_3-70b-versatile/trial_9/list_of_drugs_and_approval_status_for_in.xlsx\n",
      "Processing: What drugs target the PI3K pathway in lymphoma? | Model: llama-3.3-70b-versatile | Trial: 9\n",
      "Saved to result/llama-3_3-70b-versatile/trial_9/what_drugs_target_the_pi3k_pathway_in_ly.xlsx\n",
      "Processing: Diseases associated with the gene PIK3CA. | Model: llama-3.3-70b-versatile | Trial: 9\n",
      "Saved to result/llama-3_3-70b-versatile/trial_9/diseases_associated_with_the_gene_pik3ca.xlsx\n",
      "Processing: Biomarkers for early detection of gastric cancer. | Model: llama-3.3-70b-versatile | Trial: 9\n",
      "Saved to result/llama-3_3-70b-versatile/trial_9/biomarkers_for_early_detection_of_gastri.xlsx\n",
      "Processing: Which drugs act as PD-1 inhibitors? | Model: llama-3.3-70b-versatile | Trial: 9\n",
      "Saved to result/llama-3_3-70b-versatile/trial_9/which_drugs_act_as_pd-1_inhibitors.xlsx\n",
      "Processing: Drugs for hepatitis D and their approval status. | Model: llama-3.3-70b-versatile | Trial: 9\n",
      "Saved to result/llama-3_3-70b-versatile/trial_9/drugs_for_hepatitis_d_and_their_approval.xlsx\n",
      "Processing: What are the mechanisms of action for SGLT2 inhibitors? | Model: llama-3.3-70b-versatile | Trial: 9\n",
      "Saved to result/llama-3_3-70b-versatile/trial_9/what_are_the_mechanisms_of_action_for_sg.xlsx\n",
      "Processing: Which approved drugs are used for treating systemic lupus erythematosus? | Model: llama-3.3-70b-versatile | Trial: 9\n",
      "Saved to result/llama-3_3-70b-versatile/trial_9/which_approved_drugs_are_used_for_treati.xlsx\n",
      "Processing: What are the targets and mechanisms for tofacitinib? | Model: llama-3.3-70b-versatile | Trial: 9\n",
      "Saved to result/llama-3_3-70b-versatile/trial_9/what_are_the_targets_and_mechanisms_for.xlsx\n",
      "Processing: Provide drugs approved for prostate cancer with their target names. | Model: llama-3.3-70b-versatile | Trial: 9\n",
      "Saved to result/llama-3_3-70b-versatile/trial_9/provide_drugs_approved_for_prostate_canc.xlsx\n",
      "Processing: List pathways implicated in glioblastoma. | Model: llama-3.3-70b-versatile | Trial: 9\n",
      "Saved to result/llama-3_3-70b-versatile/trial_9/list_pathways_implicated_in_glioblastoma.xlsx\n",
      "Processing: What are the approved drugs for EGFR-mutant non-small cell lung cancer? | Model: llama-3.3-70b-versatile | Trial: 9\n",
      "Saved to result/llama-3_3-70b-versatile/trial_9/what_are_the_approved_drugs_for_egfr-mut.xlsx\n",
      "Processing: List all CDK4/6 inhibitors used for treating breast cancer. | Model: llama-3.3-70b-versatile | Trial: 9\n",
      "Saved to result/llama-3_3-70b-versatile/trial_9/list_all_cdk4_6_inhibitors_used_for_trea.xlsx\n",
      "Processing: What is the mechanism of action of osimertinib? | Model: llama-3.3-70b-versatile | Trial: 9\n",
      "Saved to result/llama-3_3-70b-versatile/trial_9/what_is_the_mechanism_of_action_of_osime.xlsx\n",
      "Processing: Which genes are targeted by monoclonal antibodies in asthma? | Model: llama-3.3-70b-versatile | Trial: 9\n",
      "Saved to result/llama-3_3-70b-versatile/trial_9/which_genes_are_targeted_by_monoclonal_a.xlsx\n",
      "Processing: Drugs with approval status for Clostridioides difficile infection. | Model: llama-3.3-70b-versatile | Trial: 9\n",
      "Saved to result/llama-3_3-70b-versatile/trial_9/drugs_with_approval_status_for_clostridi.xlsx\n",
      "Processing: Biomarkers associated with the WNT/ß-catenin pathway in cancer. | Model: llama-3.3-70b-versatile | Trial: 9\n",
      "Saved to result/llama-3_3-70b-versatile/trial_9/biomarkers_associated_with_the_wnt__-cat.xlsx\n",
      "Processing: Show drugs that inhibit the FGFR2 gene. | Model: llama-3.3-70b-versatile | Trial: 9\n",
      "Saved to result/llama-3_3-70b-versatile/trial_9/show_drugs_that_inhibit_the_fgfr2_gene.xlsx\n",
      "Processing: What diseases are treated with bevacizumab? | Model: llama-3.3-70b-versatile | Trial: 9\n",
      "Saved to result/llama-3_3-70b-versatile/trial_9/what_diseases_are_treated_with_bevacizum.xlsx\n",
      "Processing: Which pathways are targeted by mTOR inhibitors? | Model: llama-3.3-70b-versatile | Trial: 9\n",
      "Saved to result/llama-3_3-70b-versatile/trial_9/which_pathways_are_targeted_by_mtor_inhi.xlsx\n",
      "Processing: Approved drugs for plaque psoriasis and their mechanisms of action. | Model: llama-3.3-70b-versatile | Trial: 9\n",
      "Saved to result/llama-3_3-70b-versatile/trial_9/approved_drugs_for_plaque_psoriasis_and.xlsx\n",
      "Processing: What are the known targets of cabozantinib? | Model: llama-3.3-70b-versatile | Trial: 9\n",
      "Saved to result/llama-3_3-70b-versatile/trial_9/what_are_the_known_targets_of_cabozantin.xlsx\n",
      "Processing: Provide the SMILES for gefitinib. | Model: llama-3.3-70b-versatile | Trial: 9\n",
      "Saved to result/llama-3_3-70b-versatile/trial_9/provide_the_smiles_for_gefitinib.xlsx\n",
      "Processing: Genes linked to Crohns disease. | Model: llama-3.3-70b-versatile | Trial: 9\n",
      "Saved to result/llama-3_3-70b-versatile/trial_9/genes_linked_to_crohn_s_disease.xlsx\n",
      "Processing: List of drugs and approval status for respiratory syncytial virus infection. | Model: llama-3.3-70b-versatile | Trial: 9\n",
      "Saved to result/llama-3_3-70b-versatile/trial_9/list_of_drugs_and_approval_status_for_re.xlsx\n",
      "Processing: What drugs target the Hedgehog pathway in oncology? | Model: llama-3.3-70b-versatile | Trial: 9\n",
      "Saved to result/llama-3_3-70b-versatile/trial_9/what_drugs_target_the_hedgehog_pathway_i.xlsx\n",
      "Processing: Diseases associated with the gene NPM1. | Model: llama-3.3-70b-versatile | Trial: 9\n",
      "Saved to result/llama-3_3-70b-versatile/trial_9/diseases_associated_with_the_gene_npm1.xlsx\n",
      "Processing: Biomarkers for early detection of hepatocellular carcinoma. | Model: llama-3.3-70b-versatile | Trial: 9\n",
      "Saved to result/llama-3_3-70b-versatile/trial_9/biomarkers_for_early_detection_of_hepato.xlsx\n",
      "Processing: Which drugs act as CTLA-4 inhibitors? | Model: llama-3.3-70b-versatile | Trial: 9\n",
      "Saved to result/llama-3_3-70b-versatile/trial_9/which_drugs_act_as_ctla-4_inhibitors.xlsx\n",
      "Processing: Drugs for pulmonary arterial hypertension and their approval status. | Model: llama-3.3-70b-versatile | Trial: 9\n",
      "Saved to result/llama-3_3-70b-versatile/trial_9/drugs_for_pulmonary_arterial_hypertensio.xlsx\n",
      "Processing: What are the mechanisms of action for ACE inhibitors? | Model: llama-3.3-70b-versatile | Trial: 9\n",
      "Saved to result/llama-3_3-70b-versatile/trial_9/what_are_the_mechanisms_of_action_for_ac.xlsx\n",
      "Processing: Which approved drugs are used for treating migraine? | Model: llama-3.3-70b-versatile | Trial: 9\n",
      "Saved to result/llama-3_3-70b-versatile/trial_9/which_approved_drugs_are_used_for_treati.xlsx\n",
      "Processing: What are the targets and mechanisms for rituximab? | Model: llama-3.3-70b-versatile | Trial: 9\n",
      "Saved to result/llama-3_3-70b-versatile/trial_9/what_are_the_targets_and_mechanisms_for.xlsx\n",
      "Processing: Provide drugs approved for colorectal cancer with their target names. | Model: llama-3.3-70b-versatile | Trial: 9\n",
      "Saved to result/llama-3_3-70b-versatile/trial_9/provide_drugs_approved_for_colorectal_ca.xlsx\n",
      "Processing: List pathways implicated in myelodysplastic syndromes. | Model: llama-3.3-70b-versatile | Trial: 9\n",
      "Saved to result/llama-3_3-70b-versatile/trial_9/list_pathways_implicated_in_myelodysplas.xlsx\n",
      "Processing: What are the approved drugs for BRAF V600Emutant melanoma? | Model: llama-3.3-70b-versatile | Trial: 9\n",
      "Saved to result/llama-3_3-70b-versatile/trial_9/what_are_the_approved_drugs_for_braf_v60.xlsx\n",
      "Processing: List all FLT3 inhibitors used for treating acute myeloid leukemia. | Model: llama-3.3-70b-versatile | Trial: 9\n",
      "Saved to result/llama-3_3-70b-versatile/trial_9/list_all_flt3_inhibitors_used_for_treati.xlsx\n",
      "Processing: What is the mechanism of action of lenvatinib? | Model: llama-3.3-70b-versatile | Trial: 9\n",
      "Saved to result/llama-3_3-70b-versatile/trial_9/what_is_the_mechanism_of_action_of_lenva.xlsx\n",
      "Processing: Which genes are targeted by monoclonal antibodies in multiple sclerosis? | Model: llama-3.3-70b-versatile | Trial: 9\n",
      "Saved to result/llama-3_3-70b-versatile/trial_9/which_genes_are_targeted_by_monoclonal_a.xlsx\n",
      "Processing: Drugs with approval status for leprosy. | Model: llama-3.3-70b-versatile | Trial: 9\n",
      "Saved to result/llama-3_3-70b-versatile/trial_9/drugs_with_approval_status_for_leprosy.xlsx\n",
      "Processing: Biomarkers associated with the TGF-ß pathway in fibrosis. | Model: llama-3.3-70b-versatile | Trial: 9\n",
      "Saved to result/llama-3_3-70b-versatile/trial_9/biomarkers_associated_with_the_tgf-__pat.xlsx\n",
      "Processing: Show drugs that inhibit the RET gene. | Model: llama-3.3-70b-versatile | Trial: 9\n",
      "Saved to result/llama-3_3-70b-versatile/trial_9/show_drugs_that_inhibit_the_ret_gene.xlsx\n",
      "Processing: What diseases are treated with trastuzumab deruxtecan? | Model: llama-3.3-70b-versatile | Trial: 9\n",
      "Saved to result/llama-3_3-70b-versatile/trial_9/what_diseases_are_treated_with_trastuzum.xlsx\n",
      "Processing: Which pathways are targeted by PI3K inhibitors? | Model: llama-3.3-70b-versatile | Trial: 9\n",
      "Saved to result/llama-3_3-70b-versatile/trial_9/which_pathways_are_targeted_by_pi3k_inhi.xlsx\n",
      "Processing: Approved drugs for atopic dermatitis and their mechanisms of action. | Model: llama-3.3-70b-versatile | Trial: 9\n",
      "Saved to result/llama-3_3-70b-versatile/trial_9/approved_drugs_for_atopic_dermatitis_and.xlsx\n",
      "Processing: What are the known targets of vandetanib? | Model: llama-3.3-70b-versatile | Trial: 9\n",
      "Saved to result/llama-3_3-70b-versatile/trial_9/what_are_the_known_targets_of_vandetanib.xlsx\n",
      "Processing: Provide the SMILES for sorafenib. | Model: llama-3.3-70b-versatile | Trial: 9\n",
      "----- Some error occured-----\n",
      "Processing: Provide the SMILES for sorafenib. | Model: llama-3.3-70b-versatile | Trial: 9\n",
      "Processing: Genes linked to schizophrenia. | Model: llama-3.3-70b-versatile | Trial: 9\n",
      "Saved to result/llama-3_3-70b-versatile/trial_9/genes_linked_to_schizophrenia.xlsx\n",
      "Processing: List of drugs and approval status for dengue. | Model: llama-3.3-70b-versatile | Trial: 9\n",
      "Saved to result/llama-3_3-70b-versatile/trial_9/list_of_drugs_and_approval_status_for_de.xlsx\n",
      "Processing: What drugs target the JAKSTAT pathway in atopic dermatitis? | Model: llama-3.3-70b-versatile | Trial: 9\n",
      "Saved to result/llama-3_3-70b-versatile/trial_9/what_drugs_target_the_jak_stat_pathway_i.xlsx\n",
      "Processing: Diseases associated with the gene KRAS. | Model: llama-3.3-70b-versatile | Trial: 9\n",
      "Saved to result/llama-3_3-70b-versatile/trial_9/diseases_associated_with_the_gene_kras.xlsx\n",
      "Processing: Biomarkers for early detection of ovarian cancer. | Model: llama-3.3-70b-versatile | Trial: 9\n",
      "Saved to result/llama-3_3-70b-versatile/trial_9/biomarkers_for_early_detection_of_ovaria.xlsx\n",
      "Processing: Which drugs act as BCR-ABL inhibitors? | Model: llama-3.3-70b-versatile | Trial: 9\n",
      "Saved to result/llama-3_3-70b-versatile/trial_9/which_drugs_act_as_bcr-abl_inhibitors.xlsx\n",
      "Processing: Drugs for idiopathic pulmonary fibrosis and their approval status. | Model: llama-3.3-70b-versatile | Trial: 9\n",
      "Saved to result/llama-3_3-70b-versatile/trial_9/drugs_for_idiopathic_pulmonary_fibrosis.xlsx\n",
      "Processing: What are the mechanisms of action for monoclonal antibodies targeting IL-6? | Model: llama-3.3-70b-versatile | Trial: 9\n",
      "Saved to result/llama-3_3-70b-versatile/trial_9/what_are_the_mechanisms_of_action_for_mo.xlsx\n",
      "Processing: Which approved drugs are used for treating osteoporosis? | Model: llama-3.3-70b-versatile | Trial: 9\n",
      "Saved to result/llama-3_3-70b-versatile/trial_9/which_approved_drugs_are_used_for_treati.xlsx\n",
      "Processing: What are the targets and mechanisms for dupilumab? | Model: llama-3.3-70b-versatile | Trial: 9\n",
      "Saved to result/llama-3_3-70b-versatile/trial_9/what_are_the_targets_and_mechanisms_for.xlsx\n",
      "Processing: Provide drugs approved for renal cell carcinoma with their target names. | Model: llama-3.3-70b-versatile | Trial: 9\n",
      "Saved to result/llama-3_3-70b-versatile/trial_9/provide_drugs_approved_for_renal_cell_ca.xlsx\n",
      "Processing: List pathways implicated in prostate cancer. | Model: llama-3.3-70b-versatile | Trial: 9\n",
      "Saved to result/llama-3_3-70b-versatile/trial_9/list_pathways_implicated_in_prostate_can.xlsx\n",
      "Processing: What are the approved drugs for EGFR exon 20 insertionmutant lung cancer? | Model: llama-3.3-70b-versatile | Trial: 9\n",
      "Saved to result/llama-3_3-70b-versatile/trial_9/what_are_the_approved_drugs_for_egfr_exo.xlsx\n",
      "Processing: List all TRK inhibitors used for treating NTRK-fusion cancers. | Model: llama-3.3-70b-versatile | Trial: 9\n",
      "Saved to result/llama-3_3-70b-versatile/trial_9/list_all_trk_inhibitors_used_for_treatin.xlsx\n",
      "Processing: What is the mechanism of action of darolutamide? | Model: llama-3.3-70b-versatile | Trial: 9\n",
      "Saved to result/llama-3_3-70b-versatile/trial_9/what_is_the_mechanism_of_action_of_darol.xlsx\n",
      "Processing: Which genes are targeted by monoclonal antibodies in oncology immunotherapy? | Model: llama-3.3-70b-versatile | Trial: 9\n",
      "Saved to result/llama-3_3-70b-versatile/trial_9/which_genes_are_targeted_by_monoclonal_a.xlsx\n",
      "Processing: What drugs are used to treat fever? | Model: llama-3.3-70b-versatile | Trial: 9\n",
      "Saved to result/llama-3_3-70b-versatile/trial_9/what_drugs_are_used_to_treat_fever.xlsx\n"
     ]
    }
   ],
   "source": [
    "os.makedirs(root_folder, exist_ok=True)\n",
    "\n",
    "global_metrics = []\n",
    "\n",
    "for model in models:\n",
    "\n",
    "    try:\n",
    "        model_folder = os.path.join(root_folder, safe_filename(model))\n",
    "        os.makedirs(model_folder, exist_ok=True)\n",
    "\n",
    "        for trial_number in trial_numbers:\n",
    "            try:\n",
    "                trial_folder = os.path.join(model_folder, f\"trial_{trial_number}\")\n",
    "                os.makedirs(trial_folder, exist_ok=True)\n",
    "\n",
    "                for i in range(df.shape[0]):\n",
    "\n",
    "                    try:\n",
    "                        question = df.loc[i, 'Question']\n",
    "                        print(f\"Processing: {question} | Model: {model} | Trial: {trial_number}\")\n",
    "\n",
    "                        start_time = time.time()\n",
    "                        completion = client.chat.completions.create(\n",
    "                            messages=[\n",
    "                                {\"role\": \"system\", \"content\": system_prompt},\n",
    "                                {\"role\": \"user\", \"content\": question}\n",
    "                            ],\n",
    "                            model=model,\n",
    "                            temperature=0,\n",
    "                            max_completion_tokens=8192,\n",
    "                            stream=False,\n",
    "                            stop=None\n",
    "                        )\n",
    "                        elapsed = time.time() - start_time\n",
    "\n",
    "                        response_text = completion.choices[0].message.content\n",
    "                        table = parse_markdown_table(response_text)\n",
    "                        num_rows = len(table) - 1 if len(table) > 1 else 0\n",
    "\n",
    "                        base_filename = safe_filename(question.lower().replace(\" \", \"_\"))\n",
    "                        excel_filename = os.path.join(trial_folder, f\"{base_filename}.xlsx\")\n",
    "\n",
    "                        df_table = pd.DataFrame(table[1:], columns=table[0]) if num_rows > 0 else pd.DataFrame()\n",
    "                        df_metrics = pd.DataFrame(\n",
    "                            {\n",
    "                                \"Metric\": [\"Rows Retrieved\", \"Time Taken (s)\"],\n",
    "                                \"Value\": [num_rows, round(elapsed, 4)],\n",
    "                                \"trial\": trial_number,\n",
    "                                \"model\": model,\n",
    "                                \"question\": question\n",
    "                            }\n",
    "                        )\n",
    "\n",
    "                        with pd.ExcelWriter(excel_filename, engine='openpyxl') as writer:\n",
    "                            if not df_table.empty:\n",
    "                                df_table.to_excel(writer, sheet_name=\"Table\", index=False)\n",
    "                            df_metrics.to_excel(writer, sheet_name=\"Metrics\", index=False)\n",
    "\n",
    "                        # For the global summary, add one row per question/trial/model\n",
    "                        global_metrics.append({\n",
    "                            \"question\": question,\n",
    "                            \"model\": model,\n",
    "                            \"trial\": trial_number,\n",
    "                            \"rows_retrieved\": num_rows,\n",
    "                            \"time_taken_s\": round(elapsed, 4)\n",
    "                        })\n",
    "\n",
    "                        print(f\"Saved to {excel_filename}\")\n",
    "\n",
    "                    except:\n",
    "\n",
    "                        print(\"----- Some error occured-----\")\n",
    "                        print(f\"Processing: {question} | Model: {model} | Trial: {trial_number}\")\n",
    "\n",
    "                        continue\n",
    "\n",
    "                \n",
    "            except:\n",
    "\n",
    "                print(\"----- Some error occured-----\")\n",
    "                print(f\"Processing: {question} | Model: {model} | Trial: {trial_number}\")\n",
    "\n",
    "                continue\n",
    "\n",
    "\n",
    "    except:\n",
    "\n",
    "        print(\"----- Some error occured-----\")\n",
    "        print(f\"Processing: {question} | Model: {model} | Trial: {trial_number}\")\n",
    "\n",
    "        continue\n",
    "\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 10,
   "id": "ab9111bd",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Global summary saved to all_trials_summary.xlsx\n"
     ]
    }
   ],
   "source": [
    "\n",
    "# At the end, save the summary table\n",
    "df_global = pd.DataFrame(global_metrics)\n",
    "df_global.to_excel(os.path.join(root_folder, \"all_trials_summary.xlsx\"), index=False)\n",
    "print(\"Global summary saved to all_trials_summary.xlsx\")"
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "ttd3",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.10.16"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 5
}
